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ABSTRACT 
Apoptosis-induced compensatory proliferation (AiP) is a mechanism that maintains 
tissue homeostasis after stress-induced cell death. During AiP, apoptotic cells induce 
proliferation of the neighboring surviving cells to compensate for tissue loss. AiP is 
important for wound healing and tissue regeneration in several model organisms. 
Additionally, AiP is an important feature of tumorigenesis and tumor relapse as it 
contributes to tumor repopulation following radiation or chemotherapy. Using an 
overgrowth tumor model (“undead tissue”) in Drosophila melanogaster, we determined 
that the initiator caspase Dronc promotes generation of extracellular Reactive Oxygen 
Species (ROS), which drive activation of the stress kinase JNK and downstream mitogens 
to promote AiP. We also observed increased numbers of Drosophila macrophages, termed 
hemocytes, which are attracted to undead tissue. However, the specific mechanisms by 
which macrophages are recruited to undead tissue are still unclear. 
Here, we report that the tissue microenvironment of the overgrown undead tissue 
directs macrophage recruitment during AiP. We demonstrate that ROS, JNK, and the 
matrix metalloproteinase Mmp2 are important for recruiting macrophages. 
Mechanistically, undead tissue-produced ROS and active JNK damage the basement 
membrane (BM) surrounding the undead tissue, by upregulating the expression and activity 
of Mmp2. The damaged BM then recruits macrophages to the undead tissue. Taken 
together, we propose a model in which the ROS-JNK-Mmp2 signaling axis damages the 
BM of undead tissue, resulting in changes in the tissue microenvironment that recruit 
macrophages to the area of damage to promote AiP and overgrowth.   
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CHAPTER I: 
 
INTRODUCTION 
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Diwanji N., Bergmann A. (2019) Two Sides of the Same Coin – Compensatory 
Proliferation in Regeneration and Cancer. In: Deng WM. (eds) The Drosophila Model in 
Cancer. Advances in Experimental Medicine and Biology, vol 1167. Springer, Cham 
(https://doi.org/10.1007/978-3-030-23629-8_4)  
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Apoptosis: An Introduction 
A fine balance between cell survival and cell death is necessary for proper 
development of an organism. Over the past decades, it has become evident that cell death 
is a tightly regulated and programmed process. Many different mechanisms of programmed 
cell death (PCD) have been reported such as apoptosis, autophagy and regulated 
necrosis/necroptosis [1-3]. Among these, apoptosis is the best studied and evolutionarily 
most conserved form of PCD, important during development and for maintaining 
homeostasis [4, 5]. Ultrastructural studies have helped define the characteristic features of 
apoptotic cell death under physiological conditions [6]. Morphological hallmarks of 
apoptosis include cytoplasmic shrinkage, DNA condensation and nuclear fragmentation, 
retention of membrane integrity, and membrane blebbing to form apoptotic bodies that are 
rapidly engulfed and eliminated by phagocytosis without an inflammatory response [4, 6]. 
Another aspect that makes apoptotic cell death non-inflammatory is that in the dying cells 
production of type I interferons is actively inhibited by blocking activation of the STING 
pathway following exposure to damage-associated molecular patterns (DAMPs) [7, 8]. 
Thus, apoptosis is considered an “immunologically silent” form of cell death, in contrast 
to necrosis during which cells swell and rupture in response to overwhelming damage, 
causing an acute inflammatory response.  
Caspases 
Mechanistically, apoptosis requires the activation of caspases, a class of cysteine 
proteases that are present in the cells as inactive zymogens [9, 10]. The role of caspases in 
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apoptosis was first discovered in Caenorhabditis elegans by the pioneering work of 
Horvitz and colleagues [11, 12]. Since then, many caspases in different model organisms 
have been discovered – Caenorhabditis elegans has 4 caspases, Drosophila melanogaster 
has 7 caspases, mice and humans contain 11 and 13 caspases, respectively [13, 14]. 
Apoptotic caspases are subdivided into two categories based on their location in the 
signaling pathway: upstream initiator or apical caspases, which include caspase-2, -8, -9, -
10 in mammals and Dronc in Drosophila, and downstream effector or executioner caspases 
including caspase-3, -6, -7 in mammals as well as DrICE and Dcp-1 in Drosophila (Figure 
1.1) [10, 15]. Initiator caspases are defined by their long N-terminal prodomains containing 
motifs such as the caspase recruitment domain (CARD) or the death effector domain 
(DED), which mediate multimerization and activation of these enzymes by enabling their 
recruitment into large protein complexes, like the apoptosome or the DISC (death-inducing 
signaling complex). In contrast, effector caspases have short prodomains without known 
protein/protein interaction motifs and are activated through cleavage by initiator caspases 
generating large and small subunits, two of each forming the active caspase tetramer [14, 
16, 17].  
Caspase activation 
Activation of caspases is the result of a signaling cascade that is triggered upon an 
apoptotic stimulus, either in the form of developmental, homeostatic or stress cues. 
Initiation of the apoptotic signaling cascade occurs through either the intrinsic pathway or 
the extrinsic pathway. In mammals, the intrinsic pathway is regulated by the Bcl-2 family 
of proteins and involves mitochondrial outer membrane permeabilization (MOMP)  
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Figure 1.1. The apoptotic pathways in mammals and Drosophila. 
 
A. The intrinsic and extrinsic pathways in mammals. Due to the involvement of 
mitochondria, the intrinsic pathway is also referred to as the mitochondrial pathway. 
Crosstalk between the intrinsic and extrinsic pathways is mediated via cleavage and 
activation of the pro-apoptotic Bcl-2 family member Bid by Caspase-8.  
MOMP – Mitochondrial outer membrane permeabilization. 
 
B. The intrinsic and extrinsic pathways in Drosophila. In the intrinsic pathway, 
mitochondria serve as a platform for insertion of the IAP antagonists Reaper (Rpr), Hid 
and Grim. Crosstalk between the intrinsic and extrinsic pathway is mediated through 
JNK-induced expression of hid and reaper. 
 
Reproduced from: 
Diwanji N., Bergmann A. (2019) Two Sides of the Same Coin – Compensatory 
Proliferation in Regeneration and Cancer. In: Deng WM. (eds) The Drosophila Model in 
Cancer. Advances in Experimental Medicine and Biology, vol 1167. Springer, Cham3 
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followed by release of cytochrome c from the mitochondria (Figure 1.1A). The released 
cytochrome c associates with the scaffolding protein Apaf-1 (apoptotic protease-activating 
factor 1) to form the apoptosome, and thus activates caspase-9 (Figure 1.1A) [14]. In 
Drosophila, the pro-apoptotic factors Reaper, Hid and Grim initiate the intrinsic apoptotic 
signaling cascade by binding to the E3-ligase Drosophila Inhibitor of Apoptosis Protein1 
(D-IAP1), thereby promoting auto-ubiquitination and proteasomal degradation of D-IAP1 
(Figure 1.1B) [18-24]. This releases D-IAP1 inhibition of the initiator caspase Dronc, 
allowing the Apaf-1-related protein Dark to recruit Dronc into the apoptosome for 
activation [16, 24].  
In contrast to the intrinsic apoptotic pathway, the extrinsic pathway is initiated at 
the plasma membrane upon binding of extracellular ligands (e.g. FasL and TNF) to their 
respective transmembrane “death” receptors (Fas for FasL, TNFR for TNF) (Figure 1.1A). 
This leads to trimerization of the receptors promoting clustering of intracellular adaptor 
proteins (e.g., FADD (Fas-associated death domain-containing protein)), which bind the 
DED motifs in the prodomains of the initiator caspases-8 or -10, forming the DISC which 
ultimately activates caspase-8 or -10 [10, 25]. In Drosophila, the extrinsic pathway is 
thought to be initiated by binding of the TNF homolog, Eiger, to its receptors Wengen or 
Grindelwald. However, in contrast to the extrinsic pathway in mammals, the Eiger/Wengen 
or Eiger/Grindelwald complex does not activate the caspase-8 ortholog Dredd in 
Drosophila, but rather results in activation of the stress kinase JNK (c-Jun N-terminal 
kinase) (Figure 1.1B) [26-30]. Eiger-induced cell death is in part dependent on the intrinsic 
pathway as JNK transcriptionally induces expression of the intrinsic factors Hid and 
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Reaper [28, 31], thereby activating Dronc (Figure 1.1B). Once initiator caspases are active 
via the intrinsic or extrinsic pathways, they cleave and activate effector caspases. Finally, 
active effector caspases cleave a broad range of regulatory and structural proteins (such as 
lamins [32], vimentin [33] and XK-related protein 8 (Xkr8) [34]), and important enzymes 
(such as poly(ADP-ribose) polymerase (PARP) [35] and Rho-associated kinase 1 (ROCK-
1) [36, 37]), causing nuclear condensation, DNA fragmentation, membrane blebbing and 
phosphatidylserine (PS) exposure, ultimately leading to execution of the cell (reviewed by 
[38, 39]).  
Caspase regulation 
Given the important role that caspases play in the death of cells, their activation as 
well as activity are tightly regulated. Interactions with regulatory proteins or different post-
translational modifications are shown to be important for regulation of caspases. IAPs 
(inhibitor of apoptosis) are a conserved family of proteins. They have at least one 
characteristic baculovirus IAP repeat (BIR) domain that allows protein-protein interaction 
with caspases and IAP-antagonists [40]. Few IAPs also have a C-terminal RING motif that 
allows them to function as E3 ubiquitin ligases to promote ubiquitylation of caspases [40, 
41]. The Drosophila genome encodes 4 IAP family proteins: D-IAP1, D-IAP2, dBRUCE 
and DETERIN. Of these, D-IAP1 is the most critical regulator of apoptotic caspases [24]. 
D-IAP1 has 2 BIR domains that mediates interaction with Dronc (BIR2) and DrICE and 
Dcp-1 (BIR1), while its RING domain ubiquitylates them, thereby suppressing their 
activity [42, 43]. After induction of apoptosis, the inhibitory action of D-IAP1 is 
antagonized by the IAP antagonists Reaper, Hid and Grim by binding to the BIR domains 
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and mediating auto-ubiquitylation and degradation of D-IAP1 [23]. The mammalian 
ortholog of D-IAP1, XIAP, along with its inhibitory E3 ligase function, inhibits initiator 
caspase-9 by preventing its dimerization, and inhibits effector caspases -3 and -7 by 
binding to their active sites [10]. This action of XIAP is antagonized by mitochondrial IAP-
antagonists Smac/DIABLO and Omi/HtrA2 [44, 45]. Along with cellular IAPs, caspases 
are also inhibited by some baculovirus proteins like P35 and P49 [46, 47]. P35 is a cleavage 
target of effector caspases, like DrICE, and specifically inhibits these caspases by 
irreversibly forming a stable non-functional complex with them after being cleaved [48]. 
Similar to P35, P49 is also cleaved by caspases and forms an inactive complex with them 
after cleavage, however, unlike P35, it inhibits both initiator and effector caspases [49]. In 
addition to regulatory proteins, post-translational modifications also impact caspase 
activity. Ubiquitylation of caspases by IAPs is a well-studied process. D-IAP1-mediated 
ubiquitylation of Dronc, DrICE and Dcp-1 is important for their inactivation, either by 
targeting them for degradation via the proteosomal system or by inhibiting their activation, 
for example mono-ubiquitylation of Dronc at residue K78 prevents its activation in the 
apoptosome complex [43, 50-52]. Phosphorylation is another post-translational 
modification that controls the activity of caspases, for example phosphorylation at residue 
S130 in Dronc inhibits its interaction with Dark and thereby its activation [53]. 
Additionally, caspases can also be modified by nitrosylation when intracellular nitric oxide 
(NO) levels are high [54].  
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Non-apoptotic functions of Caspases 
 In recent years, accumulating evidence suggests that in addition to 
apoptosis, caspases function in a broad range of non-apoptotic processes. Non-apoptotic 
function of caspases can be defined as the role caspases play in certain cellular processes 
that do not initiate with MOMP or require activation of death receptors; but rather involve 
the caspases to function, either independently or as part of a cascade, to regulate key non-
death events. Many studies have explored the non-apoptotic roles of caspases for immune 
regulation, cell differentiation, cell migration and invasion, maintenance of tissue integrity, 
regulation of stem cell properties, neurite pruning, non-apoptotic forms of cell death, and 
intercellular signaling processes across a myriad group of organisms, tissues and cells 
(reviewed in [1, 14, 55-58]). 
Caspases in inflammation and immunity 
 Involvement of caspases in inflammation was first described by the discovery of 
caspase-1 that is responsible for proteolytic cleavage and activation of pro-inflammatory 
cytokine IL-1β in monocytes [59]. Later it was demonstrated that caspase-1 also drives 
maturation and secretion of IL-18, which at that time was known as the “interferon-γ 
inducing factor” [60]. Caspase-1 is activated by being recruited to a large multiprotein 
complex called the ‘inflammasome’ [61]. Numerous internal or external stresses like viral 
or bacterial infections that expose PAMPs (pathogen-associated molecular patterns), or 
host-derived DAMPs lead to the assembly of inflammasome complexes. Canonical 
inflammasomes are formed by several members of the intracellular nucleotide-binding 
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domain and leucine-rich repeat containing NOD-like receptor (NLR) family, the HIN200 
family member AIM2, the TRIM family member Pyrin and the adaptor protein ASC. 
Inactive procaspase-1 is recruited to the inflammasome via its CARD domain, gets 
dimerized and becomes catalytically activated, similar to activation of caspase-9 in the 
apoptosome [62]. In addition to caspase-1, the inflammatory caspase subfamily consists of 
caspase-4, -5 and caspase-11 (in mice), however they do not function in inflammatory 
cytokine activation, but rather play a role in pyroptosis (described later) [63]. Along with 
inflammatory caspases, initiator caspase-8 also helps to regulate immune responses. 
Caspase-8 mediates cleavage and activation of pro-IL-1β, as well as its secretion by 
regulating the priming and activation of the inflammasome [64].    
 In Drosophila, the caspase-8 ortholog Dredd functions in the IMD (immune 
deficiency) pathway to mount an immune response against Gram-negative bacteria. Dredd 
is recruited by dFADD downstream of peptidoglycan activation of the pathway receptors 
PGRP-LC or –LE, and mediates cleavage and activation both IMD and the NF-κB protein 
Relish to promote expression of antimicrobial peptides [65-67].  
Caspases in non-apoptotic forms of cell death 
 Although apoptosis is a major form of programmed cell death, recent studies have 
discovered additional alternative types of programmed cell death. Autophagy, regulated 
necrosis, and pyroptosis are three non-apoptotic types of programmed cell death that 
involve caspase activity.  
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Autophagy –  
 Autophagy is a catabolic process important for cell survival as well as cell death. 
During macroautophagy (referred to here as autophagy), cargo such as cytosolic proteins 
and organelles are sequestered and surrounded by a double-membrane structure called as 
the autophagosome, which fuses with the lysosome forming autolysosome to degrade the 
cargo and recycle of the material. Autophagy is a highly conserved mechanism, and 
requires several autophagy-related (ATG) proteins for the formation and maturation of the 
autophagosome [68]. Similar to apoptosis, autophagy is regulated by a sequential cascade 
of events, and specific regulators, including caspases, mediate many steps of this cascade. 
Caspase cleavage of ATG proteins either leads to abrogation of autophagy, or helps in 
promoting it depending on the cellular context [69]. Downregulation of autophagy by 
caspases is mediated by cleavage and inactivation of different ATG proteins involved in 
the core autophagy process: Caspases-3, -6, -8, -9 and -10 cleave ATG5 and ATG6/Beclin-
1 [70-72]; Caspase-6 and -8 additionally cleave ATG3 [73, 74]; while p62 is also a potential 
substrate of caspase-6 [73]. Caspase-2 suppresses autophagy by preventing accumulation 
of ROS, which are known to downregulate mTORC and activate autophagy via AMPK 
[75, 76]. Caspases promote autophagy by varied mechanisms. Caspase-9 forms a stable 
complex with ATG7, which increases the efficiency of ATG7 to bind to ATG8/LC3, 
resulting in increased autophagosome formation. In this case, catalytic activity of caspase-
9 is not required for promoting autophagy [77]. Caspase-1 in murine hepatocytes increases 
autophagic flux by up-regulating beclin-1 following mitochondrial redox stress [78]. 
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During Drosophila oogenesis, effector caspase Dcp-1 translocates to the mitochondria to 
upregulate autophagy to promote nurse cell death [79, 80].  
Regulated Necrosis –  
 Necrosis is characterized by cellular swelling and rupture of plasma membrane that 
release cytoplasmic content. Recent evidence suggests that necrosis is genetically 
regulated, leading to coining of the term “regulated necrosis or necroptosis” [2, 81]. 
Necroptosis is dependent on activity of receptor-interacting protein kinase 1 (RIPK1) and 
RIPK3 downstream of TNF receptor 1 (TNFR1). Following TNFR1 ligation with TNF, 
RIPK1 is recruited to complex I with TRADD (TNFR1-associated death domain). This is 
followed by recruitment of RIPK3 with FADD, FLIP and procaspase-8 to form the DISC 
(also called complex IIa) [81, 82]. Caspase-8 forms a heterodimer with FLIPL and cleaves 
and inactivates RIPK1 and RIPK3, thereby preventing necroptosis [83]. When caspase-8 
is inhibited, RIPK1 and RIPK3 associate to form a complex called the necrosome [84-86], 
which initiates necroptosis and culminates with formation of plasma membrane pores and 
cell death [87, 88]. Thus, caspase-8 acts as a negative regulator of necroptosis.  
Pyroptosis –  
 Pyroptosis is an inflammatory form of programmed cell death that is important for 
killing pathogen infected cells and recruiting immune cells to the site of infection. Similar 
to necrosis, pyroptotic cell death involves cytoplasmic swelling and rupture of cell 
membrane [89]. Inflammatory caspases-1, -4 and -5 (caspase-11) are involved in 
pyroptosis. Upon microbial infection, inflammatory caspases are activated either by 
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intracellular lipopolysaccharide (LPS) binding (caspases-4, -5 or -11) or the inflammasome 
(caspase-1) [90]. Activated caspases cleave Gasdermin D (GSDMD), releasing the N-
terminal fragment of GSDMD that binds to the lipids in the plasma membrane forming 
large oligomeric pores, leading to release of inflammatory cytokines IL-1β and IL-18, and 
rapid cell lysis [91-95].   
 
Signaling by apoptotic cells 
Apoptosis is no longer regarded as a cell autonomous process, and increasing 
evidence points to apoptotic cells actively influencing their neighbors for the purpose of 
tissue homeostasis, remodeling and regeneration. Apoptotic cells are known to secrete 
“find-me” and “eat-me” signals which direct their recognition and clearance by phagocytes 
[96]. However, depending on the cellular context, apoptotic cells also secrete signals that 
affect their environment, including pro-apoptotic signals that promote additional cell death, 
or mitogenic signals that induce proliferation to compensate for the cell loss [97, 98].  
The dying cells call out to the phagocytes by releasing certain “find-me” signals, 
which are recognized by the phagocytes, thus recruiting them to the site of death [96]. 
Several “find-me” signals have been identified: extracellular nucleotides – adenine 
triphosphate (ATP) and uridine triphosphate (UTP), CX3CL1/Fractalkine, sphingosine-1-
phosphate (S1P) and lysophosphatidylcholine (LPC) [99-102]. Some of these 
chemoattractant signals are released by specific caspase activity, for example caspase-3/7-
mediated cleavage of transmembrane pannexin-1 channel leads to extracellular release of 
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cytosolic ATP and UTP nucleotides that are detected via the P2Y2 G-protein-coupled 
receptor (GPCR) on macrophages [99, 103]; cleavage of CX3CL1 during apoptosis leads 
to release of a 60kDa soluble fragment that is recognized by the CX3CR1 receptor on 
macrophages [100]; chemotactic lipid S1P is released from apoptotic cells via caspase-1 
mediated cleavage of sphingosine kinase 2 [101, 104]; and finally caspase-3 mediated 
activation of calcium-independent phospholipase A2 (iPLA2) releases LPC from dying 
cells [102]. Once phagocytes are recruited, they identify apoptotic cells by recognition of 
“eat-me” signals on their surface. A classic “eat-me” signal is the lipid phosphatidylserine 
(PS) that is exposed on the outer leaflet of the plasma membrane in apoptotic cells [105, 
106]. Translocation of PS from the inner to outer leaflet of the plasma membrane occurs 
due to effector caspase-mediated inactivation of flippase ATP11C and activation of 
scramblase Xkr8 [34, 107].    
In addition to “find-me” signals, apoptotic cells also secrete signals to induce 
apoptosis of neighboring cells. This communal death behavior is triggered by pro-apoptotic 
signals originating from the initial dying cells, which propagate the apoptotic signal 
through the tissue. Such apoptosis-induced apoptosis (AiA) phenomenon is observed in 
both Drosophila and mammals. In Drosophila wing epithelial tissue, cell death in one 
compartment induces ectopic death in another compartment via secretion of the TNF 
ortholog Eiger, which activates JNK signaling in the cells of the other compartment to 
initiate apoptosis [108]. In mice, AiA occurs during progression of the hair follicle cycle, 
which is also dependent on TNFα secretion from apoptotic cells [108].  
14 
 
Lastly, apoptotic cells are also known to induce proliferation of neighboring cells, 
a process called compensatory proliferation or apoptosis-induced proliferation (AiP) [98, 
109], which is the focus of this dissertation. Compensatory proliferation is important for 
tissue repair and regeneration. Regeneration is a process that helps restore tissue integrity 
following intense trauma, and is a fundamental property of various multicellular organisms 
[110, 111]. The earliest observation of compensatory proliferation came from studies in 
Drosophila. Haynie and Bryant demonstrated that killing 40%-60% of cells from 
Drosophila larval imaginal discs (the precursor epithelial tissue which gives rise to the 
adult structures) by lethal X-ray irradiation still yielded normal adult organs due to 
subsequent increase in proliferation among the surviving cells [112]. Studies in 
Drosophila, in conjunction with other model organisms, have contributed greatly to our 
understanding of the mechanisms involved in compensatory proliferation [98, 113].      
 
Caspase-driven Compensatory Proliferation 
Compensatory proliferation is critical for tissue repair, wound healing and 
regeneration, and as such is important for maintaining tissue homeostasis post massive cell 
loss due to stress or injury. Given the strong connection between wound repair and cancer, 
with cancers being compared to “wounds that do not heal” [114], compensatory 
proliferation seems to play a role in tumor initiation and persistence as well. In addition, 
the signaling pathways utilized by apoptotic cells during compensatory proliferation can 
be hijacked by tumorigenic cells to promote their growth and for metastasis.  
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Compensatory proliferation: Studies in Drosophila melanogaster 
In Drosophila, there are at least three distinct models of AiP: “undead”, “genuine” 
and “post-mitotic” AiP (Figure 1.2). In these AiP models, apoptosis is usually induced in 
larval eye or wing imaginal discs, either by irradiation or by expression of pro-apoptotic 
factors (hid, reaper or eiger), and the signaling events in apoptotic cells are studied. These 
studies in Drosophila provided mechanistic insights into the AiP process and demonstrated 
that active caspases are important for promoting AiP [115, 116]. They established the role 
of the initiator caspase Dronc for inducing mitogenic signaling independently of its role in 
apoptosis, at least for “undead” AiP and possibly also “genuine” AiP [117-120].  
A technical challenge in these studies was the transient nature of apoptotic 
processes and the rapid clearance of dead cells, making it difficult to capture the non-
apoptotic signaling events. The key to circumvent this limitation was to block effector 
caspases by expression of the specific inhibitor protein P35 [46, 121], thus preventing 
execution of apoptosis. Under these circumstances, apoptotic signaling induced by hid or 
reaper expression, activates Dronc (which is not inhibited by P35), while cell death is 
blocked, thus allowing to uncouple the apoptotic and non-apoptotic functions of Dronc. 
Due to P35 expression, the affected cells are in an immortalized state referred to as 
“undead” (Figure 1.2A), in which active Dronc persistently signals for AiP, which 
ultimately causes overgrowth of the tissue [122, 123]. The requirement of Dronc for AiP 
was confirmed by loss-of-function analysis which suppressed the overgrowth of “undead” 
tissue [117, 119, 120, 123].  
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“Genuine” (also referred to as regenerative) and “post-mitotic” AiP are P35-
independent models during which apoptotic cells are allowed to complete the apoptotic 
process (Figure 1.2B,C). To avoid organismal lethality due to excessive cell death, 
apoptosis is either induced for a brief period of time in a spatially-restricted manner 
(“genuine”) or in a non-essential tissue such as the developing retina of the fly eye, which 
is also post-mitotic at this stage [123-128], after which, the regenerative response of the 
affected tissue is examined. In the following sections, I have summarized and compared 
the findings in these different models of AiP. 
“Undead” model of AiP –  
The “undead” model has been employed in several genetic screens for identification 
of genes important for AiP in Drosophila [123, 124, 129, 130]. Mechanistically, Dronc 
promotes the activation of JNK, and secretion of mitogens such as Wingless (Wg; a WNT-
homolog), Decapentaplegic (Dpp; a BMP/TGFβ homolog) and Spitz (Spi; an EGF 
homolog) to stimulate overgrowth [118, 123, 129, 131] (Figure 1.2A). Along with JNK, 
p53 was also shown to be important for AiP [120, 132]. Both JNK and p53 are known to 
control the expression of the pro-apoptotic genes hid and reaper. This triggers a feedback 
loop in “undead” cells amplifying the mitogenic signals (Figure 1.2A) [124, 133]. 
An important question in the field of AiP was how an initiator caspase like Dronc 
activates the stress kinase JNK. Initially, it was debated whether involvement of JNK in 
AiP was because of its apoptotic role as an inducer of the apoptotic process, or whether it 
was a downstream target of Dronc. However, identification of the feedback amplification 
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loop reconciled both these models [124, 133]. It was then speculated that a novel cleavage 
target of Dronc exists that may eventually activate JNK, though whether this is true remains 
to be seen. We recently demonstrated that the linear pathway assumed for activation of 
JNK during AiP might be more complicated than it was previously thought. This study 
established that ROS act as an intermediate step between Dronc and activation of JNK. 
Active Dronc triggers the generation of extracellular ROS in “undead” cells via the 
NADPH oxidase dDuox at the plasma membrane [124] (Figure 1.2A). These ROS are 
required for AiP, as their loss impaired JNK activation and production of mitogens. One 
of the mechanisms by which ROS activate JNK is by recruitment of Drosophila 
macrophage-like cells, called hemocytes, to the “undead” tissue (Figure 1.2A). Hemocytes 
in turn secrete Eiger which signals via its receptor Grindelwald to activate JNK back in 
“undead” cells [124, 134, 135]. If this is the only mechanism by which activation of JNK 
occurs in “undead” cells, or if any other mechanisms exist, needs to be further investigated. 
Also, whether hemocytes secrete any other factors along with Eiger is something to be 
considered moving ahead and will be discussed as part of the future directions for this 
thesis work.  
A follow-up question to this work is how Dronc activates the NADPH oxidase 
Duox at the plasma membrane. While the final mechanistic details to answer this question 
are not available yet, recent work has provided more insight into this question. Dronc is 
usually a cytosolic protein. However, in “undead” cells, Dronc showed a prominent 
localization at the plasma membrane, specifically at the basal side of the plasma membrane 
of the disc proper (DP) of imaginal discs (Figure 1.2A) [130]. Translocation of Dronc to 
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the plasma membrane was mediated by Myo1D, a class I unconventional myosin. Loss of 
Myo1D resulted in loss of the membrane localization of Dronc and suppressed the 
overgrowth of “undead” tissue [130], suggesting that the membrane localization of Dronc 
is an integral part of the “undead” AiP pathway. The specific basal localization of Dronc 
is of particular interest because Duox is also enriched at the basal side of DP (Figure 1.2A) 
[130]. Interestingly, hemocytes are attached to the basal side of the DP as well (Figure 
1.2A) (I will talk more about this in Chapter II). The model emerges that Dronc – directly 
or indirectly – activates Duox at the plasma membrane for ROS generation. It should be 
noted that Dronc has enzymatic activity at the plasma membrane [130]. 
There is precedence for membrane localization of Dronc. Another study looked at 
the dynamics of Dronc localization in the Drosophila salivary gland during development. 
In late larval stage, Dronc is localized to the cortex of salivary gland cells [136]. Here, 
membrane localization of Dronc is not required for apoptosis or AiP, but for dismantling 
of the cortical F-actin cytoskeleton in a non-apoptotic role. In contrast, during early pupal 
stages, Dronc loses its membrane localization and becomes cytosolic where it mediates 
apoptosis and salivary gland cell death [136]. 
A common theme of these two studies is that the plasma membrane serves as a 
platform for non-apoptotic activities of caspases, at least of the initiator caspase Dronc. 
This sequestration of active caspases to specific sub-cellular locations where they can 
interact with targets involved in proliferation and other non-apoptotic processes, offers an 
answer to another critical question in caspase research – how do cells escape the potential 
lethal activity of active caspases when they fulfil non-apoptotic functions.  
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Figure 1.2. Models of apoptosis-induced proliferation (AiP) in Drosophila. 
A. The “undead” AiP model. Apoptotic cells are maintained in an immortalized state, 
referred to as “undead” due to expression of the effector caspase inhibitor P35. Under 
these conditions, the unconventional myosin Myo1D transports Dronc to the basal side 
of the plasma membrane where it directly or indirectly activates the NADPH oxidase 
Duox for ROS generation. Drosophila macrophages are attracted to “undead” cells and 
release the TNF ligand Eiger which activates the JNK pathway in “undead” cells. JNK 
activity induces expression of hid and reaper, setting up a feedback amplification loop, 
and of the mitogens wg, dpp and spi which promote proliferation. The amplification 
loop signals continuously, promoting tissue overgrowth. Question marks denote 
uncertainty.  
 
B. The “genuine” (or regenerative) AiP model. Temporally and spatially restricted 
apoptosis promotes generation of intracellular ROS, some of which propagates to 
neighboring surviving cells to activate JNK and p38 signaling. The role and origin of 
Wg, Upd and Spi is uncertain in this model.  
 
C. The “post-mitotic” AiP model. Induction of apoptosis in the developing retina (a 
largely post-mitotic tissue) triggers AiP. In this case, dying photoreceptor neurons 
release the mitogen Hedgehog (Hh) which promotes proliferation of surviving, 
undifferentiated, yet post-mitotic cells. JNK signaling is not involved, however, Hippo 
signaling has been implicated in this model. 
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The aforementioned studies suggest that the basal side of the plasma membrane may 
provide a non-apoptotic compartment that permits Dronc to mediate non-apoptotic 
processes such as compensatory proliferation or cytoskeleton remodeling [130, 136, 137].  
“Genuine” model of AiP –  
The findings obtained in the “undead” AiP model were further extended with the 
P35-independent “genuine” model, which also showed the requirement of JNK for proper 
regeneration [123-127]. Along with JNK signaling, p38 and JAK/STAT signaling 
pathways are also required for “genuine” AiP [138] (Figure 1.2B). Production of ROS in 
response to transient pro-apoptotic signals was also observed in “genuine” models [124, 
138], although in this context, these ROS appear to be intracellular, and are most likely 
mitochondrial in origin. Nevertheless, despite this intracellular origin, some ROS appear 
to propagate into neighboring surviving cells where they induce activation of JNK and p38 
signaling through Akt and the redox-sensitive ASK1 factor which altogether results in 
expression of Unpaired (Upd), an IL-6 paralog [138, 139].  
However, some discrepancies do exist between the “undead” and “genuine” 
models, especially regarding the source and requirement of Wg signaling [125, 127, 131, 
140]. These discrepancies can be explained by functional redundancy between Wg and 
Wnt6, which are under control of the same damage-response element [141].  Additionally, 
hemocytes are not recruited to imaginal discs in “genuine” models, and neither is there a 
requirement for Eiger signaling nor Myo1D. These differences illustrate the context-
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dependent nature of AiP signals with very different consequences: overgrowth in “undead” 
AiP versus regeneration in “genuine” AiP. 
“Post-mitotic” model of AiP –  
In post-mitotic tissue, a completely different mechanism of AiP exists. Here, the 
non-apoptotic activity of effector caspases is important for inducing compensatory 
proliferation. Upon apoptosis induction in the differentiating Drosophila retina (which is 
largely a post-mitotic tissue), the dying photoreceptor neurons produce and secrete the 
mitogen Hedgehog (Hh) in a DrICE- and Dcp1-dependent manner, promoting proliferation 
of surrounding cells that have not yet initiated differentiation (Figure 1.2C) [128]. JNK 
signaling is not involved in “post-mitotic” AiP. Hippo signaling has been implicated in this 
type of AiP [142]. The cells that undergo AiP in this context are usually post-mitotic; 
however, they are still competent to re-enter the cell cycle and divide. Interestingly, while 
dying photoreceptor neurons produce the Hh signal for AiP, the newly formed cells can 
differentiate in all accessory cell types, but not photoreceptor neurons [143]. Expression of 
P35 in this context blocks secretion of Hh, and thereby AiP [128], indicating that effector 
caspases are required for this type of AiP. These studies highlight the notable differences 
in the mechanisms of AiP depending on distinct cell types and developmental stages. 
Compensatory proliferation in regeneration of different model organisms  
Compensatory proliferation for regeneration also occurs in a variety of different 
organisms, including Hydra, planaria, newt, Xenopus, zebrafish and mice. In the fresh 
water polyp Hydra, mid-gastric transverse bisection results in both head and tail 
23 
 
regeneration [144]. Interestingly, only head, but not tail, regeneration requires 
proliferation. Correspondingly, apoptosis is only triggered at the head-regenerating tip via 
the MAPK/CREB pathway [145], which is not observed for tail regeneration. Activation 
of effector caspases induces secretion of the mitogen Wnt3 from dying cells, thus initiating 
β-catenin-driven proliferation of surrounding cells followed by regeneration of the head 
(Figure 1.3A). Excitingly, ectopic activation of apoptosis at the tail-regenerating tip 
regenerated a head, producing a bi-headed hydra, illustrating that activation of caspases 
can change the regeneration program in this organism [146]. ROS are also produced 
immediately at the wound site, and are required for the injury-induced MAPK activation 
and apoptosis [147].  
Fresh water planarian Schmidtea mediterranea also demonstrates a remarkable 
regenerative potential [148]. Apoptosis mediated by caspase-like effectors, DjCLg3, 
occurs after amputation and is required for regeneration, but whether the apoptotic cells 
drive AiP is currently unknown [149]. A recent study demonstrated that ROS are produced 
at the wound site following amputation of the head and tail compartments of planaria, and 
inhibition of the ROS burst impaired the regeneration capacity (Figure 1.3B) [150]. This is 
reminiscent of the requirement of ROS for AiP in the “genuine” model in Drosophila [124, 
138]. It will be interesting to examine if caspases promote production of ROS in this 
regenerative context as well. 
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Figure 1.3. The role of apoptosis-induced proliferation (AiP) for regeneration in 
different animal models. 
In different model organisms, active caspases, along with inducing cell death, also help in 
promoting regeneration. The regenerative response has a common core – after activation 
of caspases, there is a damage response like production of ROS followed by activation of 
stress kinase-signaling cascade leading to production of mitogens.  
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In the vertebrate Xenopus laevis, tadpole tail amputation induces cell death, and 
apoptotic cells can be detected 12 hours post amputation. Caspase activity at the site of 
injury is essential for regeneration of the lost tail, as effector caspase inhibitors prevent cell 
proliferation and regeneration [151]. Tail amputation also induces ROS production and 
causes an elevated Oxygen (O2) influx immediately after the injury, which is thought to 
sustain ROS levels over the span of regeneration (Figure 1.3C). O2 influx together with 
ROS stabilize HIF-1α levels to induce regeneration [152, 153]. Decreasing ROS levels by 
blocking NADPH oxidases also results in impaired regeneration, possibly due to the 
requirement of ROS to activate Wnt/β-catenin, FGF and BMP signaling pathways [154, 
155]. It is not yet known if there is any crosstalk between the HIF-1α pathway and other 
signaling pathways for regeneration. It will also be interesting to understand if apoptotic 
caspases have any role in the signaling events following tail amputation.  
Similar observations are made during fin regeneration in zebrafish, Danio rerio. 
Tail fin wounding of zebrafish larvae results in generation of a tissue-scale gradient of ROS 
due to activity of Duox at the site of injury. ROS, in particular H2O2, is important for the 
recruitment of blood cells to the wounds for the purpose of healing (Figure 1.3D) [156]. A 
recent study further explored the requirement of ROS for larval tail regeneration. 
Wounding-induced ROS rapidly repositioned notochord cells to the site of damage. These 
cells secreted the mitogen Hh and activated Hh signaling, which is a key regulator of tail 
regeneration, acting upstream of the Wnt/β-catenin, FGF and Retinoic Acid signaling 
pathways [157]. In adult zebrafish, caudal fin amputation also causes sustained ROS 
production via enzymatic activity of Nox, another member of the NADPH oxidase family 
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(Figure 1.3E). ROS stimulated apoptosis and JNK activation in parallel, and both of these 
processes were required for AiP and regeneration of the fin. Expression of signaling factors 
involved in regenerative growth, like FGF20, SDF1, and Wnt proteins, were differentially 
regulated by the apoptotic pathway and JNK, suggesting these signals might be secreted 
from dying cells [158]. 
Mammals have greatly reduced regenerative potential, but do maintain the ability 
to regenerate a few select tissues, such as the liver and skin. In mice, liver regeneration 
following partial hepatectomy, along with skin wound healing, depends on the activity of 
effector caspases, caspase-3 and -7. Mechanistically, effector caspases cleave and activate 
calcium-independent phospholipase A2 (iPLA2), which leads to increased secretion of 
arachidonic acid and lysophosphocholine. These in turn induce the secretion of 
prostaglandin E2 (PGE2), which, in addition to its function in inflammation, promotes stem 
and progenitor cell proliferation, and tissue repair (Figure 1.3F) [159]. PGE2 has also been 
shown to activate Wnt signaling [160, 161]. In addition, other signaling pathways also play 
a role in liver regeneration, for example, dying hepatocytes secrete Hh, which induces 
proliferation of progenitor cells and myofibroblasts [162]. These studies highlight the role 
of caspases in inducing proliferation and repair. Regeneration of liver also depends on ROS 
(Figure 1.3F). Following acute liver injury in mice, dying hepatocytes produced IL-11, a 
pro-inflammatory cytokine, in a ROS-dependent manner. IL-11 activated the JAK/STAT 
signaling pathway in healthy hepatocytes, thus inducing compensatory proliferation [163]. 
Interestingly, ROS also induces hepatocyte necrosis, which leads to release of IL-1α, and 
in turn induction of compensatory proliferation [164]. 
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Taken together, the regenerative processes in the different organisms have a 
common theme – induction of apoptosis following amputation or wounding, a damage 
response such as production of ROS, and finally secretion of different mitogens to induce 
proliferation. In most cases, active caspases are involved in all or some of these processes. 
Interestingly, while many examples of effector caspase-driven proliferation exist, the only 
initiator caspase-dependent regenerative response so far has been described in Drosophila, 
where Dronc mediates AiP independently of its activation of effector caspases in the 
“undead” model.  
  
ROS and ROS signaling 
Reactive oxygen species (ROS) are formed upon partial reduction of oxygen, and 
include superoxide anions (O2
-), hydroxyl radical (.OH) and hydrogen peroxide (H2O2) 
[165]. They are highly unstable with a relatively short half-life. O2
- is generally considered 
to be the primary ROS and is abundantly generated by different endogenous and exogenous 
factors. O2
- is rapidly dismutated to H2O2, and in the presence of Fe
2+ or Cu2+ ions, H2O2 
can further be converted to .OH via a process known as Fenton reaction (Figure 1.4).  
Mitochondria are the primary source of intracellular O2
- [166], followed by other 
organelles such as endoplasmic reticulum (ER), peroxisomes, and the phagosomes in 
specialized phagocytic cells that display localized generation of ROS (Figure 1.4) [167]. 
In mitochondria, the electron transport chain (ETC) complexes transfer electrons from 
NADH and succinate to synthesize ATP during aerobic respiration. Leaks in the ETC, 
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especially in complex I and III cause a one electron reduction of molecular O2 to form O2
- 
in the mitochondrial matrix [166]. In the ER, H2O2 is produced by post-translational 
oxidative modifications during protein folding [167, 168], while in the peroxisomes, ROS 
are generated as byproducts of catalytic functions of enzymes involved in various 
metabolic pathways like α- and β-oxidation of very long chain fatty acids, amino acid 
catabolism, and others [169, 170]. 
Another major source of ROS are the membrane-associated NADPH oxidases Nox 
and dual oxidase (Duox) (Figure 1.4). They show widespread localization to different cell 
and organelle membranes, and account for the generation of extracellular ROS, in 
particular via Duox. They catalyze the reduction of O2 to O2
- by using NADPH as an 
electron donor [171]. These enzymes are evolutionarily conserved in eukaryotes. There are 
total of 7 Nox family members – Nox1-5 and Duox1-2 in mammals, while in Drosophila 
there is one homolog for Nox (dNox) and one for Duox (dDuox), and in C. elegans there 
is no Nox homolog, but 2 Duox enzymes present [172]. Nox proteins are characterized by 
the presence of a carboxy-terminal intracellular Flavin domain that contains binding sites 
for co-enzymes NADPH and FAD (Figure 1.4), an amino-terminal hydrophobic domain 
that forms 6 transmembranal α-helices with four highly conserved heme-binding histidine 
residues in the transmembrane domain that act as carrier to transport electrons across the 
membrane, and an additional amino-terminal intracellular Ca2+-binding EF hand domain 
observed in Nox5. Duox proteins have a similar structure as Nox5 with the addition of a 
seventh transmembrane domain and an extracellular peroxidase-homology domain (PHD)  
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Figure 1.4. Sources of ROS and Enzymes involved in Redox Signaling. 
Abbreviations used: F – Flavin domain; EF – EF hand domain; P – peroxidase homology 
domain (PHD); SOD – superoxide dismutase; Cat – catalase; GPxs – glutathione 
peroxidases; PRxs - peroxiredoxins. See text for details.  
Reproduced from: 
Diwanji N., Bergmann A. (2018) An unexpected friend - ROS in apoptosis-induced 
compensatory proliferation: Implications for regeneration and cancer, Seminars in Cell and 
Developmental Biology 80; 74-82. 
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(Figure 1.4). Thus, Duox proteins can generate O2
- through the catalytic core and 
potentially further process it through its own peroxidase domain [171].  
There is a delicate balance between ROS generation and scavenging by the 
protective antioxidant defenses in the cell. Antioxidant systems present in the cells include 
enzymes like superoxide dismutase (SOD), catalases, glutathione peroxidases (GPxs) and 
peroxiredoxins (PRxs) (Figure 1.4) [168]. SODs are responsible for catalyzing the rapid 
dismutation of highly reactive O2
- anions to H2O2: SOD1 converts cytosolic O2
-, 
mitochondrial matrix-associated SOD2 converts O2
- generated by mitochondrial ETC, 
while SOD3 is secreted extracellularly and is responsible for converting extracellular O2
- 
produced by the NADPH oxidases [173]. The antioxidant enzymes like catalases, GPxs 
and PRxs convert H2O2 to H2O and O2. The GPx family proteins reduce H2O2 by oxidizing 
glutathione, which is then reduced back by glutathione reductase using NADPH as an 
electron donor, thus normalizing the levels of reduced glutathione in the cells [174]. PRx 
family enzymes contain a redox-sensitive cysteine residue in their active site, which is 
inactivated by H2O2-mediated oxidation. Thioredoxin acts as an electron donor to reduce 
and activate PRx, thus completing the catalytic cycle [175]. 
Redox signaling 
Historically, ROS were thought to be deleterious to the cell causing oxidative stress 
by indiscriminately damaging proteins, lipids, and nucleic acids. This holds true for the 
highly reactive O2
- and .OH radicals, as they can cause irreversible oxidative damage due 
to their strong oxidizing potential and lipid insolubility, thereby contributing to cellular 
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dysfunction and various pathologies. However, it is becoming more appreciated now that 
ROS can also mediate important signaling functions, referred to as redox-signaling [176]. 
For example, H2O2 is a perfect candidate to function as second messenger or as signaling 
molecule due to its relatively long half-life, high stability, and its ability to diffuse across 
membranes. Indeed oxidation of critical cysteine residues in redox-sensitive proteins is the 
most studied mechanism by which H2O2 functions as signaling molecule [177]. The 
cellular targets of H2O2 that undergo this reversible cysteine oxidation encompass a vast 
range of biological processes. Examples include the phosphatases PTEN and PTP1B, 
kinases like MAPK and redox-reactive transcription factors like YAP1 in yeast and 
FOXO4 in mammals [167]. H2O2 oxidizes the thiol side-chain of cysteine to form reactive 
sulfenic acid (-SOH) that can form intra- and inter-molecular disulphide (-S-S-) bonds or 
cyclic sulfenamide (-S-N-) structures, or can undergo hyperoxidation to form sulfinic (-
SO2H) or sulfonic (-SO3H) acids [178]. These reversible modifications may lead to changes 
in protein structure, function or activation state.  
Along with cysteine thiols, H2O2 can oxidize several other amino acids like 
methionine, lysine, arginine, proline, histidine and tyrosine [179]. Multiple mechanisms 
have been proposed for understanding how target proteins are selected for oxidation by 
H2O2. One mechanism proposes colocalization of ROS sources and targets, so that redox 
signaling events are triggered close to the source of ROS generation [167]. For example, 
Nox proteins are often seen colocalized with putative targets like phosphatases or kinases 
at the plasma membrane, thereby influencing receptor tyrosine kinase signaling [180]. 
Another mechanism termed as “redox relay” proposes that H2O2 oxidizes the scavenging 
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enzymes like PRx or GPx, which subsequently transfer the oxidation to target proteins 
[181]. This kind of relay process is seen for H2O2-mediated oxidation of apoptosis 
signaling kinase 1 (ASK1) and downstream phosphorylation of its MAPK substrate p38, 
which is dependent on formation of an ASK1-PRx1 disulphide intermediate [182]. Yet 
another mechanism termed as “floodgate model” proposes that transient inactivation of 
scavenging enzymes by hyperoxidation or posttranslational modifications causes 
accumulation of H2O2 allowing oxidation of target proteins [183]. Thus, by localized 
alterations in the redox buffering capacity, the cell can control ROS flux for selective 
signaling events [184]. Furthermore, depending on the location of a cysteine residue within 
a protein, not all cysteine residues are equally susceptible to H2O2-mediated oxidation [185, 
186], further increasing specificity. Another form of physiological ROS regulation 
involves transport of H2O2 across cell membranes via aquaporins, which are integral 
membrane proteins involved in transport of water and small-molecule metabolites [187]. 
Aquaporins enhance the membrane permeability of H2O2, and are useful for transporting 
the extracellular H2O2 produced by NADPH oxidases across the plasma membrane to 
mediate intracellular signaling cascades [188]. 
ROS in Cancer 
ROS have a long history of being involved in the development and progression of 
cancer and increased ROS levels are considered as hallmark of many tumors [189, 190]. 
Initially, it was thought that ROS would serve as chemical mutagens that would 
indiscriminately damage cellular macromolecules such as DNA by oxidative stress, and 
thus are tumorigenic by promoting genomic instability. In addition, the more recent 
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findings that ROS, most notably H2O2, can also mediate several signaling processes in the 
cell with very specific oxidation targets has verified this view (recently reviewed in [191, 
192]). By regulating signaling events that control the cell proliferation rate, alter the 
metabolic states of the cell and promote angiogenesis, ROS are increasing the tumorigenic 
potential of the cancerous cells. Increased ROS production in cancer cells can be due to 
multiple different factors. Oncogenes such as Ras promote the generation of ROS [193-
196]. The tumor suppressor p53 is known to establish the redox balance by regulating the 
expression of antioxidants like GPx1 and SOD2, and loss in its activity can increase the 
oxidative burden in tumor cells [197-199]. Increased metabolism of the tumor cells is 
another factor that increases the ROS levels in these cells (reviewed in [190]). Many human 
tumors and cultured tumor cell lines show an upregulation of the mRNA expression and/or 
protein levels of several different Nox enzymes, which are implicated in increasing the 
cellular ROS levels. Depending on the subcellular localization of these enzymes and the 
stage of tumorigenesis, Nox-derived ROS can mediate DNA damage causing genomic 
instability or signal to activate redox-sensitive pathways, to help in initiation and 
maintenance of tumorigenesis [200, 201].  Along with this, a wide variety of human tumors 
harbor mutations in mitochondrial DNA-encoding ETC proteins, which are responsible for 
increasing the mitochondrial-derived ROS production [202].  
Nox enzymes can regulate the MAPK/ERK and PI3K/Akt/mTOR signaling 
pathways through H2O2-mediated oxidation of phosphatases involved in these processes 
[203-205]. PTEN is the primary target of H2O2, and oxidation of its active site cysteine 
(Cys124) inactivates the phosphatase, resulting in constitutive activation of the PI3K 
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pathway [203]. Inactivation of protein phosphatase 2A (PP2A) and PTP1B by H2O2-
mediated oxidation causes an increase in Akt activation. This leads to an increased cell 
proliferation response, anchorage-independent growth and survival [204, 206, 207]. 
Mitochondrial ROS are also responsible to activate the hypoxia-inducible factors (HIFs) in 
hypoxic tumor cells, thus allowing the tumor cells to adapt to the low oxygen 
microenvironment and help in its survival. Under hypoxic conditions, increased superoxide 
generated by mitochondrial ETC stabilizes HIF-1α and HIF-2α subunits [208, 209].  
AiP is involved in the etiology of multiple human cancer ([159, 210-219]; recently 
reviewed in [98]) (will be discussed further in the Chapter III). Chemo- and radiotherapy 
of human patients often aims to induce the death of the tumor cells. However, apoptotic 
tumor cells in return may generate signals for AiP and despite initial tumor regression, the 
tumor cells repopulate and the tumor grows back [211-213, 216]. Although a direct role of 
ROS for this type of tumor AiP has not been demonstrated so far, based on the work in 
several model organisms (as discussed above), it is possible that this might be the case.  
Along with being tumor-promoting, ROS can also have a tumor-suppressive 
function. For example, genetically engineered mice carrying oncogenic K-Ras and B-Raf 
mutations significantly increased tumor development and mortality upon dietary 
supplementation of the anti-oxidants N-acetylcysteine (NAC) or Vitamin E, suggesting 
that ROS prevented tumor growth in these animals [220]. 
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Hemocytes 
 Hemocytes are Drosophila blood cells analogous to mammalian macrophages, and 
are major facilitators of the cellular immune responses. There are 3 types of hemocytes 
present in flies – plasmatocytes that are involved in phagocytosis and host defense; crystal 
cells that are involved in the process of melanization and wound repair; and lamellocytes 
a highly specialized type of hemocytes that are induced under specific circumstances, like 
parasitoid wasp infections. Plasmatocytes are highly abundant and comprise 90-95% of 
total hemocytes, while crystal cells account for about 5% of total hemocytes. Lamellocytes 
are rarely observed in a healthy animal [221, 222].  
Drosophila hematopoiesis – different origins of hemocytes 
 Hemocyte development (hematopoiesis) occurs in two waves during organismal 
development: one during the embryonic stage and the second in the larval lymph gland. 
During the first wave, hemocyte progenitors originate from the embryonic head mesoderm 
and differentiate into plasmatocytes and crystal cells [223, 224]. The platelet-derived 
growth factor/vascular endothelial growth factor (PDGF/VEGF) family of growth factor 
ligands (Pvf) and receptor (Pvr) regulate hemocyte proliferation, survival and migration in 
the developing embryo [225-227]. By the end of embryogenesis, plasmatocytes are 
dispersed throughout the embryo, and crystal cells remain mainly localized at their site of 
differentiation. The GATA transcription factor Serpent (Srp) operates as the master 
regulator of embryonic hematopoiesis and cell fate determination [228, 229]; consequently, 
srp mutant embryos are devoid of all mature hemocytes [230]. The second wave of 
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hematopoiesis occurs in the larval lymph gland, which releases differentiated hemocytes 
into circulation at the end of larval stage upon onset of pupariation [231, 232]. During the 
larval stage, in addition to the lymph gland and circulating hemocytes in the hemolymph, 
hemocytes are also observed in sessile hematopoietic niches along the epidermal body wall 
in close association with peripheral nerve endings [233]. Hemocytes in the sessile niches 
are dynamic and undergo proliferation, transdifferentiation and lateral migration [233, 
234]. Sessile hemocytes can be released into circulation following developmental cues, 
such as ecdysone signaling at the end of larval stage [235], or under different mutant 
backgrounds and immune challenges, which causes an increase in circulating hemocyte 
numbers in larvae [224]. Both embryonic and larval hemocytes persist into adults as there 
is no active hematopoiesis occurring at that stage [231, 236].   
Hemocytes in wound repair and tumorigenesis 
 Similar to vertebrate macrophages, plasmatocytes function as professional 
phagocytes engulfing apoptotic corpses and pathogens [225]. Additionally, plasmatocytes 
also secrete components of the extracellular matrix (ECM) during development, secrete 
cytokines and antimicrobial peptides following infection, help in wound healing, and play 
a role in tumorigenesis [237-239]. Upon tissue damage, plasmatocytes (referred to as 
hemocytes hence forth) are recruited to the wound, where they induce scab formation, 
phagocytosis of dead cells and epithelial repair. In embryos, wounding induces a rapid 
calcium flash wave that activates Duox within wounded epithelium to generate H2O2 that 
acts as a chemo-attractant for recruiting hemocytes to the wound [240, 241]. Similar H2O2-
mediated recruitment of macrophages to wound sites is seen in different model organisms, 
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like zebrafish, where larval tail fin wounding leads to activation of Duox at the site of 
injury, and generation of a tissue-scale gradient of H2O2 that promotes leukocyte 
chemotaxis to the wound [156]. In both these cases, H2O2 activates the Src family kinase 
(Src42A in Drosophila and Lyn in zebrafish) in blood cells to mediate migration to the 
wound site [242, 243]. In Drosophila larvae, recruitment of hemocytes to wounds is more 
passive, primarily adhesive capture from circulation triggered by disrupted basement 
membrane (BM) [244, 245]. In the Drosophila adult gut, injury leads to recruitment of 
hemocytes which then induce intestinal stem cell proliferation by secreting Dpp [246]. 
Hemocytes can also remotely stimulate intestinal stem cell proliferation after septic injury 
via the production of the IL-6-like cytokines Unpaired 2 and Unpaired 3 [247].   
As seen for mammalian macrophages, hemocytes are recruited to tumors and have 
both tumor-promoting as well as tumor-inhibiting roles. Tumors in imaginal discs induced 
by mutations in polarity genes (scribble (scrib), discs large (dlg) or lethal giant larvae (lgl)) 
cause hemocyte recruitment to areas of BM damage, where the hemocytes secrete the 
cytokine Eiger to inhibit tumor growth [245, 248]. However, in the context of oncogenic 
Ras-induced tumors, recruited hemocytes via Eiger secretion now promote tumor growth 
and invasion [249]. A similar response is observed during AiP in undead tissue where 
recruited hemocytes via Eiger secretion induce proliferation and overgrowth, though the 
mechanism of hemocyte recruitment to the undead tissue is not yet known [124]. Thus, 
there may be common processes, such as disrupted BM, that are important for hemocyte 
recruitment to all Drosophila larval epithelial tumors; while distinct tumor-intrinsic 
signaling pathways may exist that direct particular hemocyte responses to the tumors. Such 
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functions of hemocytes are analogous to vertebrate tumor-associated macrophages (TAMs) 
which promote tumor functions and pro-inflammatory cytokine production through TNF-
α signaling [250]. Most human solid tumors have a high density of macrophage infiltration, 
which usually correlates with poor patient prognosis. Tumor-derived factors reprogram the 
polarization of TAMs towards the “alternatively-activated” M2 phenotype. TAMs are 
responsible for promoting tumor-inflammation, cell growth, angiogenesis, matrix 
remodeling and metastasis, while inhibiting anti-tumor immune responses, thus supporting 
tumorigenesis [251]. Like mammalian macrophages, Drosophila hemocytes show 
functional plasticity; though, whether hemocytes also undergo differential activation is not 
known. It is however tempting to hypothesize that the tumor or the undead epithelium 
promotes alternative activation of hemocytes to change their tumor-inhibitory function to 
a proliferation-inducing tumor-promoting role.  
 
The Basement Membrane 
 The basement membrane (BM) is a specialized extracellular matrix (ECM) 
structure that surrounds most tissues like the blood vessels, muscles, fat and nerves, and 
underlies the epithelia. It provides structural support to the developing tissues, helps divide 
tissue into compartments and also regulates cellular behavior and signaling events. The 
sheet-like BM structure is a result of two independent self-assembling polymeric networks 
of laminin and collagen linked by several additional ECM proteins like perlecan and 
nidogen. BMs are associated with the underlying cells via integrin and dystroglycan 
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receptors [252]. There is a great amount of diversity in BM due to presence of several 
isoforms and post-translational modifications of BM components and regulatory proteins. 
This diversity of BM is important for regulating several key cell and tissue properties, 
including cell differentiation, cell polarity, tissue shape, filtration, and resistance to 
mechanical stresses [253]. Proper assembly and function of the BM is important for 
organismal survival as mutations in any of the BM components cause early embryonic 
lethality [254].   
BM core components  
 The core components of BM are highly conserved in multicellular organisms and 
comprise of type IV collagen, laminin, nidogen and perlecan [255]. Type IV collagen is a 
nonfibrillar collagen and is the most abundant protein in the BM. It is necessary for BM 
integrity, though is not essential for the initial formation of BM, and is important for 
imparting stiffness to the BM [256, 257]. Mammals have 6 distinct chains of type IV 
collagen (α1-α6) encoded by 6 genes, while Drosophila has 2 type IV collagen genes 
(Cg25C and viking) [258-260]. Each α-chain is composed of a N-terminal 7S domain, a 
triple helical collagenase domain and a C-terminal globular non-collagenous (NC1) 
domain. The α-chains form trimers in the cell, and are secreted outside in the ECM where 
they self-assemble to form a supramolecular network by several intermolecular interactions 
[258, 261]. The collagen network is also crosslinked by disulfide and sulfilimine bonds 
conferring mechanical and tensile strength to the BM [257, 262]. Similar to type IV 
collagen, laminin self-assembles to form an extensive network in the ECM. Laminin is a 
heterotrimeric protein made up of α, β and γ chains. In mammals there are 5 α, 4 β and 3 γ 
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chains which assemble to form 16 different heterotrimeric laminin isoforms [263]. 
Whereas in Drosophila there are 2 α chains (laminin A and wing blister), a single β (laminin 
B1) and γ (laminin B2) chain that assemble into 2 laminin heterotrimers (Laminin A and 
Laminin W) [264, 265]. The laminin α chain is longer and contains C-terminal laminin-
type globular (LG) domains, which are lacking in the shorter β and γ chains. The N-
terminal of all 3 chains has LN domains which participate in polymerization to form the 
laminin scaffold network [263]. Laminins interact with cell surface receptors via α chain 
LG domains [266]. Nidogen is a glycoprotein composed of three globular (G) domains 
linked with rod-like domains [267]. Nidogen binds to both type IV collagen and laminin 
via its G domains (G2 and G3 respectively), thus linking the two scaffolding networks 
[267-269]. Mammals have 2 nidogen isoforms while Drosophila has only 1 isoform. The 
last core component of the BM is the heparan sulfate proteoglycan Perlecan. In Drosophila, 
perlecan is encoded by the terribly reduced optic lobes (trol) gene [270]. Perlecan has 5 
distinct domains that have binding sites for nidogen, type IV collagen, laminin, integrins, 
α-dystroglycan and heparin [271, 272]. Additionally, perlecan binds to several growth 
factors, like TGFβ, BMPs, Hh, VEGF and FGF, thus tethering them to the BM [273, 274].   
BM receptors 
Along with the core components that make up the BM, the receptors that link the 
BM to the cell surface are equally important for proper assembly of the BM. Integrins and 
dystroglycan are the two major types of cell surface receptors that interact with the BM 
components. Integrins are heterodimeric transmembrane glycoproteins made up of one α 
and one β subunit. The mammalian genome has 18 α and 8 β subunit genes forming 24 
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unique integrin heterodimers [275]. On the other hand, the Drosophila genome encodes 
only 5 α and 2 β subunits to form position specific (PS) integrins. Of these, βPS 
(myospheroid) is the most common β subunit forming heterodimers with the 5 α subunits 
– αPS1 (multiple edematous wings), αPS2 (inflated), αPS3 (scab), αPS4 and αPS5; while 
the second β subunit (βν) is reported to form a heterodimer with αPS3 [276-278]. Integrin 
heterodimers share a conserved structure consisting of a large extracellular domain that 
binds BM ligands, a single-pass transmembrane domain and a short cytoplasmic tail that 
binds to numerous intracellular effector proteins to transduce the extracellular signals 
inside the cells [279]. Integrins are activated by bidirectional signaling process – “inside-
out” activation occurs after binding of intracellular adaptor proteins, like talin and kindlin, 
to the cytoplasmic tail of β-subunit which drives conformational change in the integrin 
heterodimers allowing their interaction with BM ligands; “outside-in” activation occurs 
after integrin-ligand engagement, and leads to clustering of integrins to form a network of 
cytoplasmic and cytoskeletal proteins into focal adhesions to transmit extracellular 
mechanical force for regulating cell behavior [279]. Different integrin heterodimers 
recognize and bind to BM components like laminin (α3β1, α6β1, and α6β4), type IV 
collagen (α1β1, α2β1, α10β1, and α11β1) and fibronectin (α5β1, αVβ3) in mammals [258, 
280, 281]. A number of studies in Drosophila have shown that αPS1/βPS heterodimer 
binds to Laminin A and type IV collagen, while αPS2/βPS and αPS3/βPS heterodimers 
bind to Laminin W [282-286]. Dystroglycan is the other conserved transmembrane BM 
receptor, and functions as part of the dystrophin glycoprotein complex (DGC) to connect 
the ECM to actin cytoskeleton via the cytoplasmic adaptor dystrophin [287, 288]. In 
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mammals and Drosophila, dystroglycan is encoded by a single gene, however, in 
mammals, post-translational cleavage of dystroglycan gene product gives rise to 
extracellular glycoprotein α-dystroglycan and the transmembrane protein β-dystroglycan 
that stay physically connected to each other, which is not observed for Drosophila 
dystroglycan [287, 289]. α-dystroglycan interacts with LG domains in laminin and 
perlecan, and requires O-linked glycosylation modifications for proper interaction [288, 
290-292]. β-dystroglycan via its cytoplasmic tail binds to actin, either directly or indirectly 
through dystrophin in muscles or utrophin in epithelial cells [293].   
BM sources 
 BM components are produced either locally by the cells or they are secreted from 
a distant source and incorporated into the BM of the tissue. In C. elegans, body wall 
muscles secrete type IV collagen which is incorporated into the BM in distal sites, while 
perlecan is always deposited locally in the BM close to its site of synthesis [294].  In 
Drosophila, depending on the stage of development, different sources secrete BM 
components. In embryos, during early stages of development, mesoderm locally expresses 
laminin, while in the later stage, hemocytes are the primary source for BM components 
such as type IV collagen, laminin, perlecan, SPARC (secreted protein acidic and rich in 
cysteine) and peroxidasin, which are deposited onto developing tissues [260, 264, 295-
299]. As the embryo transitions into larva, fat body takes over as the primary source of BM 
components along with hemocytes. Fat body adipocytes secrete all the BM components 
(laminin and nidogen are also secreted by hemocytes), which are released in the 
hemolymph and are incorporated in the BM of imaginal discs and other distal organs [300, 
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301]. Following metamorphosis, larval BMs are degraded during the pupal stage and new 
BMs are incorporated in adult flies, and although not much is known about the BM sources 
in adults, one example studied in detail is the follicular epithelium in the adult female flies 
that surrounds the developing egg in the ovary and locally secretes all the BM components 
important for shaping the egg during oogenesis [283, 302].   
BM assembly 
BM assembly is a multi-step process and initiates with the deposition of laminin on 
the cell surface where it tightly associates with integrin and dystroglycan receptors [252]. 
On the cell surface, laminin heterotrimers via the LN domain on α, β and γ subunits form 
ternary complexes with adjacent laminins thus self-assembling into polymers [303]. This 
self-assembly is dependent on calcium [304]. Loss of laminin or deletion of LG domains 
inhibiting interaction with receptors prevent the assembly of BM completely, and also 
cause early embryonic lethality (E5.5 in mice; embryonic death in Drosophila) [303, 305-
308]. Following laminin assembly, type IV collagen network is deposited onto the BM. 
Upon secretion of protomers from the cell, NC1 domain of type IV collagen binds chloride 
leading to its dimerization, thereby initiating polymerization [309, 310]. Self-assembly 
starts by formation of NC1 hexamers and 7S tetramers. The NC1 hexamers are further 
stabilized by sulfilimine crosslinks formed by peroxidasin and bromine ions, while 
disulfide bridges stabilize the tetramers [262, 311, 312]. Extracellular chaperone-like 
proteins such as SPARC also play important role in type IV collagen secretion from the 
cell, assembly and diffusion to distal tissues [296, 300, 313]. Similar to laminin, loss of 
type IV collagen also leads to improper BM assembly and embryonic death albeit at a later 
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developmental stage than that observed for laminin (E10-11 in mice; differentiated 
embryos fail to hatch in Drosophila) [256, 314, 315]. Nidogen and perlecan then bridge 
the two networks, thus stabilizing the BM structure. Nidogen via its G3 domain interacts 
with LE domain in laminin γ subunit, and its G2 domain binds to type IV collagen [267, 
269]. Individual loss of the 2 nidogen isoforms does not affect BM growth or development 
in mice, however loss of both together cause embryonic lethality indicating their 
redundancy [316-319]. Similarly in Drosophila, nidogen is not required for viability and 
development of the flies, but is important for BM formation in fat body and flight muscles, 
and works by linking the type IV collagen and laminin networks. Nidogen deposition in 
BM of fat body is dependent on both laminin and type IV collagen, but in turn does not 
influence their assembly, indicating that nidogen is not important for initial BM assembly 
but plays a role in maintaining BM stability [301, 320].  Perlecan, similar to nidogen, does 
not self-assemble but instead is secreted as a single molecule that incorporates into the 
assembled BM network. Perlecan is critical for BM maintenance, though it is not important 
for initiating the BM assembly. Loss of perlecan does not affect BM development but 
causes embryonic lethality in mice (E10.5-19) and Drosophila [274, 321]. Perlecan 
incorporation in the BM is dependent on type IV collagen [300]. Finally, perlecan acts like 
a bridge binding laminin network, type IV collagen network as well as nidogen [272, 322].  
MMPs and BM remodeling 
 BM is a dynamic structure that undergoes turnover and remodeling during normal 
development or during wound repair. This process is important for regulating the BM 
composition and structure, as well as for releasing bound growth factors [323]. BM is also 
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degraded or remodeled in various cancers, which is considered to be important for cancer 
cell invasion and metastasis, for promoting tumor angiogenesis, and for modulating the 
immune responses [324-326]. One of the key enzymes responsible for BM degradation is 
the matrix metalloproteinase (MMP). MMPs are a family of zinc-dependent multi-domain 
endopeptidases. MMPs are either secreted outside the cell or are anchored to the cell 
membrane. All members of this family share a conserved domain structure consisting of a 
signal peptide used for secretion of the enzyme, a pro-domain containing a highly 
conserved cysteine-switch motif, a catalytic domain with zinc-binding site, a flexible hinge 
domain and a hemopexin domain that determines substrate specificity. The membrane-
anchored MMPs additionally may have a transmembrane domain or a 
glycosylphosphatidylinositol (GPI) anchor attached to the hemopexin domain [323, 327]. 
MMPs are produced as zymogens and kept inactive by interaction of the cysteine residue 
in the pro-domain cysteine-switch motif with the zinc-ion in the catalytic site. MMPs are 
subsequently activated in the extracellular space by disrupting this cysteine interaction, a 
mechanism called cysteine switch, either via proteolytic cleavage removing the pro-
domain, or by oxidizing the thiol group in cysteine residue [327, 328]. Activity of MMPs 
is also controlled by the inhibitor TIMP (tissue inhibitor of matrix metalloproteinases) 
[329]. Mammals have about 23 MMPs and 4 TIMPs, while Drosophila has 2 MMPs 
(Mmp1 and Mmp2) and 1 TIMP [330-332]. Drosophila Mmp1 is a secreted MMP, while 
Mmp2 has a GPI-anchor and is tethered to the membrane; however, recent in vitro evidence 
suggests that both MMPs have secreted and membrane-tethered isoforms, though it is not 
known whether these isoforms also exist in vivo [333]. Mmp1 and Mmp2 are both capable 
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of degrading BM components, like type IV collagen and perlecan, but show differences in 
substrate affinity and activity, and consequently are important for tumor invasion [245, 
330, 334-338].  
 
Rationale of the Thesis 
 Caspase-driven AiP is important for regenerative responses with implications in 
cancer. The undead tissue in Drosophila can be used as a model for understanding the 
contributions of AiP to overgrowth and tumor. We previously reported that the undead 
tissue generates extracellular ROS, which are important for AiP, as their loss suppresses 
the overgrowth of undead tissue [124]. In addition to ROS, undead tissue has an increased 
number of hemocytes, specifically plasmatocytes, present on the overgrown epithelium 
(Figure 2.1). Interestingly, hemocytes on the overgrown undead tissue have an altered 
morphology and localization (Figure 2.1). Based on our previous work, we know that 
hemocytes are important for AiP, and work downstream of ROS [124]. However, an 
important question still unanswered is: how are hemocytes recruited to the overgrown 
undead tissue. 
The aim of this doctoral thesis was to characterize the role hemocytes play in AiP 
and undead tissue. In particular, this work aimed to elucidate how hemocytes are recruited 
to the undead tissue. Larval hemocytes are not recruited via directed migration as seen for 
embryonic hemocytes, but rather are recruited to wounds or tumors by adhesion following 
BM damage [244, 245]. I hypothesized that hemocytes might be recruited to undead tissue 
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in a similar adhesive capture manner. Degradation of BM is an important first step in 
adhesive capture of hemocytes to wounds and tumors; therefore, I examined BM integrity 
in the undead tissue to determine if it is damaged. I also identified the mechanisms of BM 
damage in the undead tissue and how it correlates with different neoplastic and hyperplastic 
tumor models in Drosophila. Finally, I confirmed the role of BM damage in recruiting 
hemocytes to undead tissue in the context of AiP and overgrowth. The results from my 
investigations are summarized in Chapter II of the thesis.  
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CHAPTER II: 
 
BASEMENT MEMBRANE DAMAGE BY ROS- AND JNK-
MEDIATED MMP2 ACTIVATION DRIVES MACROPHAGE 
RECRUITMENT TO OVERGROWN TISSUE IN DROSOPHILA 
 
 
 
 
 
A modified version of the following chapter is currently under revision at Nature 
Communications: 
N. Diwanji and A. Bergmann. “Basement Membrane damage by ROS- and JNK-mediated 
Mmp2 activation drives macrophage recruitment to overgrown tissue in Drosophila.” 
 
Figure 2.2 was originally published in:  
C.E. Fogarty*, N. Diwanji*, J.L. Lindblad*, M. Tare*, A. Amcheslavsky*, K. Makhijani, K. 
Bruckner, Y. Fan, A. Bergmann. “Extracellular Reactive Oxygen Species Drive Apoptosis-
Induced Proliferation via Drosophila Macrophages” Curr Biol 26(5) (2016) 575-84.  
*Co-first authors  
  
Lara Strittmatter from the Electron Microscopy core at UMMS helped with EM image 
acquisitions for Figure 2.1; 2.3; 2.5 
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ABSTRACT 
Macrophages are one of the major immune cell types infiltrating tumors, and help promote 
tumor growth and metastasis. Understanding how macrophages are recruited to tumors is 
important for inhibiting tumor progression, and for developing novel therapeutic strategies. 
To elucidate the mechanism of macrophage recruitment, we utilized an overgrowth tumor 
model (“undead” model) in larval Drosophila imaginal discs that are attached by a high 
number of macrophages. Here, we report that changes to the microenvironment of the 
overgrown undead tissue are important for recruiting macrophages. First, we describe a 
correlation between generation of reactive oxygen species (ROS) and damage of the 
basement membrane (BM) in all neoplastic, but not hyperplastic, models examined. We 
demonstrate that ROS and the stress kinase JNK mediate the accumulation of matrix 
metalloproteinase 2 (Mmp2), which damages the BM. Finally, the damaged BM recruits 
macrophages to the undead tissue. Taken together, we propose a model where macrophage 
recruitment to overgrowing tissue is a multi-step process requiring ROS- and JNK-
mediated Mmp2 activation and BM damage. These findings have novel implications for 
understanding the role of the tumor microenvironment for macrophage activation. 
 
 
Keywords: 
Macrophages, hemocytes, cancer, ROS, JNK, basement membrane, metalloproteinase, 
Drosophila 
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INTRODUCTION 
Tumor-associated macrophages (TAMs) are one of the major immune cells that 
infiltrate the tumor and provide an inflammatory environment important for cancer 
progression [251, 339]. They play a role in tumor growth, invasion, angiogenesis and 
immunosuppression, thus helping in tumor survival and metastasis [340]. Often, apoptotic 
tumor cells release signals that attract circulating monocytes to the tumors where they 
undergo differentiation and alternative activation to yield M2-polarized TAMs [341-344]. 
The tumor microenvironment also helps in TAM recruitment [343, 345], although not 
much is known about which cells of the microenvironment contribute to this process. While 
the identities of several key molecular and cellular players in TAM recruitment are well 
established, there still remains a need to better understand the dynamic interactions that 
occur between the tumor and its microenvironment during this complex immune response.  
Drosophila melanogaster has become a valuable model system to dissect the 
fundamental, mechanistic and conserved aspects of inflammatory responses [346, 347]. 
Several studies have reported the presence of macrophages in different Drosophila tumor 
models [245, 248, 249, 348, 349] (reviewed in [239]). These macrophages, termed 
hemocytes, have tumor promoting as well as tumor inhibiting functions, analogous to the 
activity of mammalian macrophages. One such overgrowth-promoting role of hemocytes 
was recently described in the context of apoptosis-induced proliferation (AiP) [124].  
AiP is a form of compensatory proliferation where active caspase-initiated 
signaling cascades in apoptotic cells drive proliferation of neighboring healthy cells, and 
thus help to maintain tissue homeostasis following significant cell loss [350] (reviewed in 
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[98, 351]). Early work in Drosophila has revealed that the Caspase-9-like initiator caspase 
Dronc is critical for at least one type of AiP [117, 119, 120, 123, 129]. To decipher the 
signaling pathways important for AiP, caspases are activated by expression of the IAP-
antagonist hid, but the final step of cell death execution is blocked by co-expression of the 
effector caspase inhibitor p35, thereby keeping the cells in a permanent apoptotic state that 
is referred to as “undead”. Because P35 specifically inhibits the activity of effector 
caspases, Dronc remains uninhibited and can persistently signal for AiP leading to 
overgrowth of the undead tissue [122, 123]. If undead tissue is induced by co-expression 
of hid and p35 using the ey-Gal4 driver (ey>hid,p35), the portion of the larval eye imaginal 
discs that is expressing ey-Gal4 (Figure 2.1c) and the resulting adult heads are overgrown 
[123].  
Using the undead model, we reported recently that active Dronc leads to production 
of extracellular reactive oxygen species (ROS) by stimulation of the transmembrane 
NADPH oxidase Dual oxidase (Duox) which attracts hemoytes and leads to the activation 
of the stress kinase JNK (c-Jun N-terminal Kinase) to drive AiP [124]. JNK triggers the 
release of the mitogens Wg, Dpp and EGF to induce AiP [118, 123, 129] as well as induces 
the expression of hid, setting up an amplification loop that continuously signals in undead 
cells for AiP [124, 133]. Similar amplification loops were also observed in tumor models 
in Drosophila [349, 352-354]. 
The Drosophila larval eye-antennal imaginal disc gives rise to the adult eyes and 
head. It is made up of two juxtaposed epithelial cell layers, the columnar disc proper (DP) 
cell layer and the squamous peripodial epithelium (PE), which face each other apically 
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separated by a lumen while their basal sides are exposed to the hemolymph and are 
surrounded by a basement membrane (Figure 2.3a) [355]. Interestingly, hemocytes 
attached to the eye discs are always observed at the basal side of the DP, not on the PE. On 
control discs, hemocytes form large cell aggregates invariably on the posterior side of the 
morphogenetic furrow (MF) (Figure 2.1a-f). Ultrastructural analysis show that the 
hemocytes on control discs show a more rounded morphology (Figure 2.1b,c,e,f). 
However, on undead discs, hemocytes spread out to the anterior of the MF, often as single 
cells, are less spherical and extend cellular protrusions which make contact with the 
epithelial cells of the undead tissue (Figure 2.1g-i). These differences in hemocyte behavior 
on the undead tissue indicate that they are getting “activated”, and we have defined such 
changes in hemocyte localization, morphology, and presence of cellular extensions as an 
“activated” form of hemocytes (Figure 2.1k). About half of the hemocytes on undead discs 
display the activated phenotype (Figure 2.1k). There is also an overall increase in hemocyte 
numbers on the undead tissue (Figure 2.1j), as well as in the hemolymph. There is a 
significant increase in circulating hemocyte numbers in the larvae with undead tissue 
compared to the controls (Figure 2.1l). These data indicate that additional hemocytes are 
coming into circulation and are getting recruited to the overgrown undead tissue. However, 
the specific mechanisms of hemocyte recruitment and activation to the undead tissue are 
not known. One possibility could be that ROS produced by undead or tumor cells help 
attract circulating hemocytes to the overgrown tissue [124, 349]. Indeed, loss of ROS upon 
expression of extracellular catalase hCatS or Duox RNAi causes a significant reduction in 
total hemocytes on undead tissue (Figure 2.2c,d) [124].  
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Figure 2.1. Undead discs have increased numbers of hemocytes 
(a,d,g) Hemocytes (labeled by plasmatocyte-specific antibody NimC; red in (a, d, g); grey 
in (a’, a’’, d’, d’’, g’, g’’)) in control ey-Gal4 (a) and ey>p35 (d) discs are present in tight 
cellular clusters (magnified in (a’’, b’’)) at the boundary of the differentiating 
photoreceptor neurons (labeled by ELAV; green in (a, d, g)). In undead ey>hid,p35 
overgrown discs, hemocytes are present as single cells or in small clusters, are spread out 
over the undead portion of the eye disc and are increased in numbers (g-g’’). These 
hemocytes extend cellular protrusions (yellow arrowheads) indicating an activated 
phenotype (g’; magnified in g’’). Discs are outlined by yellow lines; the ey-Gal4 expression 
area is outlined by white dotted lines in (a, d, g). Scale bars, 100μm (a, a’, d, d’, g, g’) and 
50μm (a’’, d’’, g’’). 
(b,e,h) Scanning electron microscopy (SEM) images of control (ey-Gal4 (b) and ey>p35 
(e)) and experimental (undead) (ey>hid,p35 (h)) eye imaginal discs focusing on hemocytes 
attached to DP side. The control discs show clustered and rounded hemocytes (b, e). In 
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contrast, undead eye discs show single hemocytes present with cellular protrusions as 
indicated by yellow arrowhead in (h). Scale bars, 10μm.  
(c,f,i) Transmission electron microscopy (TEM) images of control (ey-Gal4 (c) and 
ey>p35 (f)) and experimental (undead) (ey>hid,p35 (i)) eye imaginal discs focusing on the 
DP side. The control discs show rounded hemocytes sitting on the disc cells (c,f), while the 
undead eye discs have a lot more hemocytes with cellular protrusions in contact with disc 
cells as indicated by yellow arrowheads in (i). Scale bars, 5μm (c) and 2μm (f, i). 
(j-k) Quantification of hemocyte recruitment (j) and activation (k) in control and undead 
ey>hid,p35 discs. Hemocyte activation was measured by the % of total hemocytes that had 
one or more cellular protrusions. 48% of total recruited hemocytes in ey>hid,p35 discs had 
an activated morphology, while the controls did not show any activated hemocytes (e). 
Total number and % of activated hemocytes were analyzed by one-way ANOVA with 
Tukey’s multiple comparisons test. ****p < 0.0001, n.s. = no statistical significance (n=20 
discs per genotype analyzed). 
(l) Quantification of total circulating hemocyte numbers in the hemolymph of larvae with 
control and undead ey>hid,p35 discs. The larvae were bled, hemolymph collected, total 
number of hemocytes were counted using hemocytometer, and analyzed by one-way 
ANOVA with Tukey’s multiple comparisons test. ***p<0.001, ****p < 0.0001 (n=12 (ey-
Gal4), 13 (ey>p35) and 20 (ey>hid,p35) larvae analyzed per genotype). 
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Figure 2.2. Loss of ROS correlate with loss of hemocytes from undead tissue. 
The ey-Gal4 expressing areas in the anterior portion of the larval eye imaginal discs which 
corresponds to undead tissue in (b,c,d), lies between the yellow dotted lines. Hemocytes 
are detected by the pan-hemocyte specific antibody anti-Hemese (red in a,b,c,d; grey in 
(a’,b’,c’,d’). Cleaved Caspase 3 (CC3) antibody labeling is shown in green (a,b,c,d) and 
grey (a”,b”,c”,d”). Scale bars: 50μm. 
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(a) In ey>p35 control discs, hemocytes (red in a; grey in a’) are found in a clumped 
aggregate pattern along the boundary between anterior proliferating and posterior 
differentiating eye tissue (visualized by ELAV labeling in blue (a); separated by the right 
yellow dotted line). They are also present as a cell aggregate in the antennal portion of the 
imaginal disc (left). CC3 labeling is not detectable in these control discs (a”) 
(b) Hemocytes adhere as single cells or small cell clusters on undead ey>hid,p35 eye tissue 
with reduced spherical morphology (b’). They are present in overgrown areas which in this 
case extend into the posterior portion of the disc as visualized by the disrupted ELAV 
pattern (blue). There is strong CC3 labeling in this portion of the eye discs (b”). 
(c-d’’) Hemocyte association with ey>hid,p35 eye disc is abolished or reduced to control 
levels upon loss of ROS by transgenic expression of Duox RNAi (c) and hCatS (d). The 
ELAV pattern is normalized in these discs (blue in c, d) indicating suppression of abnormal 
growth. CC3 labeling is reduced, but not absent, in (c”,d”) compared to ey>hid,p35 discs 
alone (b”). 
Originally published in [124] and modified with permission. 
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However, it is not clear by what mechanisms ROS contribute to recruiting hemocytes to 
the undead tissue. Similar requirement of ROS for hemocyte recruitment has been observed 
in the wound healing response in the Drosophila embryo [356]. Additionally, damage to 
the basement membrane following wounding or in RasV12scrib tumors is also a mechanism 
that is sufficient for hemocyte recruitment in Drosophila larvae [244, 245]. 
The basement membrane (BM) is a thin-layered polymer of matrix proteins that 
surrounds the basal side of epithelial tissue including imaginal discs (Figure 2.3a) [357]. 
The BM is important for tissue morphogenesis and maintaining tissue shape, and provides 
a mechanical barrier which prevents tumor cells from invading into distant tissues [336, 
358, 359]. Major components of the BM are type IV collagen, Laminins, Perlecan and 
Nidogen [252, 261, 360]. These components are produced and secreted by fat body cells 
and hemocytes, and incorporated into the BM at imaginal discs and other tissues [296, 300, 
360, 361]. Matrix metalloproteinases (MMPs) are Zinc-containing extracellular proteases 
that are critical for the assembly and reorganization of the BM [323, 324]. The Drosophila 
genome encodes two MMP genes, Mmp1 and Mmp2. Both MMPs have membrane-tethered 
and secreted forms [330, 331, 333]. 
Here, we report that the microenvironment of the overgrown undead tissue is 
important for recruiting hemocytes. The BM of undead imaginal discs is severely damaged. 
This damage to the BM integrity correlates with production of ROS and activation of JNK 
in undead tissue as well as in several neoplastic epithelial tumor models. However, ROS 
and JNK are not sufficient to cause BM damage in normal tissue. We found that Mmp2, 
but not Mmp1, is necessary and sufficient for disrupting the BM of undead as well as 
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normal tissue. Both ROS and JNK regulate the expression of Mmp2, and there is a strong 
accumulation of Mmp2 protein specifically at the basal side of DP cells. Finally, the 
damaged BM is sufficient for recruiting hemocytes from the circulation to the tissue. These 
data illustrate the influence of the tumor microenvironment for recruiting hemocytes to 
further promote tumor growth.   
 
RESULTS 
Undead discs have damaged BM 
Previous studies have implicated the BM and tissue damage as a mechanism by 
which circulating hemocytes are recruited to wounds or tumors [244, 245, 356]. To 
determine if hemocyte recruitment to undead discs is dependent on BM damage, we 
examined the integrity of the BM using antibodies that detect the BM components Perlecan 
and Laminin. In undead ey>hid,p35 discs, the BM is severely disrupted compared to 
control (ey-Gal4 and ey>p35) discs, which have an intact and uniform BM (Figure 2.3b-
d’; Figure 2.4). There appear to be gaps, folds and deposits of the BM of undead discs 
around which hemocytes are attached (Figure 2.3d,d’). Damage to the surface of undead 
imaginal discs was also directly observed by scanning electron microscopy (SEM) and 
transmission electron microscopy (TEM) (Figure 2.3e-j’). Importantly, BM damage as 
assessed by Perlecan and Laminin immunolabeling as well as SEM and TEM was observed 
in all experimental (undead) discs, while all control discs displayed an intact BM (Figure 
2.3k).  
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Figure 2.3. Undead discs have damaged basement membranes (BM) 
(a) Schematic representation of a surface view (XY; left) and an orthogonal section view 
(YZ; right) along the red dotted line through a 3rd instar larval eye-antennal imaginal disc. 
The columnar epithelial cells of the disc proper (DP) and the squamous epithelial layer of 
the peripodial epithelium (PE) are apically separated by a lumen. Their basal surfaces are 
surrounded by the basement membrane (BM, green) and together face the hemolymph. 
Hemocytes attach specifically at the basal side of the DP.  
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(b-d’) Representative examples of control (ey-Gal4 (b-b’) and ey>p35 (c-c’)) and 
experimental (undead) (ey>hid,p35 (d-d’)) eye imaginal discs labeled for the BM with anti-
Perlecan antibody (green), hemocytes with anti-NimrodC (NimC) antibody (red) and 
ELAV (blue) which marks the posterior photoreceptor neurons. Panels (b, c and d) are 
single slices focusing on the basal side of the DP. The yellow boxed areas in (b-d) are 
magnified in (b’-d’) focusing on the basal side of the DP. Compared to the continuous 
Perlecan labeling of the control eye discs, which suggests that the BM uniformly surrounds 
the discs (b-c’), the Perlecan labeling of undead discs shows areas where the BM is absent 
or discontinuous with gaps and punctate-like appearance (d-d’). Hemocytes (red) are seen 
adjacent to the damaged BM area as indicated by white arrowheads in d’. Scale bars, 
100μm. 
(e-g’) Scanning electron microscopy (SEM) images of control (ey-Gal4 (e-e’) and ey>p35 
(f-f’)) and experimental (undead) (ey>hid,p35 (g-g’)) eye imaginal discs focusing on the 
DP side. The yellow boxed areas in (e-g) are magnified in (e’-g’). The control discs show 
smooth and intact BM (e-f’). In contrast, undead eye discs show patchy and degraded 
surface of BM as indicated by yellow arrowheads in (g’). Scale bars, 200μm (e-g) and 1μm 
(e’-g’).  
(h-j’) Transmission electron microscopy (TEM) images of control (ey-Gal4 (h-h’) and 
ey>p35 (i-i’)) and experimental (undead) (ey>hid,p35 (j-j’)) eye imaginal discs focusing 
on the DP side. The yellow boxed areas in (h-j) are magnified in (h’-j’). The control discs 
show continuous and intact BM (h-i’), while the undead eye discs have areas where BM is 
missing or discontinuous as indicated by yellow arrowheads in j’. Scale bars, 0.5μm (h-j) 
and 0.2μm (h’-j’).   
(k) Table showing the frequency of BM damage observed for the controls and undead discs 
as assayed by immunolabeling with Perlecan and Laminin, as well as SEM and TEM. 
100% of all undead ey>hid,p35 eye discs show some degree of damage to the BM, while 
none of the control eye discs have a damaged BM.  
(l) Quantification of Perlecan labeling at DP normalized to PE as internal control reveals 
that the BM is damaged in undead ey>hid,p35 discs compared to controls. Quantification 
of Perlecan fluorescence is taken from single slices at the basal surface of DP and PE and 
is signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-Sidak test 
for multiple comparisons. **p < 0.01, n.s. = no statistical significance (n=18 (ey-Gal4), 20 
(ey>p35) and 26 (ey>hid,p35) discs).  
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Figure 2.4. Laminin labeling in undead discs shows damage to the BM 
(a-c’) Representative examples of control (ey-Gal4 (a-a’) and ey>p35 (b-b’)) and 
experimental (undead) (ey>hid,p35 (c-c’)) eye imaginal discs labeled for the BM with anti-
Laminin antibody (red). Panels (a, b, c) are single slices focused on the basal side of DP. 
The white boxed area in (a-c) is magnified in (a’-c’) focusing on the basal side of the DP. 
Compared to the continuous Laminin labeling of the control eye discs, which suggests that 
the BM uniformly surrounds the discs (a-b’), the Laminin labeling of undead discs shows 
areas where the BM is absent or discontinuous with gaps and punctate-like appearance (c-
c’). Scale bars, 100μm (a-c) and 50μm (a’-c’). 
(d) Quantification of Laminin labeling reveals that the BM in undead ey>hid,p35 discs is 
damaged. Fluorescence intensity at PE was used as internal control for normalization. 
Quantification of Laminin fluorescence is taken from single slices at the basal surface of 
DP and PE and is signal intensity per μm2 ± SEM analyzed by one-way ANOVA with 
Holm-Sidak test for multiple comparisons. ****p < 0.0001, n.s. = no statistical significance 
(n=12 (ey-Gal4), 10 (ey>p35) and 12 (ey>hid,p35) discs of each genotype analyzed).  
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Figure 2.5. The BM on the PE side of undead discs is not damaged 
(a-i’) Representative examples of control (ey-Gal4 (a-c’) and ey>p35 (d-f’)) and 
experimental (undead) (ey>hid,p35 (g-i’)) eye imaginal discs labeled for the BM with anti-
Perlecan antibody (green in a, d, g), anti-Laminin antibody (red in b, e, h) and Scanning 
Electron Microscopy (SEM) images (c-c’, f-f’, i-i’) focusing on the PE side. Panels (a, b, 
d, e, g, h) are single slices focused on the basal side of PE. The yellow boxed area in (c, f, 
i) is magnified in (c’, f’, h’) focusing on the basal side of PE. Undead discs show similar 
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uniform BM as seen for control discs at the PE side indicating that BM is not damaged. 
Scale bars, 100μm (a, b, d, e, g, h), 200μm (c, f, i) and 1μm (c’, f’, i’). 
(j, k) Quantification of Perlecan (j) and Laminin (k) labeling reveals that the damage of the 
BM in undead ey>hid,p35 discs is selectively observed at the basal side of the DP while 
the labeling at the PE side is comparable among the controls and experimental discs. 
Quantification of Perlecan and Laminin fluorescence is taken from single slices at the basal 
surface of DP and PE and is signal intensity per μm2 ± SEM analyzed by one-way ANOVA 
with Holm-Sidak test for multiple comparisons. **p < 0.01, ****p < 0.0001, n.s. = no 
statistical significance  
(For j: n=18 (ey-Gal4), 20 (ey>p35) and 26 (ey>hid,p35) discs); (For k: n=12 (ey-Gal4), 
10 (ey>p35) and 12 (ey>hid,p35) discs) of each genotype analyzed. 
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Interestingly, these irregularities of the BM occur only at the DP side of the undead discs, 
while the BM on the PE side is not affected (Figure 2.3d,g; Figure 2.4c; Figure 2.5). 
Consistently, as the result of BM damage, Perlecan and Laminin fluorescence are only 
reduced on the DP, but not PE, side of undead eye discs (Figure 2.3l; Figure 2.4d; Figure 
2.5j,k). Based on these observations, we used the fluorescence on the PE side as an internal 
control for quantifying the changes in Perlecan and Laminin fluorescence on the DP side 
(Figure 2.3l; Figure 2.4d).  Because hemocytes are also only present at the DP side of 
undead discs (Figure 2.3a), these data imply that damaged BM might be responsible for 
recruiting hemocytes to these overgrown discs.   
Next, we examined whether BM damage is triggered simply due to the activation 
of the apoptosis pathway. Because expression of hid without p35 in the eye imaginal disc 
using ey-Gal4 causes early larval lethality, we expressed hid in the pouch area of the wing 
imaginal disc using a spalt-Gal4 driver (salEPv>hid). Although the BM in these 
experiments does not appear to be as smooth as in the control, it is still intact without any 
gaps, and the Perlecan intensity is comparable to control discs (Figure 2.6a-b’,d). However, 
when these discs were made undead by co-expression of p35 (salEPv>hid,p35), the BM 
now shows signs of damage with appearance of gaps and holes in the Perlecan labeling, 
and significant decrease in Perlecan fluorescence (Figure 2.6c,c’,d). These data suggest 
that induction of the apoptosis pathway alone is not sufficient for a significant BM damage. 
Instead, it is the undead condition that is responsible for the BM damage. 
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Figure 2.6. Induction of Apoptosis does not damage the BM 
BM detected by Perlecan (red in (a, b, c); grey in (a’, b’, c’)). GFP marks the domain where 
Gal4 is expressed. Scale bars, 100μm. 
(a-c) Apoptosis induced by expression of hid does not damage the BM (b-b’). Perlecan 
labeling is slightly disrupted around the hid-expressing area (b’), but no gaps or absence of 
Perlecan labeling is observed and is comparable to the GFP-only control (a-a’). Undead 
tissue created by expression of hid and p35 (c-c’) shows damage to the BM by Perlecan 
labeling with gaps appearing in and around the hid,p35-expressing area (c-c’). Panels (a, 
a’, b, b’, c, c’) are single slices focused on the basal side of DP. 
(d) Quantification of Perlecan intensity in (a-c) were taken from single slices at the basal 
surface of DP and PE. Fluorescence intensity at PE was used as internal control for 
normalization. Signal intensity per μm2 ± SEM analyzed by Unpaired T test. n.s. = no 
statistical significance (n=16 (salEPv>GFP),  5 (salEPv>hid, GFP), and 11 (salEPv>hid,p35 
GFP) discs of each genotype analyzed).  
67 
 
BM damage correlates with ROS production in neoplastic tumor models 
Based on the observation that overgrown undead discs have a damaged BM, we 
next asked whether the BM damage is simply a consequence of the overgrowth. To address 
this question, we examined several different neoplastic and hyperplastic overgrowth 
(tumor) models in Drosophila. First, the mosaic RasV12lgl condition is a neoplastic tumor 
model in Drosophila, characterized by unrestricted proliferation, failure to differentiate, 
tissue invasion and ultimately death of the organism [335, 362-364]. Mosaic RasV12lgl eye 
discs show disruption of BM as visualized by gaps in Perlecan labeling (Figure 2.7a,a’; 
quantified in Figure 2.9a), similar to the related RasV12scrib condition [335, 364]. Second, 
epithelial tissue mosaic for vps25, a component of the ESCRT-II complex involved in 
endosomal protein sorting, is highly overgrown and neoplastic in nature [365-368]. vps25 
mutant clones induce non-cell autonomous overgrowth due to increased proliferation and 
cell survival of non-mutant cells. Examining the BM in this neoplastic tumor model, we 
observed disruptions of Perlecan labeling at mosaic discs indicating that there is BM 
damage in this tumor context (Figure 2.7c,c’; Figure 2.9a). Third, the Hippo signaling 
pathway is an important regulator of cell proliferation and cell death, and mutations in 
pathway components like hippo cause a hyperplastic phenotype characterized by increased 
proliferation, but leaving cellular architecture intact [363, 369-372]. Interestingly, even 
though hippo mosaic discs are strongly overgrown, they do not show disruption of the BM 
by Perlecan labeling. The overgrown discs have a uniform and intact BM surrounding the 
mutant and normal cells and do not show any gaps in Perlecan labeling (Figure 2.7e,e’; 
Figure 2.9a). Finally, deregulation of the Notch pathway is also associated with tumors in 
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both humans and Drosophila, and the eyeful condition is one such Notch-induced 
hyperplastic overgrowth model in Drosophila eye imaginal discs [373]. In overgrown 
eyeful discs, an intact BM is observed without any irregularities in Perlecan labeling 
(Figure 2.7g; Figure 2.9a). Taken together, these data imply that BM damage is not a 
universal hallmark for all overgrowth models.    
To identify commonalities in these tumor models that would result in differential 
effects on BM integrity, we investigated for the presence of ROS. Elevated ROS levels are 
characteristic of multiple cancers and are thought to promote tumor growth [192]. Using 
the ROS indicator dye dihydoethidium (DHE), we found that the neoplastic RasV12lgl 
mosaic discs have increased ROS production (Figure 2.7b,b’; quantified in Figure 2.9b), 
similar to the related RasV12scrib tumor (ref. [349]). Likewise, vps25 mosaic discs are also 
characterized by a marked increase in ROS production. Intense DHE puncta are observed 
in and around tumor clones (Figure 2.7d,d’; Figure 2.9b). In contrast, the hyperplastic 
hippo mosaics as well as the eyeful discs do not produce any detectable ROS as indicated 
by the absence of DHE labeling in these overgrown discs (Figure 2.7f,h; Figure 2.9b). 
Together, these data suggest that BM damage and ROS production correlate in the disc, 
and this correlation coincides with the induction of neoplastic growth (Figure 2.7i). 
Similarly, undead discs also demonstrate ROS production [124, 134, 135], as well as BM 
damage (Figure 2.3), providing evidence for a correlative link between ROS and BM 
damage in this overgrowth context as well. 
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Figure 2.7. BM damage correlates with ROS production in neoplastic tumor models 
Except for eyeful (g,h), tumor clones were generated by the MARCM technique using ey-
FLP and are marked by GFP (a-f). eyeful is uniformly expressed in the ey-Gal4 domain. 
The BM is detected by anti-Perlecan labeling (red in (a), (c) and (e); grey in (a’), (c’), (e’) 
and (g)). ROS is detected by the dihydroethidium (DHE) indicator dye (red in (b), (d) and 
(f); grey in (b’), (d’), (f’) and (h)). Panels (a, a’, c, c’, e, e’ and g) are single slices focusing 
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on the basal side of DP. Panels (b, b’, d, d’, f, f’ and h) are maximum intensity projections. 
Quantifications of the Perlecan and DHE labeling in Figure 2.9a,b. Scale bars, 100μm. 
Exact genotypes:  
(a,b) yw ey-FLP/+; lgl4 FRT40A/tub-Gal80 FRT40A; act>y+>Gal4, UASGFP56ST/+. 
(c,d) yw ey-FLP/+; FRT42D vps25N55/FRT42D tub-Gal80; act>y+>Gal4 UAS-
GFP56ST/+. 
(e,f) yw ey-FLP/+; FRT42D hpo42-47/FRT42D tub-Gal80; act>y+>Gal4 UAS-
GFP56ST/+. 
(g,h) yw ey-Gal4/+; UAS-Dl UAS-psq UAS-lola/+. 
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Figure 2.8. Hemocytes and JNK activation in different tumor models 
Except for eyeful (g,h), tumor clones were generated by the MARCM technique using ey-
FLP in the eye imaginal discs and are marked by GFP (a-f). eyeful is uniformly expressed 
in the ey-Gal4 domain (exact genotype: ey>Dl,lola,psq). Hemocytes are detected by NimC 
(red in (a, c, e); grey in (a’, c’, e’, g)). Activation of JNK is detected by phospho-JNK 
(pJNK) antibody (red in (b, d, f); grey in (b’, d’, f’, h)). Scale bars, 100μm  
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(a, c, e, g) Hemocytes attached to mosaic discs of neoplastic tumor models such as 
RasV12lgl4 (a-a’) and vps25 (c-c’) show an activated morphology, around tumor clones as 
indicated by yellow arrowheads in (a’) and (c’). In contrast, although the hyperplastic 
tumor models such as hippo mosaics (e-e’) and eyeful (g) have a high number of hemocytes 
attached to the discs, these hemocytes do not have an activated morphology. The 
hemocytes present are tightly clustered, are not present as single cells, and do not have 
extended cellular protrusions. Quantified in Figure 2.9c,d. 
(b, d, f, h) The neoplastic tumor mosaics show upregulated active JNK (b-b’; d-d’), while 
the hyperplastic models do not have activated JNK (f-f’; h), suggesting a correlation 
between hemocyte activation, JNK activation with production of ROS and damage to BM 
(Figure 2.7). Quantified in Figure 2.9e. 
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Figure 2.9. Quantifications for Figure 2.7 and Figure 2.8 
(a) Quantification of Perlecan intensity in Figure 2.7 (a, c, e, g) taken from single slices at 
the basal surface of DP and PE, and represented as a ratio of fluorescence intensity at DP 
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to PE compared to control (ey-Gal4) Perlecan intensity ratio. Fluorescence intensity at PE 
was used as internal control for normalization. Signal intensity per μm2 ± SEM analyzed 
by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p < 0.0001, n.s. 
= no statistical significance. (n=18 (control - ey-Gal4), 17 (RasV12lgl4), 12 (vps25N55), 12 
(hpo42-47) and 12 (eyeful) discs of each genotype analyzed). 
(b) Quantification of DHE intensity in Figure 2.7 (b, d, f, h) taken from maximum intensity 
projections, represented as mean signal intensity per μm2 ± SEM analyzed by one-way 
ANOVA with Holm-Sidak test for multiple comparisons. **p<0.01, ****p < 0.0001, n.s. 
= no statistical significance. (n=3 (control - ey-Gal4), n=10 (RasV12lgl4), 10 (vps25N55), 8 
(hpo42-47) and 13 (eyeful) discs of each genotype analyzed). 
(c-d) Quantification of hemocyte recruitment (c) and activation (d) in Figure 2.8 (a, c, e, 
g), compared to control (ey-Gal4 from Figure 2.1j,k). Hemocyte activation was measured 
by the % of total hemocytes that had one or more cellular protrusions. Total number and 
% activated hemocytes were analyzed by one-way ANOVA with Tukey’s multiple 
comparisons test. *p<0.05, **p<0.01, ****p < 0.0001, n.s. = no statistical significance 
(n=20 (control - ey-Gal4), n=15 (RasV12lgl4), 12 (vps25N55), 12 (hpo42-47) and 15 (eyeful) 
discs of each genotype analyzed). 
(e) Quantification of pJNK intensity in Figure 2.8 (b, d, f, h) taken from maximum intensity 
projections, represented as mean signal intensity per μm2 ± SEM analyzed by one-way 
ANOVA with Holm-Sidak test for multiple comparisons. ***p<0.001, ****p < 0.0001, 
n.s. = no statistical significance. (n=3 (control - ey-Gal4), n=11 (RasV12lgl4), 7 (vps25N55), 
10 (hpo42-47) and 5 (eyeful) discs of each genotype analyzed). 
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In undead AiP, ROS directly or indirectly activate hemocytes followed by activation of 
JNK [124]. Therefore, we tested for activation of hemocytes and JNK in the overgrowth 
models. Consistently and as shown previously, RasV12lgl and vps25 mosaic discs are 
characterized by increased JNK signaling [362, 365, 374, 375] (see also Figure 2.8b,d; 
Figure 2.9e). Furthermore, these neoplastic discs are associated with hemocytes of an 
activated morphology (Figure 2.8a,c; Figure 2.9c,d). In contrast, although both the hippo 
mosaic and eyeful hyperplastic discs are associated with an increased number of 
hemocytes, these hemocytes are present in tight cellular aggregates and only few show 
cellular extensions (Figure 2.8e,e’,g; Figure 2.9c,d), indicating that they are not activated. 
JNK is also not activated in these discs as indicated by the lack of pJNK labeling (Figure 
2.8f,f’,h; Figure 2.9e).  
Taken together, these results suggest that there is a correlation of increased 
production of ROS, BM damage as well as activation of hemocytes and JNK in neoplastic 
tumor models like RasV12lgl and vps25. On the other hand, hyperplastic tumors caused by 
hippo mutants and eyeful lack these characteristics. Based on these observations, we 
propose that the undead ey>hid,p35 model represents a neoplastic model as it shows all 
these neoplastic characteristics that are absent in the hyperplastic models.    
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ROS and JNK are required for BM damage of undead discs, and together are 
partially sufficient for BM damage  
Our observations suggest that there is a correlation between ROS production and 
BM damage, and therefore we determined if ROS are required for BM damage. RNAi-
induced knockdown of Duox, the NADPH oxidase which synthesizes ROS in undead discs 
[124], or overexpression of the secreted catalase hCatS results in loss of ROS and 
suppression of ey>hid,p35 overgrowth (Figure 2.2) [124, 134, 135]. Under these ROS-
depleted conditions, BM disruption as measured by Perlecan and Laminin labeling was 
also suppressed (Figure 2.10a-c; quantified in e; Figure 2.11a-c’, quantified in e) 
suggesting that ROS are required for BM damage. Along with suppression of BM damage, 
loss of ROS also causes impaired hemocyte recruitment to the discs and loss of JNK 
activation [124].  
Next, we determined if ROS are sufficient for BM damage. However, 
overexpression of Duox is not sufficient for ectopic ROS production in control discs [130]. 
To overcome this problem, we exposed wild-type eye discs to hydrogen peroxide (H2O2) 
ex vivo, and then monitored the effect on the BM. Exposure of discs to H2O2-containing 
media had no effect on the BM. Perlecan labeling was intact and comparable to the control 
without H2O2 (Figure 2.10f-g’, l). These data suggest that although ROS are required for 
BM damage, they are not sufficient to induce the damage, implying that other factors may 
also contribute to BM damage.  
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Figure 2.10. ROS and JNK are required for BM damage, and together cause partial 
damage to the BM of imaginal discs 
(a-d) In ey>hid,p35 eye imaginal discs, RNAi-induced depletion of ROS-producing Duox 
(b), transgenic overexpression of a secreted catalase hCatS (c) and inactivation of JNK by 
expression of dominant negative JNK (JNKDN) (d) results in suppression of BM damage 
compared to undead controls (a). Single slices focusing on the basal side of DP show intact 
and uniform Perlecan labeling. Quantified in (e). Scale bars, 100μm 
(e) Quantification of Perlecan intensity in (a-d) is taken from single slices at the basal 
surface of DP and PE. Fluorescence intensity at PE was used as internal control for 
normalization. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-
Sidak test for multiple comparisons. ****p < 0.0001, n.s. = no statistical significance. 
(n=26 (ey>hid,p35), 20 (duox RNAi), 25 (hCatS) and 17 (JNKDN) discs of each genotype 
analyzed) 
(f-g’) Representative examples of wild type (ey-Gal4) eye imaginal discs incubated ex vivo 
in Schneider’s media with 0μM H2O2 (f) or 50μM H2O2 (g) labelled with antibody against 
Perlecan. Scale bars, 100μm 
(h-k’’) Representative examples of wing imaginal discs with wild-type (h-i”) or hyper-
activated JNK (hepCA) (j-k”) incubated ex vivo in Schneider’s media with 0μM H2O2 (h, j) 
or 50μM H2O2 (i, k) and labelled with antibody against Perlecan. The yellow boxed areas 
in (h’, i’, j’ and k’) are magnified in (h”, i”, j” and k”). Hyper-activation of JNK in presence 
of ROS causes BM damage as indicated by yellow arrowheads in (k”). Scale bars, 100μm 
(l) Quantification of Perlecan intensity in (f-k) is taken from single slices at the basal 
surface of DP and PE. Fluorescence intensity at PE was used as internal control for 
normalization. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-
Sidak test for multiple comparisons. n.s. = no statistical significance. (n=14 (ey-Gal4 0μM 
H2O2), 16 (ey-Gal4 50μM H2O2), 4 (salEPv>GFP 0μM H2O2), 7 (salEPv>GFP 50μM H2O2), 
6 (salEPv>hepCA,GFP 0μM H2O2) and 15 (salEPv>hepCA,GFP 50μM H2O2) discs of each 
genotype analyzed). 
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Figure 2.11. Effect of ROS and JNK on Laminin and JNK hyper-activation on BM 
(a-d’) Representative examples of ey>hid,p35 discs expressing Duox RNAi (b-b’), hCatS 
(c-c’) and JNKDN (d-d’) labeled with anti-Laminin antibody compared to ey>hid,p35-only 
(a,a’). Single slices focusing on the basal side of DP show intact and uniform Laminin 
labeling (red in (a-d); grey in (a’-d’)). Quantified in (e). Scale bars, 100μm.  
(e) Quantification of Laminin intensity in (a-d) taken from single slices at the basal surface 
of DP and PE. Fluorescence intensity at PE was used as internal control for normalization. 
Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-Sidak test for 
multiple comparisons. ****p < 0.0001, n.s. = no statistical significance. (n=12 
(ey>hid,p35), 7 (duox RNAi), 14 (hCatS) and 10 (JNKDN) discs analyzed). 
(f-g’) Hyper-activation of JNK by over-expressing a constitutively activated construct of 
the JNKK Hep (hepCA) in the GFP positive area of the wing pouch does not damage the 
BM. Quantified in (h). Scale bars, 100μm 
(h) Quantification of Perlecan intensity in (f-g) taken from single slices at the basal surface 
of DP and PE. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-
Sidak test for multiple comparisons. n.s. = no statistical significance. (n=16 (salEPv>GFP), 
and 13 (salEPv>hepCA, GFP) discs analyzed).  
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One such BM damage-contributing factor may be JNK. Activation of JNK is an 
important factor for AiP and is dependent on ROS [123, 124, 129]. To determine if JNK is 
necessary for BM damage, we blocked JNK activity by expressing a dominant negative 
construct (JNKDN) in ey>hid,p35 discs and monitored the effect on BM integrity. Loss of 
JNK signaling strongly impairs BM damage. Perlecan and Laminin labeling are not 
disrupted (Figure 2.10d,e; Figure 2.11d,e), suggesting that JNK activation is required for 
BM damage. 
Next, we asked whether activation of JNK signaling can promote BM damage. 
Because expression of a constitutively active JNK kinase transgene (hepCA) using ey-Gal4 
causes early larval lethality, we expressed hepCA in the wing imaginal disc using salEPv-
Gal4. However, salEPv>hepCA discs, similar to the salEPv>GFP control wing discs, are not 
characterized by BM damage (Figure 2.11f-h). Therefore, similar to ROS, JNK activation 
is required, but not sufficient for BM damage. 
Finally, we tested whether H2O2 treatment of wing discs with increased JNK 
activity can cause damage to the BM ex vivo. Similar to H2O2-treated eye discs (Figure 
2.10g), treatment of salEPv-GFP control wing discs did not significantly damage the BM 
(Figure 2.10i-i’’). However, treatment of salEPv>hepCA wing discs with H2O2 causes a slight 
but non-significant damage to the BM in the salEPv-expression domain (Figure 2.10k-k’’,l). 
These data suggest that under these ex vivo conditions, combined activation of JNK 
signaling and exposure to H2O2 partially damages the BM. However, the damage under 
these conditions is very subtle and not as strong as in undead discs (Figure 2.10l), 
suggesting that potentially additional factors are involved in BM damage. 
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Figure 2.12. Hemocyte numbers do not correlate with BM damage of undead discs 
(a-b) In ey>hid,p35 eye imaginal discs, heterozygous srpneo45 suppresses the overgrowth 
phenotype[124], however, the BM is still damaged. Perlecan labeling shows areas of gaps 
and discontinuities around the discs (a-b, quantified in c). Scale bars, 100μm. 
(c) Quantification of Perlecan intensity in (a-b) taken from single slices at the basal surface 
of DP and PE. Fluorescence intensity at PE was used as internal control for normalization. 
Signal intensity per μm2 ± SEM analyzed by Unpaired T test. n.s. = no statistical 
significance. (n=26 (ey>hid,p35), 15 (ey>hid,p35;srpneo45/+) discs analyzed). 
(d-e’) Heterozygous srpneo45 in ey>hid,p35 undead discs causes the hemocytes to adopt an 
inactive morphology, where they form cellular aggregates along the morphogenetic furrow 
and do not extend cellular protrusions indicated by yellow arrowheads.  
(f-g) Quantification of hemocyte recruitment (f) and activation (g) in ey>hid,p35 and 
ey>hid,p35;srpneo45/+ discs. Hemocyte activation was measured by the % of total 
hemocytes that had one or more cellular protrusions. Total number and % activated 
hemocytes were analyzed by Unpaired T test. ****p < 0.0001 (n=20 (ey>hid,p35), 18 
(srpneo45/+) discs analyzed).   
82 
 
Hemocytes do not damage the BM of undead discs 
To exclude the possibility that recruited hemocytes themselves are damaging the 
BM of undead discs, we analyzed the BM of undead discs in a heterozygous serpent (srp) 
background. srp encodes a GATA-type Zn finger transcription factor which is required for 
hemocyte differentiation [376]. The srpneo45 allele specifically affects hemocyte 
differentiation [230] and dominantly suppresses the adult overgrowth phenotype of 
ey>hid,p35 animals [124]. Despite this suppression of overgrowth, the BM of ey>hid,p35 
discs heterozygous for srpneo45 was still disrupted with large gaps in Perlecan labeling 
(Figure 2.12a-c). Similar to control discs (Figure 2.1a,b), on these discs, fewer hemocytes 
are present that form aggregates with very little cellular protrusions indicating a naïve 
morphology (Figure 2.12d-g). These results indicate that that there is no linear relationship 
between BM damage and the amount of hemocytes attached to the discs and suggest that 
BM damage occurs largely independently of hemocytes. 
 
MMPs are upregulated in the undead discs 
Matrix metalloproteinases (MMPs) are well known for their remodeling function 
of the extracellular matrix [323, 324]. The Drosophila genome encodes two MMP genes, 
Mmp1 and Mmp2 (ref. [331, 332]). To determine if MMPs play a role in BM damage of 
undead discs, we first examined if MMPs are expressed in undead discs. Previous studies 
have shown that JNK activation triggers upregulation of Mmp1, in tumors as well as in the 
undead discs, and often Mmp1 is used as a marker of JNK activity [118, 123, 124, 129, 
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334]. Consistent with these results, we observe a marked upregulation of Mmp1 transcript 
and protein levels in ey>hid,p35 undead discs compared to controls (Figure 2.14a, f-h). 
Likewise, Mmp2 transcripts, as detected by qPCR, are also upregulated in undead discs 
(Figure 2.14a), and there is an accompanying increase in Mmp2 protein levels (Figure 
2.13a-c). In control discs, Mmp2 protein is usually localized in the cells of the PE and 
apically in DP cells with little localization at the basal side (Figure 2.13a’,b’,d). Most 
strikingly, in undead discs, Mmp2 protein is not only upregulated at the PE (Figure 2.14b), 
but also shows a strong accumulation at the basal side of the DP (Figure 2.13c’,d), where 
the BM is preferentially damaged (Figure 2.3d,g,j). Interestingly, Mmp2 protein levels are 
uniformly upregulated across the entire disc, even outside of the ey-Gal4 expression 
domain (Figure 2.13c; Figure 2.14c). Mmp2 RNAi strongly reduces this uniform 
upregulation (Figure 2.14d,e) suggesting that uniform upregulation of Mmp2 is real and 
that the Mmp2 antibody is specific for Mmp2. Because Mmp2 is produced both as 
membrane-anchored and secreted proteins [333], the easiest explanation for the uniform 
distribution of Mmp2 in undead discs is the secreted nature of Mmp2. Interestingly, there 
is also a weak upregulation of Mmp2 in ey>p35 control discs (Figure 2.13a,b; Figure 
2.14a). However, despite this upregulation, there is no accumulation of Mmp2 protein at 
the basal side of the DP in ey>p35 discs (Figure 2.13d). 
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Figure 2.13. Upregulation of Mmp2 levels and activity in undead discs requires ROS 
and JNK 
(a-c) Representative examples of control (ey-Gal4 (a-a’) and ey>p35 (b-b’)) and undead 
(ey>hid,p35 (c-c’)) eye imaginal discs labeled for Mmp2 (red and grey) and ELAV (blue). 
Orthogonal (YZ) section views (a’, b’, c’) show increased localization of Mmp2 at the 
basal side of the DP in undead ey>hid,p35 discs compared to controls. Scale bars, 100μm. 
(d) Quantification of Mmp2 intensity in (a-c) taken from single slices at the basal surface 
of DP. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-Sidak 
test for multiple comparisons. ****p < 0.0001, n.s. = no statistical significance (n=19 (ey-
Gal4), 17 (ey>p35) and 26 (ey>hid,p35) discs of each genotype analyzed). Quantification 
of Mmp2 intensity at the PE shown in Figure 2.13b. 
(e-g) Examples of ey>hid,p35 eye imaginal discs with Duox RNAi (e), transgenic over-
expression hCatS (f) and of dominant negative JNK (JNKDN) (g) labeled for Mmp2 (red 
and grey) and ELAV (blue). Orthogonal (YZ) cross section views (e’, f’, g’) show 
suppression of the Mmp2 upregulation (red and grey) at the basal side of the DP compared 
to undead ey>hid,p35 discs. Scale bars, 100μm. 
(h) Quantification of Mmp2 intensity in (e-g) taken from single slices at the basal surface 
of DP. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-Sidak 
test for multiple comparisons. ****p < 0.0001, n.s. = no statistical significance (n=26 
(ey>hid,p35), 18 (duox RNAi), 19 (hCatS) and 20 (JNKDN) discs of each genotype 
analyzed). 
(i-k) Mmp2 activity measured by fluorometric assay using fluorescein-linked DQ-gelatin 
substrate. ey>hid,35 disc lysates show increased cleavage activity of DQ-gelatin substrate 
indicated by a marked increase in fluorescence compared to controls (i). This increased 
cleavage activity is lost upon knockdown of Mmp2, and is comparable to Mmp2 
overexpression (j). Mmp2 activity in ey>hid,p35 undead discs is dependent on ROS and 
JNK as the fluorescence intensity of the substrate decreases upon loss of ROS or 
downregulation of JNK activity (k). 
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Figure 2.14. MMPs in undead discs. 
(a) Mmp1 and Mmp2 mRNA measured by qPCR. Compared to ey-Gal4 control eye discs, 
the relative levels of Mmp1 and Mmp2 transcripts are significantly upregulated in undead 
ey>hid,p35 eye discs. Graph plotted as mean±SD of 3 independent biological replicates 
and normalized to ey-Gal4. p-value calculated by Unpaired T test. **p < 0.01, ***p<0.001.  
(b) Quantification of Mmp2 intensity in Figure 4 (a-c; e-g) taken from single slices at the 
basal surface of the PE. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA 
with Holm-Sidak test for multiple comparisons. ****p < 0.0001, n.s. = no statistical 
significance (n=19 (ey-Gal4), 17 (ey>p35) and 26 (ey>hid,p35), 18 (duox RNAi), 19 
(hCatS) and 20 (JNKDN) discs of each genotype analyzed).  
(c-d) RNAi against Mmp2 is efficient and shows almost complete reduction of Mmp2 
protein levels in ey>hid,p35 discs. Quantified in (e). Scale bars, 100μm. 
(e) Quantification of Mmp2 intensity in (c, d) taken from maximum intensity projections, 
represented as mean signal intensity per μm2 ± SEM analyzed by Unpaired T test. 
****p<0.0001. (n=26 (ey>hid,p35), 9 (Mmp2 RNAi) discs of each genotype analyzed). 
(f-h) Mmp1 protein levels are increased in undead discs. Representative examples of 
control (ey-Gal4 (f) and ey>p35 (g)) and undead (ey>hid,p35 (h)) eye imaginal discs 
labeled for Mmp1 protein (grey). Scale bars, 100μm. 
(i-k) Upregulation of Mmp1 in undead discs is mediated by ROS and JNK. Examples of 
ey>hid,p35 eye imaginal discs with RNAi against ROS-producing Duox (i), expression of 
a secreted catalase hCatS (j) and dominant negative JNK (JNKDN) (k) labeled for Mmp1 
(grey). Scale bars, 100μm. 
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Figure 2.15: ROS and JNK are not sufficient to induce Mmp2 expression 
(a-d’) Representative examples of wing imaginal discs with wild-type (a-b’) or hyper-
activated JNK (hepCA) (c-d’) incubated ex vivo in Schneider’s media with 0μM H2O2 (a, c) 
or 50μM H2O2 (b, d) and labelled with antibody against Mmp2. Scale bars, 100μm 
(e) Quantification of Mmp2 intensity in (a-d) taken from maximum intensity projections. 
Signal intensity per μm2 ± SEM analyzed by two-way ANOVA with Tukey’s multiple 
comparisons test. n.s. = no statistical significance. (n=4 (salEPv>GFP 0μM H2O2), 9 
(salEPv>GFP 50μM H2O2), 4 (salEPv>hepCA,GFP 0μM H2O2) and 15 (salEPv>hepCA,GFP 
50μM H2O2) discs of each genotype analyzed) 
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Mmp2 upregulation is mediated by ROS and JNK  
Because of the accumulation of Mmp2 at the basal side of the DP, and because - as 
shown below - only Mmp2, but not Mmp1, is required for BM damage, we sought to 
understand what mediates the upregulation of Mmp2 in undead discs. As shown previously, 
Mmp1 regulation is dependent on JNK signaling in general (Figure 2.14k) [334] and on 
ROS signaling in undead discs (Figure 2.14i,j) [124]. Likewise, upregulation of Mmp2 is 
suppressed by loss of ROS or inactivation of JNK (Figure 2.13e-g). Excitingly, upon loss 
of ROS or JNK in undead discs, the increased accumulation of Mmp2 at the basal side of 
the DP is also strongly reduced and is similar to control discs (Figure 2.13e’-g’,h). This is 
consistent with the notion that upregulation of Mmp2 is dependent on JNK and ROS. 
Together, these data imply that the upregulation of Mmp2 in undead discs is controlled by 
ROS and JNK, thereby placing Mmp2 downstream of them in the AiP pathway.  
Next, we asked whether H2O2 treatment of wing discs and increased JNK activity, 
individually or together, are sufficient to upregulate Mmp2 ex vivo. H2O2 treatment of 
salEPv-GFP control wing discs or hyper-activation of JNK (salEPv>hepCA) did not affect 
Mmp2 levels (Figure 2.15b,b’,c,c’), and neither did treatment of salEPv>hepCA wing discs 
with H2O2 cause any detectable change to the Mmp2 levels in the sal
EPv-expression domain 
(Figure 2.15d,d’). These data suggest that under these ex vivo conditions, activation of JNK 
signaling and exposure to H2O2, either independently or together, are not sufficient to 
upregulate Mmp2.  
 
90 
 
Mmp2 has increased enzymatic activity in undead discs in a ROS- and JNK-
dependent manner 
To examine whether the elevated Mmp2 levels in undead discs also correspond to 
increased enzymatic activity, we performed several enzymatic assays. Fluorescent dye-
quenched- (DQ-) gelatin is a polymer-substrate that contains multiple quenched FITC 
conjugates. Cleavage of DQ-gelatin into monomers releases the green fluorescence of 
FITC which can be analyzed in several ways [333, 377]. First, in fluorometric assays of 
protein lysates from imaginal discs, we measured a significant increase in fluorescence in 
ey>hid,p35 undead discs compared to control discs (Figure 2.13i). This increased 
enzymatic activity in ey>hid,p35 discs can be suppressed by Mmp2 knockdown and is 
comparable to discs that overexpress Mmp2 (salEPv>Mmp2) (Figure 2.13j) suggesting that 
Mmp2 accounts for this increased cleavage activity towards the DQ-gelatin substrate. 
Furthermore, reduction of ROS and inhibition of JNK suppresses the enzymatic activity of 
Mmp2 in fluorogenic assays (Figure 2.13k). 
Second, we performed ex vivo in situ zymography assays with eye discs of different 
genotypes. In these assays, the DQ-gelatin substrate was incubated with dissected, unfixed 
imaginal discs and the fluorescence scored under the confocal microscope [377]. While 
control discs show a uniform, low-level fluorescence across the disc, we noted an increased 
enzymatic activity through release of fluorescence quenching at undead discs (Figure 
2.16a-c; yellow arrow heads in (c)). Mmp2 RNAi restores the fluorescence quenching 
(Figure 2.16d) suggesting that Mmp2 accounts for this enzymatic activity. Furthermore, 
the enzymatic activity of Mmp2 is dependent on JNK and ROS (Figure 2.16e-g).  
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Figure 2.16. Increased Mmp2 activity in undead discs depends on ROS and active 
JNK 
(a-g) Representative examples of in situ zymography to detect Mmp2 enzymatic activity 
in ey>hid,p35 (c) compared to controls (a, b). ey>hid,p35 discs (c) show an increase of 
enzymatic cleavage activity towards the fluorogenic DQ-gelatin substrate (yellow 
arrowheads) visible by small puncta, which are not present in control discs (a,b). 
Knockdown of Mmp2 removes these puncta (d) suggesting that Mmp2 accounts for the 
enzymatic activity. Similarly, Mmp2 activity is suppressed upon loss of ROS by 
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knockdown of Duox (e) or transgenic over-expression of hCatS (f), and inactivation of JNK 
(JNKDN) (g). Hemocytes also label strongly for the fluorogenic substrate (yellow arrows in 
b,c,e). Scale bars, 100μm. 
(h-i) Representative gels of gelatin gel zymogram to detect Mmp2 activity. In-gel cleavage 
of gelatin substrate by Mmp2 causes a clear band on a dark background indicating active 
enzyme. The protein lysates from ey>hid,p35 discs have an increased Mmp2 activity as 
seen by a clear band (yellow arrowhead) that is absent in the controls (h). Knockdown of 
Mmp2 suppresses the cleavage of gelatin substrate (h). Loss of ROS by knockdown of 
Duox or transgenic over-expression of hCatS, and inactivation of JNK (JNKDN) also 
suppresses the cleavage of in-gel gelatin substrate (i) indicating reduced Mmp2 activity. 
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Interestingly, hemocytes attached to the discs also label strongly for this fluorescence 
marker (Figure 2.16b,c; yellow arrows) suggesting that they also contain enzymatic activity 
towards DQ-gelatin. 
Third, using gel zymography, where Mmp2 activity is recognized by loss of the in-
gel gelatin substrate as visualized by clear band upon Coomassie staining [333, 378], there 
is an increased gelatin cleavage activity in ey>hid,p35 extracts which is suppressed by 
Mmp2 knockdown (Figure 2.16h) as well as by reduction of ROS or JNK activity (Figure 
2.16i). Taken together, these data suggest that the increased Mmp2 protein levels at undead 
discs have an increased enzymatic activity in a JNK- and ROS-dependent manner.  
 
Mmp2, but not Mmp1, is required for BM damage and AiP 
After establishing that MMPs are upregulated and that Mmp2 has increased 
enzymatic activity in a ROS- and JNK-dependent manner in undead discs, we investigated 
whether MMPs play a role in damaging the BM. Knockdown of Mmp1 by RNAi did not 
significantly suppress the BM damage of undead discs (Figure 2.17a,b,d). RNAi against 
Mmp1 also did not affect hemocyte recruitment to the overgrown discs. High numbers of 
hemocytes are still observed on these discs and many have the activated morphology with 
cellular protrusions (Figure 2.17e-f’,h,i).  
In contrast, RNAi against Mmp2 strongly suppressed the BM damage of 
ey>hid,p35 discs. Perlecan labelling is intact and uniform around the discs (Figure 
2.17c,d). Interestingly, knockdown of Mmp2 also impaired hemocyte recruitment to the  
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Figure 2.17. Mmp2, but not Mmp1, is required for BM damage, hemocyte 
recruitment and AiP 
(a-c) RNAi against Mmp2 suppresses BM damage of ey>hid,p35 discs (c), while Mmp1 
RNAi has no effect on BM damage (b) compared to undead controls (a). Single slices 
focused on the basal side of DP show intact and uniform Perlecan labeling at the basal side 
of the DP in Mmp2 RNAi discs (c), while Mmp1 RNAi discs (b) still had gaps and 
irregularities as in mock (RFP) RNAi discs (a). Quantified in (d). Scale bars, 100μm.  
(d) Quantification of Perlecan intensity in (a-c) is taken from single slices at the basal 
surface of DP and PE. Fluorescence intensity at PE was used as internal control for 
normalization. Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-
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Sidak test for multiple comparisons. ****p < 0.0001, n.s. = no statistical significance (n=26 
(mock (RFP) RNAi), 14 (Mmp1 RNAi), and 16 (Mmp2 RNAi) discs of each genotype 
analyzed). 
(e-g’) Recruitment and activation of hemocytes (detected by NimC in grey) to ey>hid,p35 
discs is severely impaired upon knockdown of Mmp2 (g), while Mmp1 RNAi does not 
affect hemocyte recruitment (f) similar to mock (RFP) RNAi discs (e). The yellow boxed 
area in (e-g) is magnified in (e’-g’). Cellular protrusions of hemocytes, indicating activated 
morphology, are also lost in Mmp2 RNAi discs (g’), while Mmp1 RNAi discs still have 
hemocytes with cellular protrusions (f’). Scale bars, 100μm.  
(h, i) Quantification of hemocyte recruitment (h) and activation (i) in ey>hid,p35 discs 
compared to knockdown of Mmp1 and Mmp2. Mmp2 RNAi significantly decreased the 
total number of hemocytes present on ey>hid,p35 discs, while Mmp1 RNAi had no effect 
on the hemocyte recruitment (h). Hemocyte activation was measured by the %age of total 
hemocytes that had one or more cellular protrusions. Mmp1 RNAi discs had similar %age 
of hemocytes that showed an activated morphology as seen for ey>hid,p35 discs, while the 
Mmp2 RNAi discs had very few of the recruited hemocytes which also displayed activated 
morphology (i). Total number and % of activated hemocytes were analyzed by one-way 
ANOVA with Tukey’s multiple comparisons test. ****p < 0.0001, n.s. = no statistical 
significance (n=20 discs per genotype analyzed). 
(j-l) Mmp2 knockdown suppresses overgrowth. Representative images of adult heads of 
ey>hid,p35 animals that are expressing either mock (RFP) RNAi (j), Mmp1 RNAi (k) or 
Mmp2 RNAi (l). Mmp2 RNAi (l) suppresses overgrowth of adult heads, while Mmp1 RNAi 
(k) does not affect the overgrowth. Overgrowth of adult heads is determined by presence 
of ectopic bristles and ocelli, expansion of head capsule width, and amorphous mass of 
head tissue. Suppression of overgrowth is calculated as the shift to a more wild-type-like 
appearance and absence of additional bristles. Additionally, Mmp2 RNAi also suppresses 
larval imaginal disc overgrowth, as seen in (c) and (g), where the disc morphology is 
restored and ELAV pattern is normalized, in contrast to ey>hid,p35 discs in (a) and (e). 
Scale bars, 100μm 
(m) Quantification of the suppression of adult ey>hid,p35 overgrowth by Mmp2 RNAi. 
Based on qualitative screening criteria, progeny was scored as wild-type (WT) (black bars) 
or overgrown (red bars). Suppression is measured by a shift in percentage to WT from 
overgrown animals that is significantly different as determined by Fisher’s exact test. 
****p < 0.0001, n.s. = no statistical significance (n=100 to 150 flies counted per genotype).  
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Figure 2.18. Effect of MMP RNAi on Laminin  
(a-c’) Representative examples ey>hid,p35 discs expressing Mmp1 RNAi (b-b’) and 
Mmp2 RNAi (c-c’) labeled with anti-Laminin antibody. Single slices focusing on the basal 
side of DP show intact and uniform Laminin labeling upon knockdown of Mmp2, but no 
effect on BM damage upon Mmp1 RNAi compared to ey>hid,p35 (red in (a-c); grey in (a’-
c’)). Quantified in (d). Scale bars, 100μm.  
(d) Quantification of Laminin intensity in (a-c) taken from single slices at the basal surface 
of DP and PE. Fluorescence intensity at PE was used as internal control for normalization. 
Signal intensity per μm2 ± SEM analyzed by one-way ANOVA with Holm-Sidak test for 
multiple comparisons. ****p < 0.0001, n.s. = no statistical significance. (n=12 
(ey>hid,p35), 7 (Mmp1 RNAi) and 16 (Mmp2 RNAi) discs of each genotype analyzed). 
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discs, and of the few hemocytes that are present, only very few show any change in 
morphology, indicating a failure to adopt the activated phenotype (Figure 2.17g,g’,h,i). 
Similar data were also obtained by Laminin labeling as BM marker (Figure 2.18). 
To gain insight into the functional requirement of MMPs for inducing overgrowth 
during AiP, we monitored the effect of MMP RNAi knockdown on the adult overgrowth 
phenotype of ey>hid,p35 animals. While knockdown of Mmp1 did not have any significant 
effect on overgrowth, Mmp2 RNAi significantly suppressed the overgrowth phenotype of 
ey>hid,p35 animals (Figure 2.17j-m). Three independent RNAi transgenes targeting Mmp2 
gave consistent results (Figure 2.19a). Along with the effects on the adult overgrowth 
phenotype, hemocyte behavior and BM, knockdown of Mmp2 also suppressed other AiP 
markers like production of ROS and activation of JNK (Figure 2.19b-g). Given the 
observations that ROS and JNK are required for Mmp2 upregulation in undead discs 
(Figure 2.13e-h), and in turn that Mmp2 controls ROS and JNK activity (Figure 2.19b-g) 
suggest that Mmp2 participates in the feedback amplification loop which operates in 
undead cells to induce AiP and overgrowth [124]. Combined, these results indicate that 
Mmp2, but not Mmp1, is important for BM damage as well as hemocyte recruitment, and 
it participates in the feedback amplification loop to promote overgrowth of undead 
ey>hid,p35 discs.   
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Figure 2.19. Mmp2 participates in the feedback amplification loop to induce AiP 
(a) Schematic representation of the effects of three independent Mmp2 RNAi lines on the 
ey>hid,p35 overgrowth phenotype. Based on qualitative screening criteria, progeny are 
scored as wild-type (WT) (black bars) or overgrown (red bars). Suppression is measured 
by a shift in percentage to WT from overgrown animals that is significantly different as 
determined by Fisher’s exact test. ****p < 0.0001. (n=100 to 150 flies counted per 
genotype). 
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(b-c) Knockdown of Mmp2 (c) suppresses ectopic production of ROS (detected by DHE 
indicator dye) compared to ey>hid,p35 undead discs (b). Scale bars, 100μm. 
(d) Quantification of DHE intensity in (b-c) taken from maximum intensity projections, 
represented as mean signal intensity per μm2 ± SEM analyzed by Unpaired T test. ****p 
< 0.0001. (n=16 discs per genotype analyzed). 
(e-f) Mmp2 RNAi suppresses activation of JNK (f) observed in ey>hid,p35 discs (e). 
Activated JNK is detected by pJNK antibody. Scale bars, 100μm. 
(g) Quantification of pJNK intensity in (e-f) taken from maximum intensity projections, 
represented as mean signal intensity per μm2 ± SEM analyzed by Unpaired T test. ****p 
< 0.0001. (n=10 discs per genotype analyzed). 
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Mmp2-mediated BM damage recruits hemocytes 
Next, we addressed if Mmp2 is sufficient for damaging the BM. Because expression 
of Mmp2 under ey-Gal4 control in the eye disc caused early larval lethality, we expressed 
it in the wing disc using salEPv-Gal4. While overexpression of Mmp1 had no effect on the 
BM (Figure 2.20a-b”’; quantified in Figure 2.21a), expression of Mmp2 severely damaged 
the BM. There was complete absence of Perlecan in the area where Mmp2 was expressed 
(Figure 2.20c-c”’, Figure 2.21a) consistent with previous results [245]. Strikingly, the area 
of damage extended even beyond the Mmp2-expression domain, not just at DP but even 
on the PE side (Figure 2.20c-c’, Figure 2.21a) consistent with the notion that Mmp2 protein 
has secreted isoforms. These results imply that Mmp2, but not Mmp1, is both necessary 
and sufficient to cause damage to the BM.  
Finally, we examined if the damage to the BM is sufficient to recruit hemocytes. In 
contrast to eye imaginal discs, there are no hemocytes attached to unstressed (control) wing 
discs (Figure 2.20d,d’). Likewise, hemocytes are not recruited to discs expressing Mmp1 
which have undamaged BM (Figure 2.20e-e’).  However, we do observe high numbers of 
hemocytes attached to the discs that have damaged BM due to expression of Mmp2 (Figure 
2.20f,f’’; Figure 2.21b) consistent with previous findings [245]. Interestingly, some of 
these hemocytes also display the activated morphology (Figure 2.21c,d). Importantly, 
expression of Mmp2 did not lead to ectopic production of ROS or caspase activation 
(Figure 2.20g-l’; Figure 2.21e,f), thus excluding the possibility that ROS or apoptosis are 
responsible for the recruitment of hemocytes to discs with damaged BM.  
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Figure 2.20. Mmp2-mediated BM damage recruits hemocytes 
BM is detected by anti-Perlecan antibody (red in a, a”, b, b”, c, c”; grey in a’, a”’, b’, b”’, 
c’, c”’). Hemocytes are detected by NimC (red in d, e, f; grey in d’, e’, f’). ROS is detected 
by dihydroethidium (DHE) indicator dye (red in g, h, i; grey in g’, h’, i’). Active caspases 
are detected by cDcp-1 antibody (blue in j, k, l; grey in j’, k’, l’). GFP marks the SalEPv 
domain where Gal4 is expressed. Scale bars, 100μm. 
(a-c”’) Over-expression of Mmp2 is sufficient to damage the BM. Single slices focusing 
on the basal side of DP and orthogonal views show big gaps in Perlecan labeling upon 
expression of Mmp2 (yellow arrows) (c-c”’), indicating that BM is damaged. In contrast, 
the BM is intact as judged by uniform Perlecan labeling upon expression of Mmp1 (b-b”’) 
similar to control (a-a”’) indicating Mmp1 does not damage BM. Quantified in Figure 2.21. 
(d-f’) Damage to BM recruits hemocytes. Hemocytes are usually absent from wing discs 
(control d, d’). Expression of Mmp1 does not recruit hemocytes to the discs (e-e’). 
However, upon expression of Mmp2 (f-f’), high numbers of hemocytes are recruited to the 
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discs which have damaged BM. A few of these recruited hemocytes show “activated” 
morphology and are indicated by yellow arrowheads. Quantified in Figure 2.21. 
(g-i’) Expression of Mmp2 does not cause ectopic production of ROS (DHE labelings) (i-
i’), similar to control (g-g’) and expression of Mmp1 (h-h’). Quantified in Figure 2.21. 
(j-l’) Expression of Mmp2 does not cause ectopic cell death indicated by absence of active 
caspases (cDcp-1) in (l-l’), similar to control (j-j’) and expression of Mmp1 (k-k’). 
Quantified in Figure 2.21. 
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Figure 2.21. Quantifications for Figure 2.20 
(a) Quantification of Perlecan intensity in Figure 2.20a-c taken from single slices at the 
basal surface of DP and PE. Signal intensity per μm2 ± SEM analyzed by one-way 
ANOVA with Holm-Sidak test for multiple comparisons. ***p<0.001, ****p < 0.0001. 
(n=16 (salEPv>GFP),2 17 (salEPv>Mmp1, GFP) and 26 (salEPv>Mmp2, GFP) discs of each 
genotype analyzed). 
(b-c) Quantification of hemocyte recruitment (b) and activation (c) in Figure 2.20d-f. 
Hemocyte activation was measured by the % of total hemocytes that had one or more 
cellular protrusions. Total number and % activated hemocytes were analyzed by one-way 
ANOVA with Tukey’s multiple comparisons test. ****p < 0.0001 (n=20 (salEPv>GFP), 
17 (salEPv>Mmp1, GFP) and 20 (salEPv>Mmp2, GFP) discs of each genotype analyzed). 
(d) Representative image of activated hemocytes on salEPv>Mmp2, GFP disc labeled with 
anti-NimC antibody. Hemocytes with cellular protrusions indicated by yellow arrowheads 
mark the activated phenotype of hemocytes. 
(e) Quantification of DHE intensity in Figure 2.20g-i taken from maximum intensity 
projections, represented as mean signal intensity per μm2 ± SEM analyzed by one-way 
ANOVA with Holm-Sidak test for multiple comparisons. n.s. = no statistical significance. 
(n=11 (salEPv>GFP), 13 (salEPv>Mmp1, GFP) and 14 (salEPv>Mmp2, GFP) discs of each 
genotype analyzed). 
(f) Quantification of cDcp-1 intensity in Figure 2.20j-l taken from maximum intensity 
projections, represented as mean signal intensity per μm2 ± SEM analyzed by one-way 
ANOVA with Holm-Sidak test for multiple comparisons. n.s. = no statistical significance 
(n=6 (salEPv>GFP), 7 (salEPv>Mmp1, GFP) and 11 (salEPv>Mmp2, GFP) discs of each 
genotype analyzed). 
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Taken together, these findings demonstrate that BM damage alone is sufficient to recruit 
hemocytes to the discs. 
 
DISCUSSION 
In this study, we show a correlation between ROS generation and BM damage not 
only in the undead AiP model, but also in several neoplastic tumor models in Drosophila. 
Our data further suggest that MMPs, most notably Mmp2, are upregulated in a ROS- and 
JNK-dependent manner. Mmp2 is responsible for the BM damage of imaginal discs and 
the subsequent recruitment of hemocytes. Intriguingly, the BM damage is observed 
specifically at the basal side of DP cells in undead discs, while the BM at the PE is 
unaffected. This makes sense as Duox, the NADPH oxidase responsible for synthesizing 
ROS in undead discs, is also localized preferentially at the basal side of DP cells [130]. 
Correspondingly, we also observed a strong accumulation of Mmp2 protein at the basal 
side of DP cells in undead discs. Combined, these observations strengthen the view that 
ROS and Mmp2 interdependently affect the integrity of the BM.   
Although some of the hemocytes that are recruited to discs with damaged BM due 
to Mmp2 overexpression display an activated morphology, they do not induce overgrowth 
(Figure 2.18c,f). This is in stark contrast to hemocytes at undead discs, which are known 
to mediate AiP and overgrowth of undead tissue [124]. Therefore, hemocytes at undead 
discs behave differently than hemocytes under normal developmental or wound healing 
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conditions [347]. It is enticing to speculate that ROS may provide a signal that causes the 
different behavior of recruited hemocytes at the undead tissue (Figure 3.1b). 
In addition, ROS may have more than one function in this process. Previous studies 
have proposed a ROS-mediated post-translational activation of mammalian Mmp2 via a 
“cysteine-switch” mechanism [379]. A highly conserved cysteine in the amino-terminal 
region of Mmp2 directly ligands with the active-side Zinc, thereby maintaining Mmp2 
proenzyme latency. Oxidation of this cysteine residue disrupts its interaction with Zinc 
leading to proteolytic processing and activation of the enzyme [379]. We show that 
enzymatic activity of Mmp2 in undead discs is dependent on ROS (Figure 2.14k; Figure 
2.16). It will be interesting to determine ROS activates Mmp2 by a similar “cysteine-
switch” mechanism in the undead model for damaging the BM. This would also explain 
why we observe some areas of strong BM damage, others with weak damage, even though 
Mmp2 is uniformly upregulated at the basal side of DP cells throughout the undead disc. 
ROS are not produced uniformly in the undead disc, and discrepancies in ROS production 
would determine Mmp2 activation status across the disc. Upregulation and activation of 
MMPs is a common theme across multiple cancers [380-382], and it would be interesting 
to see if a similar correlation exists between ROS production and MMP activation in these 
tumor contexts, and if the “cysteine-switch” mechanism is a common occurrence for ROS-
dependent MMP activation in tumors. 
Furthermore, the observation that hemocytes are recruited to imaginal discs with 
damaged BM in response to overexpressing Mmp2 (Figure 2.20f) in the absence of 
apoptotic cells or detectable ROS (Figure 2.20i,l) suggests that hemocyte recruitment per 
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se is not dependent on apoptotic “find-me” signals or chemoattractants such as ROS. 
Instead, it may imply that circulating hemocytes are constantly surveying the 
microenvironment for damage, and once they encounter a disrupted BM, they are attracted 
for possible repair of the damage. An interesting follow-up question is to understand how 
the circulating hemocytes sense and adhere to the damaged microenvironment. One 
possibility could be that the damage of the BM might expose some otherwise cryptic 
receptors on the surface of the discs, which are not accessible to the hemocytes in imaginal 
discs with an intact BM. This may be a mechanism by which hemocytes distinguish a 
damaged versus healthy microenvironment.  
Similar to Drosophila hemocytes, mammalian macrophages constantly survey the 
microenvironment for presence of damage, tumorous growth or pathogens. In case of 
tumors, circulating monocytes are recruited to the tumor by chemokines secreted by the 
tumor cells, including apoptotic tumor cells [342-344, 383]. Interestingly, apoptotic 
lymphoma cells also express and process mammalian Mmp2 (ref. [342]) showing clear 
parallels between vertebrates and our work in Drosophila. Future studies will help 
illuminate whether macrophages are also recruited to the tumor by a similar BM damage-
sensing mechanism as seen for Drosophila hemocytes. Such a mechanism of macrophage 
recruitment would have an effect on therapeutic interventions that aim to block chemokine 
secretion by tumors, as they may not be sufficient to prevent TAM accumulation.   
Our data suggest the Mmp2 expression in undead cells is dependent on JNK 
signaling (Figure 2.13h,i). That is surprising as previous work indicated that only Mmp1, 
but not Mmp2, expression is dependent on JNK in otherwise normal tissue [334]. We 
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confirmed the results of reference [334] by expression of an activated form of JNKK 
(hepCA) and failed to observe Mmp2 expression (Figure 2.15c). Even in the presence of 
H2O2, Mmp2 was not up-regulated in discs expressing an activated form of JNKK 
(salEPv>hepCA) in the ex vivo experiments (Figure 2.15d), also explaining why we do not 
observe significant BM damage under these conditions (Figure 2.10k,l). These results 
suggest that the undead environment triggered by co-expression of hid and p35 provides a 
special condition for the upregulation of Mmp2. 
BM and ECM degradation in general is the first step for metastatic tumor cells to 
leave their niche and invade other tissues [384-386]. However, in case of undead discs, BM 
damage is not sufficient to allow metastatic invasion as undead cells do not leave their 
tissue niche to invade other tissues. This suggests that additional stimuli are required for 
gaining metastatic properties along with BM damage. Future studies could explore possible 
mechanisms by inducing metastatic behavior of undead cells. 
In conclusion, we have identified a mechanism by which ROS can dictate the 
recruitment of macrophages to the overgrowing discs by modulating Mmp2 levels that 
cause damage to the BM. Furthermore, these results indicate that undead tissue shares 
similar properties to neoplastic tumors with many overlapping “hallmarks of cancer”. 
Overall, our data strongly imply the role of the tumor microenvironment in recruiting 
macrophages to the tumor, and also highlight the importance of Drosophila undead tissue 
as a model to study the interplay between tumors and immune cells.  
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EXPERIMENTAL PROCEDURES  
Fly stocks 
The following mutant and transgenic stocks were used: ey-Gal4, salEPv-Gal4 (ref.[387]), 
UAS-p35, UAS-hid, UAS-hepCA, UAS-RasV12, hmlΔnRFP (ref. [233]), lgl4 (ref. [388] ), 
vps25N55 (ref. [365]), hpo42-47 (ref. [372]), srpneo45 (ref. [230]). UAS-based RNAi and over-
expression lines for the following genes were obtained from the Bloomington Drosophila 
Stock Centre: Mmp1 (#31489, #58700, #58701, #58702, #58703), Mmp2 (#31371, #58705, 
#58706, #61309, #65935), RFP RNAi (mock RNAi) (#67984), UAS-JNKDN (BskDN) 
(#6409). UAS-Duox RNAi and UAS-hCatS were a kind gift from Won Jae Lee (ref. [389]). 
The exact genotype of the following stocks is:  
ey>p35: ey-Gal4 UAS-p35/CyO 
ey>hid,p35: UAS-hid; ey-Gal4 UAS-p35/CyO,tub-GAL80 
eyeful: ey-Gal4>UAS-delta, GS88A8 UAS-lola and UAS-pipsqueak (ref. [373]) 
The ey>hid,p35 stock was crossed to w1118 as control or RNAi and mutant lines, and the 
offspring was scored for suppression of head capsule overgrowth phenotype. Screening 
results are presented as percentage of animals with either wild-type or overgrown 
phenotype.  
All crosses were maintained at 25°C. Except where noted, most crosses were performed 
using the Gal4/UAS system (ref. [390]). Tumor mosaic eye discs were induced using the 
MARCM technique [391] with ey-FLP (ref. [392]) to generate mosaics with tumor clones 
marked by GFP [364].  
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Immunofluorescence staining and visualization 
Imaginal discs were dissected from late 3rd instar larvae, fixed, and stained using standard 
protocols [123]. The following primary antibodies were used: rabbit anti-Perlecan (1:1000, 
kind gift from Stefan Baumgartner)[270], rabbit anti-Laminin (1:500, abcam ab47651), 
mouse anti-NimC (1:100, P1a,P1b, kind gift from István Andó)[393], rabbit anti-Mmp2 
(1:500, #436, kind gift from Kendal Broadie)[394], rabbit anti-cleaved Dcp-1 (1:250, Cell 
Signaling), rabbit anti-phospho JNK (1:200, Promega), rat anti-ELAV (1:50) and mouse 
anti-Mmp1 (1:50) (DSHB). Secondary antibodies were donkey Fab fragments from 
Jackson ImmunoResearch. Eye-antennal discs were counter-labeled with the nuclear dye 
DAPI to visualize tissue outline.  
DHE labeling was performed on unfixed imaginal discs as described previously [395]. 
Imaginal discs were dissected from 3rd instar larvae in fresh Schneider’s medium, incubated 
in DHE (Invitrogen, Cat#D23107) solution for 5 min, washed with PBS, mounted in 
Vectashield mounting media, and imaged immediately.  
Images were obtained with a Zeiss LSM 700 confocal microscope, analyzed with Zen 2012 
imaging software (Carl Zeiss) and processed with Adobe Photoshop CS6. All image scale 
bars represent 100μm. 
 
Electron Microscopy 
Samples were processed and analyzed at the University of Massachusetts Medical School 
Electron Microscopy core facility by Lara Strittmatter according to standard procedures.  
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Scanning Electron Microscopy – Imaginal discs from 3rd instar larvae were dissected and 
fixed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 1 hour 
at room temperature, and then at 4oC overnight and post-fixed in 1% (w/v) osmium 
tetroxide for 1 hour at room temperature. The imaginal discs were dehydrated through a 
graded series of ethanol to 100% and then transferred into porous sample holders and 
Critical Point Dried in liquid CO2. The dried samples were transferred to aluminum SEM 
stubs coated with adhesive carbon tape, the edges were painted with silver conductive paste 
and the SEM stubs were sputter coated with Au/Pd (80/20).  The specimens were then 
examined using an FEI Quanta 200 FEG MKII scanning electron microscope at 10 kV 
accelerating voltage. 
Transmission Electron Microscopy - Imaginal discs from 3rd instar larvae were dissected 
and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.2 for 1 hour at 
room temperature and post-fixed with 1% osmium tetroxide for 1 hour at room 
temperature. Samples were in block stained with a 1% uranyl acetate aqueous solution 
(w/v) at 6oC overnight, dehydrated in ethanol, and infiltrated first with two changes of 
100% propylene oxide and then with a 50%/50% propylene oxide/SPI-Pon812 resin 
mixture, and finally polymerized at 68oC in flat pre-filled embedding molds. The samples 
were then reoriented, and ultra-thin sections (approx. 70 nm) were placed on copper 
support grids and contrasted with lead citrate and uranyl acetate. Sections were examined 
using the CM10 TEM with 100kV accelerating voltage, and images were captured using a 
Gatan TEM CCD camera. 
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ex vivo H2O2 experiment 
Imaginal discs were dissected from 3rd instar larvae in fresh Schneider’s medium. The 
medium was then replaced with 50μM H2O2 (Sigma-Aldrich, Cat#H1009) solution in 
Schneider’s medium or fresh Schneider’s medium (control) and incubated for 60 min at 
25°C. Eye discs were washed with PBS and fixed in 4% PFA in PBS for 30 min at RT, 
followed by standard protocols for immunofluorescence and imaging.  
 
Counts and analysis of on-disc hemocytes 
Imaginal discs were dissected from 3rd instar larvae from control and undead animals fixed 
and stained using anti-NimC antibody and DAPI. Imaginal discs were imaged using 
confocal microscopy. Total number of hemocytes attached to the discs were counted using 
multi-point tool in ImageJ software. Activated hemocytes were identified by presence of 
one or more cellular extensions detected by NimC labeling and counted by the multi-point 
tool in ImageJ. 
 
Mmp2 activity assays 
Mmp2 fluorogenic activity assays were performed using the fluorescein labeled DQ-
gelatin, as part of the EnzChek™ Gelatinase/Collagenase Assay Kit (Invitrogen E12055), 
following manufacturers’ instructions using 25 μg/ml substrate. Imaginal discs were 
dissected from 3rd instar larvae and lysed with 100 μl of lysis buffer (50 mM TrisHCl, pH 
7.4, 150 mM NaCl, 1% Triton X-100 and Halt protease inhibitors (Thermo-Fisher)). 
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Samples were sonicated for 5 minutes using BioRuptor according to the manufacturer’s 
protocol (medium power, 10 min, 30 s on and 30 s off at 4oC), and protein concentrations 
of supernatants were measured by Bradford Assay. Protein lysates were added directly to 
the substrate and incubated at 37oC for different time points, after which the fluorescence 
intensity was measured on Beckman Coulter DTX 880 microtiter plate reader at 450/8 nm 
excitation and 535/25 nm emission.  
The in situ zymography was performed as previously described with minor modifications 
[377]. Mmp2 activity was detected using the fluorescein labeled DQ-gelatin substrate on 
dissected unfixed imaginal discs. Imaginal discs were dissected from 3rd instar larvae in 
fresh Schneider’s medium. The medium was then replaced with 10 μg/ml DQ-gelatin 
substrate in Schneider’s medium and incubated in the dark for 15 minutes at 29oC, washed 
with PBS, mounted in Vectashield mounting media, and imaged immediately.  
For gel zymography assays, imaginal disc protein lysates were prepared exactly as 
described for the fluorogenic assay. 30 μg of protein lysate was resuspended in 2x Novex 
non-reducing sample buffer and samples were run on Novex 10% Zymogram Plus gel 
containing 0.1% gelatin (ZY00100BOX). After electrophoresis, gels were incubated with 
Novex Zymogram Renaturing Buffer and Novex zymogram Developing Buffer, then 
stained with SimplyBlue Safestain (LC6060), all according to manufacturer’s instructions 
(Invitrogen).  
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Quantitative Real-Time PCR (qRT-PCR) 
Total RNA from 20 eye discs was isolated using Trizol (Invitrogen). cDNA was 
synthesized from 1μg of RNA with the QuantiTect Reverse Transcription Kit (Qiagen). 
For RT-PCR analysis, 50 ng of cDNA per reaction was subjected to 40 amplification 
cycles. Real-time quantification was performed using Power SYBR green PCR Master Mix 
reagents (Applied Biosystems) on QuantStudio 6 Flex Real-Time PCR System (Applied 
Biosystem) according to the manufacturer’s instructions. rp49 expression was used as an 
internal control for normalization. Three experiments for each genotype were averaged. 
Sequences for isoform-specific primers are as follows: 
Rp49 forward: CCAGTCGGATCGATATGCT 
Rp49 reverse: ACGTTGTGCACCAGGAACT 
Mmp1 forward: CACCTACAAGAACGGCAAGA 
Mmp1 reverse: CGCTGATTTCCTTAGGGTAGAC 
Mmp2 forward: TTACCTCATGCAGTTTGATTATCT 
Mmp2 reverse: CTCCACGTAAGATCCGTTCTG 
 
Quantification and Statistical Analysis 
For quantification of confocal images, the ‘Histo’ function of Zen 2012 imaging software 
(Carl Zeiss) was used. Region of interest (entire eye-antennal imaginal discs or salEPv-Gal4 
domain of wing imaginal discs) was outlined for each disc and mean signal intensity was 
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determined. For Perlecan, Laminin and Mmp2 staining intensity quantification, single 
sections at basal side of DP and PE were selected and separately measured. For Perlecan 
and Laminin quantifications, because the BM was only affected at the DP, but not at the 
PE (Figure 2.5), the signal intensity at PE was used as an internal control to normalize the 
signal intensity at DP for each disc, and graphed as “Mean Normalized Fluorescence at DP 
to PE”. For DHE, pJNK and cDcp-1, staining intensity was measured for the maximum 
intensity projections. At least three biological repeats were performed for all experiments 
and total number of discs used for quantification was indicated in the legends for each 
figure. Analysis and graph generation was done using GraphPad Prism 7.04. Statistical 
analysis for Perlecan, Laminin, Mmp2, DHE, pJNK and cDcp-1 intensity was performed 
using one-way ANOVA with Holm-Sidak test for multiple comparisons. Data is 
represented as the mean ± SEM of pooled results obtained from the indicated number of 
samples in each experiment. Statistical analysis for hemocyte counts was performed using 
one-way ANOVA with Tukey’s test for multiple comparisons. Statistical analysis of Mmp1 
and Mmp2 qPCR was performed using two-tailed unpaired Student’s T test. Data is 
represented as mean ± SD of three independent biological replicates. Statistical analysis 
for adult counts was performed using Fisher’s exact test. P values: * p<0.05; ** p<0.01; 
*** p<0.001; **** p <0.0001. 
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Summary of Findings 
Apoptosis-induced proliferation (AiP) is a mechanism in which active caspases 
function in a non-apoptotic manner to induce proliferation following stress-induced cell 
death. In our undead AiP model, initiator caspase Dronc promotes proliferation by 
activating JNK signaling via extracellular ROS production and recruitment and activation 
of hemocytes, the Drosophila macrophages. Though ROS and hemocytes are important for 
the process of AiP, the exact mechanisms by which they contribute to AiP are still under 
active investigation. One proposed function for ROS is to recruit and activate hemocytes 
to the overgrown undead tissue; however, their mode of action is unclear. In this thesis, we 
have characterized the mechanism by which hemocytes are recruited to overgrown tissue. 
Using the undead AiP model, we have identified that the tissue microenvironment plays a 
major role in recruiting hemocytes. Both ROS and JNK are important for this process, and 
in concert regulate the levels and activity of matrix metalloproteinase Mmp2. Mmp2 then 
degrades the basement membrane (BM), and this BM damage is responsible for recruiting 
hemocytes from circulation. We have demonstrated that the damage to the BM is only 
present at the disc proper (DP) side of the undead tissue and not at the peripodial epithelium 
(PE) side (Figure 2.3, 2.4, 2.5). This is an interesting finding and helps us to justify why 
hemocytes are always attached to the undead tissue at the DP side and rarely at the PE side 
(Figure 2.1, 2.3). The reason BM is degraded specifically at DP side and not PE side can 
be explained by the increased localization of Mmp2 at the basal side of DP in the undead 
tissue. We propose the following model to explain the recruitment of hemocytes at undead 
eye imaginal discs –  
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Figure 3.1. Recruitment of hemocytes by Mmp2-mediated BM damage in undead 
tissue 
(a) In normal epithelial cells, Duox, JNK, Dronc and Drice are synthesized, but are 
inactive. The basement membrane is intact and naïve hemocytes are attached to the eye-
antennal imaginal disc at the basal side of the disc proper. Please note the apical-basal 
polarity of the cells. 
(b, left) In undead epithelial cells, expression of hid activates Dronc, but apoptosis is not 
induced due to co-expression of p35 which inhibits Drice and generates the undead 
condition. Instead, Dronc activates Duox, which synthesizes extracellular ROS (ROS). 
These ROS may provide the initial stimulus for activation of the naïve hemocytes.  
(b, middle) Activated hemocytes release factors including the TNF ortholog Eiger which 
signal back to the undead cells. JNK is activated and induces the expression of hid, setting 
up an amplification loop. JNK – directly or indirectly – also induces the expression of 
Mmp2 resulting in accumulation of Mmp2 protein at the basal side of the plasma 
membrane. ROS may also further activate Mmp2.  
(b, right) Upregulated Mmp2 damages the BM at the basal side. The BM damage recruits 
additional hemocytes to further strengthen the amplification loop, resulting in AiP. 
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In wild-type control eye discs, naïve hemocytes are present in tight cellular clusters around 
the morphogenetic furrow (Figure 3.1a; Figure 2.1a-f). The function of the hemocytes at 
control discs is unknown, but their morphology suggests that they are in a naïve (inactive) 
state. In contrast, in undead tissue, extracellular ROS produced by Duox, directly or 
indirectly, could provide an initial signal to activate the hemocytes present on the discs, 
causing them to secrete signaling factors, including the TNFα-ortholog Eiger, to activate 
JNK in undead cells (Figure 3.1b, left and middle panel). JNK in turn triggers the feedback 
amplification loop through induction of hid, but also through upregulation of Mmp2 (Figure 
3.1b, middle panel). Mmp2 protein now accumulates at the basal side of the DP in undead 
discs, and cleaves and damages the BM, consequently recruiting additional hemocytes to 
the undead discs (Figure 3.1b, right panel), which in turn release more signals for 
maintaining JNK activity. This further propels the amplification loop resulting in release 
of mitogens for AiP and overgrowth. 
Recruitment of hemocytes to areas of BM damage has been reported in several 
different contexts of epithelial wounds or tumors in Drosophila larvae [244, 245]. Our data 
in the undead discs reinforce these findings and provide additional evidence for BM 
damage-mediated recruitment of hemocytes in the context of undead tissue and AiP. 
Additionally, we demonstrate that ROS and cell death are not required for hemocyte 
recruitment, further signifying that chemoattractant or apoptotic “find-me” signals are not 
involved in recruiting hemocytes to the discs in larvae. Thus, the mechanism of BM 
degradation to recruit circulating hemocytes to the areas of “damage” in larvae seems to 
be a universal occurrence irrespective of the type of “damage” observed. These results 
121 
 
reiterate the importance of hemocytes as sentinel cells that survey the environment for signs 
of damage, similar to mammalian macrophages, and the disruption of BM might 
accordingly serve as the first indication of danger, consequently recruiting hemocytes to 
mount a response. 
 
Role of Mmp2 in the undead tissue  
 The role of MMPs in ECM and BM degradation is well established. Drosophila has 
two MMPs, in contrast to about 23 in mammals, making it a convenient model to delineate 
individual MMP functions without the problem of redundancy [323]. Both MMPs in 
Drosophila play a role in development of the organism, though with varied developmental 
requirements [332]. It was thought that the differences between the two MMPs arise from 
their distinct localization, Mmp1 is secreted while Mmp2 is membrane-tethered, and these 
localization differences determined the functional requirements for these enzymes [330-
332]. However, a recent study demonstrated that both Mmp1 and Mmp2 have secreted and 
membrane-tethered forms, at least in vitro in Drosophila S2 cells [333]. This study also 
speculated that the functional differences observed for the MMPs might stem from their 
different substrate specificities. Nevertheless, several studies have demonstrated a role for 
both MMPs in targeting different BM components, consequently degrading the BM. In the 
wing imaginal discs and in salivary glands, both Mmp1 and Mmp2 target type IV collagen 
Viking [245, 335, 396]. Additionally, Mmp2 targets Laminin in the salivary glands [397]. 
On the other hand, in the salivary gland imaginal ring, Mmp1 has no effect on Viking but 
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instead targets Perlecan for BM damage [337]. These examples highlight the similarities 
and differences in MMP substrate specificities, and also indicate that MMPs may show 
tissue specific substrate variations for BM components.  
Mmp2 for BM damage and AiP 
In our undead model, we observe that only Mmp2 is necessary for damaging the 
BM, while Mmp1 is dispensable. RNAi-mediated knockdown of Mmp2, but not Mmp1, 
suppresses the BM damage in undead eye imaginal discs (Figure 2.17a-d). To test for 
sufficiency of MMPs for damaging BM, we looked in the wing imaginal discs, as 
expressing MMPs in the eye discs caused severe growth retardation of eye discs and 
lethality. Surprisingly, Mmp1 had no effect on Perlecan or Laminin in the wing discs, while 
Mmp2 efficiently cleaved both Perlecan and Laminin. Most wing disc promoters also drive 
expression in the salivary glands, and we observed that Mmp2 was sufficient to cleave 
Perlecan in the salivary gland as well. Thus, in addition to type IV collagen Viking, we can 
now add Perlecan and Laminin to the list of substrates for Mmp2 in the wing discs and 
salivary gland. Mmp1 appears to have limited function in imaginal discs for BM damage, 
and seems to only use type IV collagen as a substrate. We were unable to study type IV 
collagen in our undead discs as the Viking-GFP construct that is used for looking at type 
IV collagen suppresses the overgrowth phenotype. The reason for this abnormal 
suppression could be attributed to the presence of GFP, which for reasons unknown 
suppresses the ey>hid,p35 overgrowth phenotype (based on my observations and from 
several other lab members). It will be interesting to test the type IV collagen antibody [398] 
in our model; first to verify whether Mmp2 cleaves type IV collagen in undead tissue as 
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well, and second to determine if Mmp1 cleaves type IV collagen in the undead eye discs. 
However, RNAi-mediated knockdown of Mmp1 did not suppress the overgrowth 
phenotype of ey>hid,p35 undead discs (Figure 2.17k,m), or hemocyte recruitment to the 
discs (Figure 2.17f,h,i). Furthermore, RNAi-mediated knockdown of Mmp1 did not 
suppress production of ROS or activation of JNK. These data indicate that Mmp1 is not 
involved in the undead model of AiP. Conversely, RNAi-mediated knockdown of Mmp2 
suppresses the ey>hid,p35 adult overgrowth phenotype (Figure 2.17l,m; Figure 2.19a), 
ROS production (Figure 2.19b-d), hemocyte recruitment and activation (Figure 2.17g,h,i) 
and JNK activation (Figure 2.19e-g). These data demonstrate the novel requirement of 
Mmp2 for overgrowth and AiP, and highlight the proliferation-promoting role of Mmp2 in 
this context.  
The next step would be to understand whether Mmp2 is important for AiP because 
of its BM damaging function or whether Mmp2 also has additional functions that contribute 
to proliferation. Several studies have shown the importance of MMPs in contributing to 
cell proliferation in tumor cells by modulating the bioavailability or activation of growth 
factors, like TGF-β or EGFs [327, 399, 400]. It is interesting to note that these are some of 
the same ligands (Dpp/TGF-β and Spi/EGF) that are important for inducing AiP [118, 123]. 
There is evidence for MMPs directly cleaving and activating the ligands, or MMPs 
cleaving the BM components to release the ligands tethered to the BM. In Drosophila, Dpp 
physically interacts with type IV collagen, and degradation of BM by Mmp2 releases Dpp 
to induce signaling for regulating tissue growth in wing discs [396, 401]. Thus, it will be 
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interesting to determine if Mmp2, directly or indirectly via degradation of BM, releases 
Dpp or other ligands that promote proliferation in undead tissue.  
Regulation of Mmp2 
We observe an upregulation of both the MMPs, Mmp1 and Mmp2, at the transcript 
and protein levels (Figure 2.13, 2.14) in our undead model. This increase is dependent on 
ROS and JNK, as loss of either leads to reduced levels of Mmp1 and Mmp2. Increase in 
Mmp1 levels makes sense as it is a direct transcriptional target of JNK [334], and we have 
previously demonstrated that in undead tissue increased JNK activation causes an increase 
in Mmp1 levels [124]. On the other hand, JNK-dependent increase of Mmp2 is surprising. 
Previous reports have suggested that Mmp2 is not transcriptionally regulated by JNK [334, 
335]. We also observe similar results where Mmp2 protein levels are unchanged when we 
hyper-activate JNK signaling (via expression of the hepCA construct) (Figure 2.15c). This 
is in contrast to our results in undead tissue where we see a clear dependency of Mmp2 
levels on JNK activation (Figure 2.13g,h). It is possible that under undead conditions, 
Mmp2 is a novel transcriptional target of JNK. Evaluating the cellular events that mediate 
these differences in JNK transcriptional control of Mmp2 will be essential to address this. 
Another possibility is that some other yet unidentified transcriptional factor, either in 
cooperation with JNK, or itself under the control of active JNK, is responsible for Mmp2 
transcriptional upregulation. Analysis of the Mmp2 promoter sequence for putative 
transcription factor binding sites would help us identify the factors involved in Mmp2 
transcriptional control in undead discs [402]. We could then also check the transcription 
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factor interactome to identify potential protein-protein interactions between transcriptional 
factors involved in Mmp2 regulation [403].  
A striking observation in our study was that Mmp2 shows an asymmetrical 
localization in normal eye imaginal discs, which is changed in the undead discs. In the 
control discs, Mmp2 is localized at the apical surface of the cells, with little to no Mmp2 
protein at the basal surface as observed by antibody labeling (Figure 2.13a’,b’). In undead 
discs, the overall Mmp2 levels increase, but now along with apical localization, Mmp2 also 
shows increased basal localization (Figure 2.13c’,d). This upregulated Mmp2 at the basal 
surface sets precedence for BM damage specifically at the basal side of DP. This is a really 
interesting observation and warrants further examination to understand what dictates this 
change in Mmp2 localization and basal accumulation in the undead discs. Not much is 
known about the trafficking dynamics of Mmp2 in Drosophila. Studies in different 
mammalian cell culture models have described involvement of endocytic and exocytic 
vesicle-mediated trafficking pathways for MMP membrane targeting and secretion [404-
407]. It is possible that in the undead tissue there is high vesicular trafficking that targets 
newly transcribed Mmp2 to the cell surfaces, both apical and basal. We could test this by 
modulating different Rab GTPases to target different secretory pathways in the undead 
model and check the effect on Mmp2 localization, BM damage and overgrowth of undead 
tissue in general. Increased vesicular targeting of Mmp2 to the surface would also help 
explain the surprising observation that Mmp2 is ubiquitously upregulated throughout the 
basal surface of the disc, even in the antennal region that is not undead. A second 
explanation for this observation could be that Mmp2 protein diffuses along the cell 
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membrane into the antennal part of the disc where it is not expressed. However, we also 
cannot rule out the possibility that there could be some other component downstream of 
both ROS and JNK that diffuses broadly to induce Mmp2 expression in the entire disc. 
  All the neoplastic tumor models that we examined (from Figure 2.7, including 
RasV12scrib- model) showed upregulation of Mmp2, similar to undead tissue, though a key 
difference was that the upregulation of Mmp2 was not uniform in the tumor clones as 
observed for the undead tissue. On the other hand, Mmp1 was uniformly upregulated in 
these tumors, similar to previously reported work from our lab and by others [334, 349]. It 
will be important to distinguish why neoplastic tumors and undead tissue have this 
discrepancy in Mmp2 upregulation, and if similar factors play a role in regulation of Mmp2 
across these different models. One possible avenue to explore could be loss in apical-basal 
polarity that is observed in neoplastic tumors but not in undead tissue, which might confer 
additional complexities in the tumors, perhaps affecting transcription of Mmp2. We did 
not systematically characterize the requirement of Mmp1 or Mmp2 for BM damage in the 
different neoplastic models. In the RasV12scrib tumor model, loss of Mmp1 or Mmp2 
partially suppressed tumor invasion [334, 335]. Most likely Mmp1 and Mmp2 have 
partially redundant functions in the tumor clones for damaging the BM by targeting 
different BM components, thereby promoting tumor invasion. This seems to be the case as 
simultaneous loss of both the MMPs in the RasV12scrib tumor clones significantly reduced 
tumor invasiveness [334]. Similar analysis of MMP function for BM damage and invasion 
is lacking in the RasV12lgl and vps25 tumor models. Furthermore, it will be interesting to 
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delineate the role of ROS and JNK in these different tumor contexts for regulation of 
MMPs and BM damage for the purpose of tumor invasion.  
Following the observation that Mmp2 levels are increased in a ROS and JNK-
dependent manner in the undead tissue, an important follow-up question is whether the 
increased enzyme levels also correspond to increased enzymatic activity. To assess this, 
we performed zymogram assays in the ey>hid,p35 undead tissue to test for the enzymatic 
activity of Mmp2. Interestingly, we observed high activity of Mmp2 in the undead tissue 
compared to the controls (2.13i; 2.16). This indicates that the upregulated Mmp2 enzyme 
is functional and highly active in the undead tissue. Excitingly, this increased activity of 
Mmp2 is dependent on both ROS and JNK, as loss of either of them abrogated the increase 
in Mmp2 activity (2.13k; 2.16). It is possible that the reduction in Mmp2 activity under 
these circumstances is indirect due to reduced Mmp2 levels upon loss of ROS or active 
JNK. Nonetheless, there is precedence for ROS directly regulating enzymatic activity of 
MMPs. MMPs are kept catalytically inactive by interactions between cysteine residue 
thiols in the prodomain (“cysteine-switch” motif) and the active-site zinc atom [328, 379]. 
Any interruption in this zinc-cysteine bond activates the pro-enzyme; and multiple in vitro 
studies have shown that ROS can modulate the activity of MMPs by reacting with these 
cysteine thiols [408-411]. This is a possible mechanism by which Duox-generated ROS 
could activate Mmp2 in the undead discs. However, it will be technically challenging to 
directly test whether this cysteine-switch mechanism is being activated by ROS in the 
undead tissue for the following reasons – mutating the cysteine residue in Mmp2 to any 
other amino acid would lead to constitutive activation of the enzyme independent of ROS 
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as the active-site zinc will no longer be bound. Secondly, manipulating levels of ROS in 
the undead discs cause suppression of overgrowth and reduction in Mmp2 levels, thus 
making it difficult to analyze the contribution of ROS for activating Mmp2. However, one 
possible way to assess for ROS-induced Mmp2 activation would be to correlate ROS 
generation with increased Mmp2 activation. We could test this by examining Mmp2 
activity in areas with ROS in undead discs using the DQ-gelatin fluorogenic substrate (to 
test for Mmp2 activity) simultaneously with DHE indicator dye (to stain for ROS) in an ex 
vivo setting. In the undead discs, increase in Mmp2 activity causes highly fluorogenic 
puncta due to release of quenching in the substrate (Figure 2.16c), and if our hypothesis is 
true, these fluorescent puncta would co-localize with strong DHE signal, indicating that 
increased ROS production leads to increased Mmp2 activity. Though this is a correlative 
observation, it would still help us bridge the gap between ROS and Mmp2 activation in our 
undead model.   
We observe upregulation of Mmp2 and an increase in its enzymatic activity in the 
undead discs. Active Mmp2 can now cleave and damage the BM of the undead discs. 
However, uniform upregulation of Mmp2 in the entire disc does not compare with the BM 
damage, which is observed exclusively at DP side and not PE side of the disc. We propose 
the following model that justifies this discrepancy observed between Mmp2 upregulation 
and the restricted damage to BM. Previous work from our lab has demonstrated that Duox 
preferentially localizes to the basal side of DP in the undead discs [130], indicating that 
ROS are specifically produced basally at the DP side. These basally produced ROS could 
activate Mmp2 localized at the DP membrane, leading to degradation of the BM. This 
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would explain why the BM at PE is not damaged even though we observe high levels of 
Mmp2 at the PE membrane as well (Figure 2.14b). Even at DP side, BM is not uniformly 
damaged, and we observe areas of strong loss of BM integrity (loss or punctate appearance 
of Perlecan and Laminin) while there are areas where BM is still intact. These differences 
can be due to the fact that ROS are not produced uniformly in the undead tissue [124]; 
consequently, we would expect that Mmp2 is not equivalently activated throughout the DP 
even though it is uniformly upregulated at the membrane. We observe exactly this in our 
ex vivo Mmp2 activity assay, where we do not detect the fluorogenic DQ-gelatin substrate 
puncta throughout the undead disc (Figure 2.16c). As a consequence, we do not observe 
complete degradation of BM at DP side. Thus, Mmp2 is under dual regulation – JNK (or 
another transcription factor) regulates it at the transcript level, while its activity is regulated 
by ROS. In the undead discs, where we have both these processes active, we see the 
increase in Mmp2 levels and activity, and as a result the disruption of BM integrity.  
To assess whether this regulation of Mmp2 by ROS and JNK occurs even in wild-
type non-overgrown discs, we activated JNK signaling in the discs and incubated them 
with H2O2. While testing this ex vivo is not ideal, we currently do not have any genetic 
tools to induce ROS generation without inducing overgrowth in vivo. While JNK signaling 
alone does not upregulate Mmp2 (Figure 2.15c, and previously shown by [334]), ROS and 
JNK together should be sufficient to upregulate and activate Mmp2, similar to the undead 
discs. Contrary to our expectations, we did not observe an increase in Mmp2 levels upon 
activation of JNK signaling in the presence of H2O2 (Figure 2.15d,e). There are, however, 
few caveats to consider with these data. The first and foremost being that this experiment 
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was performed ex vivo, so it is really difficult to compare it to the events that happen in 
vivo. It is likely that there are additional factors that are important for Mmp2 regulation in 
vivo that are not represented in ex vivo settings. Additionally, we only assessed H2O2 for 
regulating Mmp2, while not characterizing the role of other ROS, like superoxide, which 
are also present in the undead discs (in fact DHE specifically detects superoxide). It is still 
unclear what role these different ROS play in the undead model, and while we always 
assumed that H2O2 is the only ROS that is important for signaling events, this may not hold 
true in the cells. Therefore, including a free radical inducer, like paraquat, along with H2O2 
in the ex vivo setting would be important to help address this issue. Finally, the dynamics 
of signaling are difficult to predict ex vivo and the time frame we looked at may not be 
sufficient to allow a significant increase in protein levels that could be detected by IF. It is 
possible that ROS and JNK together do affect Mmp2 levels in the ex vivo setting, albeit 
minimally, but this subtle increase is not detectable by antibody labeling. We can address 
this by performing more sensitive assays, like qRT-PCR, and examining changes at the 
transcript level after the ex vivo assay. Moreover, we can perform the Mmp2 activity assay 
using DQ-gelatin substrate on discs following the ex vivo assay to detect changes in Mmp2 
activity. These assays could help us better understand if ROS and JNK together are 
sufficient for Mmp2 upregulation and activation. Nevertheless, ROS and JNK together 
partially damage the BM, as evidenced by irregularities in Perlecan labeling (Figure 2.9k), 
providing functional evidence to their upregulation of Mmp2. However, the damage under 
these conditions is not as strong as in undead discs (Figure 2.9l), further implying their 
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partial contribution and the potential involvement of additional factors for Mmp2 
upregulation and BM damage. 
Mmp2 and feedback amplification loop 
We show a requirement for ROS and JNK to upregulate Mmp2 levels and activity 
in our undead model. On the other hand, Mmp2 in turn affects ROS production and JNK 
activation (Figure 2.19b-g). These data imply that Mmp2 participates in the feedback 
amplification loop in the undead tissue. This is an interesting result and indicates that 
Mmp2 helps sustain the signaling processes needed to maintain proliferation in undead 
tissue. However, expression of Mmp2, and subsequently BM damage, does not induce 
ectopic ROS production (Figure 2.20i) or JNK activation in the wing discs in the absence 
of any other stimulus. Moreover, expression of Mmp2 does not induce overgrowth of the 
salEPv>Gal4 domain in the wings (compare GFP positive area in Figure 2.20a and c). This 
suggests that Mmp2, or BM damage, by itself is not sufficient to promote proliferation. 
Thus, even though Mmp2 participates in the feedback amplification loop, it is not sufficient 
to trigger the loop. However, in the presence of P35, which makes the tissue vulnerable to 
become undead, expression of Mmp2 leads to production of ROS, activation of JNK, slight 
overgrowth of the tissue and BM damage. This indicates that under susceptible conditions 
Mmp2 is sufficient to induce proliferation and trigger the feedback amplification loop. 
Moving forward, it would be important to understand what exactly P35 does in the cells 
that make them predisposed to becoming overgrown following a specific altercation, like 
expressing Mmp2, which under normal conditions does not induce proliferation or 
apoptosis. This would help us better interpret our results in this artificial undead model.  
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We have not yet established whether damage to the BM in general is important for 
triggering the feedback amplification loop, or whether it is a specific function of Mmp2, 
independent of its role in damaging the BM. There are a few possible ways to address the 
individual contributions for inducing the feedback amplification loop. First, to test the role 
of BM damage, we could damage the BM of discs expressing p35 without the presence of 
Mmp2 (p35,Mmp2 RNAi). Using an ex vivo disc culture assay, we can treat these discs 
(ey>p35;Mmp2 RNAi) with collagenase to degrade the BM and check for production of 
ROS or activation of JNK following this treatment. Though culturing discs ex vivo is not 
ideal, it would provide a quick answer to the requirement of BM damage for inducing the 
feedback amplification loop. Additionally, we can employ the previously described sterile 
wounding assay to damage the BM of wing discs (ref [245]) expressing p35,Mmp2 RNAi 
in vivo and test for ectopic production of ROS, activation of JNK, and induction of 
proliferation. A more direct assay would be to damage the BM in ey>p35 or salEPv>p35 
discs by expressing a different extracellular protease, like ADAMTS (AdamTS-A) [412] 
or cysteine cathepsins (CP1) [413], and then determining if that is sufficient to trigger the 
feedback amplification loop. These different approaches would help us address the 
contribution of BM damage for inducing proliferation and the feedback amplification loop. 
If however, these assays demonstrate that BM damage is not sufficient for inducing this 
process, we could conclude that BM damage has no functional consequence for overgrowth 
and is purely incidental due to Mmp2 expression; and focus on further elucidating the 
mechanism by which Mmp2 induces proliferation. We could also test the requirement of 
Mmp2 in the genuine AiP model. BM is not damaged by induction of apoptosis (salEPv>hid 
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in Figure 2.5 and preliminary results using DEts>hid model). Thus, using these genuine 
AiP models, we could determine whether Mmp2 is important for regeneration and AiP 
independent of BM damage.    
 
Effect of undead tissue overgrowth on hemocytes: Recruitment and Activation 
Hemocytes, the Drosophila macrophages, are essential for tissue remodeling and 
repair following damage due to wounding. Additionally, hemocytes are also involved in 
tumorigenesis, and based on the tumor context can prevent or promote tumor growth [238]. 
Hemocytes in Drosophila larvae accumulate at the sites of damage resulting from 
epidermal wounds or epithelial tumors, and this recruitment of hemocytes is dictated by 
damage to the BM [244, 245]. Similarly, in our undead model, we observe BM damage 
helps to recruit hemocytes to the overgrown discs. Based on previous studies, this method 
of adhesive capture seems to be the main driving factor for recruiting hemocytes in the 
larvae. On the other hand, in embryos, hemocytes undergo chemotaxis along a 
chemoattractant gradient, like that of the Pvf ligands or H2O2 [243]. We observed that BM 
damage, induced by expressing Mmp2, was sufficient for hemocyte recruitment to larval 
discs even in the absence of ROS or cell death (Figure 2.20). These data indicate that in 
this context, chemoattractants like ROS or apoptotic “find-me” signals are not required for 
attracting hemocytes to the imaginal discs. Although this holds true when we express 
Mmp2 in the wing discs (or salivary glands), we cannot completely rule out the 
involvement of chemotactic signals to attract hemocytes to the undead discs. While we do 
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show a requirement for BM damage to recruit hemocytes to undead tissue, it is not clear 
whether this is the only condition important for recruitment of hemocytes, or whether 
chemoattractants, like ROS, also play a role. In our experiments, we could not completely 
segregate the contribution of BM damage and ROS for recruiting hemocytes to the undead 
tissue. Any manipulation of the ROS levels caused suppression of the BM damage, while 
preventing BM damage in turn suppressed ROS production, due to the feedback 
amplification loop. In either of these conditions, hemocytes were lost from the discs 
indicating that they were not getting recruited. One possible solution to this conundrum is 
to perform an ex vivo transwell migration assay. We could have the undead disc culture in 
the bottom compartment of the transwell setup and add hemocytes in the top chamber. 
Under these conditions, if hemocytes sense any chemotactic signals from the undead tissue, 
they would cross the transwell membrane and migrate towards the undead tissue in the 
bottom chamber. Thus, presence of hemocytes on the undead discs would indicate that 
hemocytes display directed migration in the absence of adhesive capture. It would then be 
easy to determine if ROS or some other ligands provide the chemotactic cues for mediating 
hemocyte migration. Alternatively, we could develop a model to induce ROS genetically 
in the control discs, either by disrupting the mitochondrial oxidative chain or by 
manipulating the intracellular ROS-producing organelles like endoplasmic reticulum (ER) 
or peroxisomes, and then characterize if that is sufficient to recruit hemocytes. However, 
we first need to determine that these ectopically produced ROS in the control disc do not 
trigger the feedback amplification loop leading to damage of BM. Additionally, we can 
perform RNA-sequencing of the undead tissue to identify any differentially expressed 
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putative chemoattractant ligands, and determine if any of them are sufficient to recruit 
hemocytes.   
While there is a clear role of BM damage in recruiting hemocytes to the undead 
tissue, we have not yet determined the mechanism by which BM cleavage attracts 
hemocytes. It is possible that damage to the BM might expose some cryptic epitopes or 
release hydrophobic molecules that are usually sequestered inside the BM space [414]. 
Additionally, the degraded BM components themselves are released in the hemolymph 
from the undead tissue. These different factors acting as DAMPs would be perceived as 
“non-self” entities by the hemocytes in circulation, ultimately causing the recruitment of 
hemocytes towards the damaged area. Hemocytes secrete ECM components like type IV 
collagen and laminin [260, 264]. Therefore, their recruitment to the area of damaged BM 
could be primarily to fix the damage and repair the BM. Interestingly, in the TEM 
ultrastructural analysis of the undead discs, we observed some hemocytes that appeared to 
be embedded in ECM-like structures (Figure 2.1i). It will be interesting to determine if the 
hemocytes on undead tissue secrete the BM components. Using a hemocyte-specific driver, 
we could knockdown individual BM components specifically in the hemocytes, and 
examine the effect on the degree of BM damage in undead tissue. Using mutant conditions 
for BM components would be difficult to interpret as the mutant background would affect 
the fat body cells as well, which are the major source of most BM components in 
Drosophila larvae [300]. It is enticing to hypothesize that in the undead tissue hemocytes 
are recruited to repair the BM damage, but the tissue microenvironment induces their 
“activation” causing these cells to change their function to now promote tissue overgrowth. 
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Another possibility could be that the recruited hemocytes indeed help in restoring some 
BM integrity, preventing the undead cells from leaving their niche and invading other 
tissues. This could be the reason we never observe any invasion phenotypes with the 
undead tissue, unlike that seen for neoplastic tumor models, even though both these models 
have a degraded BM.  
Another area to explore for future work is the nature of hemocyte attachment to the 
discs following recruitment to areas of BM damage. The adhesive capture method of 
hemocyte recruitment is reminiscent of the “rolling and tethering” response of vertebrate 
leukocytes during extravasation [415]. The tight association of hemocytes with the undead 
tissue indicates that hemocytes are not just sitting on top of the tissue but are perhaps 
interacting with some receptors on the disc cells. Integrins on the cell surface may serve as 
one such interacting receptor. Under normal conditions, integrin receptors use laminin as 
a ligand for adhering BM to the cell surface and inducing intracellular signaling processes 
[416]. However, under BM damaging conditions, these receptors would no longer bind to 
laminins and would be available to capture hemocytes onto the tissue, a process similar to 
the “rolling and tethering” mechanism. To test this hypothesis, we looked at the βPS 
integrin subunit, encoded by myospheroid, in the undead AiP context. We observed that 
βPS transcript and protein levels are increased in the undead tissue, and interestingly, 
RNAi-mediated knockdown of this subunit suppressed the overgrowth phenotype, 
indicating that βPS is required for AiP. Interestingly, we also observed loss of hemocytes 
from the undead tissue upon knockdown of myospheroid. However, contrary to our 
expectations, βPS was not required for hemocyte attachment in the context of BM damage 
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without overgrowth (salEPv>Mmp2,mys RNAi). Increased numbers of hemocytes were still 
accumulated in the areas of BM damage. These data suggest that βPS may not be the 
receptor involved in attaching hemocytes to the discs. However, we cannot rule out the 
possibility that βPS may play a specialized role in capturing hemocytes under undead 
conditions. Future work would help elucidate the requirement of βPS in undead tissue for 
hemocyte capture from circulation. Additionally, we can test if the other BM receptor, 
Dystroglycan, is important for this process. Similar to βPS, Dystroglycan is also 
upregulated in undead tissue and is required for AiP-induced overgrowth. However, we 
have not yet examined the requirement of Dystroglycan for hemocyte adhesion in the 
undead tissue, which is definitely something to follow-up with in the future. Alternatively, 
another approach to address the hemocyte adhesion question is to identify the receptors in 
hemocytes that allow them to attach to the undead tissue. Different scavenger and 
phagocytic receptors, like the CD36-ortholog Croquemort, Nimrod family members Eater, 
Draper and NimrodC1, are present on hemocytes that mediate recognition of apoptotic 
cells or bacteria [417-420]. These receptors might promote novel binding interactions with 
cell surface epitopes in the undead tissue. Targeted knockdown of these receptors in the 
hemocytes would help address their requirement in hemocyte attachment to the overgrown 
undead tissue.    
In our undead model, we observe high numbers of hemocytes attached to the 
overgrown discs with altered morphology, which we termed “activated” hemocytes (Figure 
2.1k). Additionally, the undead tissue-associated hemocytes are necessary for inducing 
overgrowth [124]. The next important question will be to examine how hemocytes are 
138 
 
activated on the undead tissue to promote overgrowth. Classically, upon bacterial or 
parasitic wasp infections, activation of hemocytes was characterized by an increase of 
phagocytic ability, an increase in lamellocyte numbers in the larvae, as well as changes to 
cell shape of hemocytes, where the cells show more spreading and presence of filopodial 
and lamellipodial extensions [421]. Similarly, hemocytes on the undead tissue display 
changes in cell shape, more spreading and presence of cellular extensions. Remarkably, 
hemocytes recruited to the area of BM damage following epidermal wounding also 
displayed comparable changes to hemocyte morphology [244]. These data highlight the 
parallels between wounds and overgrown undead tissue in regards to hemocyte activation. 
It will be interesting to determine if similar signaling events involved in cell morphology 
changes during infections and phagocytosis also occur in hemocytes on the undead tissue. 
Several studies have demonstrated the role of Rho-family GTPases, Rho1, Rac1/Rac2 and 
Cdc42, in regulating the actin cytoskeleton for changes in cell shape and formation of 
cellular protrusions [422-424]. Interestingly, these same Rho-family GTPases are also 
required for hemocyte migration during embryogenesis or in wound healing responses 
[425]. Additionally, JNK is required in hemocytes for the formation of cellular protrusions 
via its regulation of Rho1 and Rho-kinase [424]. The function of JNK to induce cellular 
changes in hemocytes is really interesting, and warrants further examination to determine 
if JNK is activated in hemocytes in the undead model. One potential candidate for 
activating JNK in hemocytes is ROS produced by the undead tissue. Redox sensitive 
signaling events are often triggered in proximity to the source of ROS production, and 
Duox-generated ROS may act on the attached hemocytes on undead tissue. Indeed, the 
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redox reporter GST-D-GFP [426] is active in hemocytes attached to undead tissue, 
indicating that they are responding to redox events [134]. One of the targets of redox 
signaling in cells is the apoptosis signaling kinase ASK1. H2O2-mediated activation of 
ASK1 leads to downstream activation of JNK and p38 [427, 428]. ASK1 thus acts as an 
important molecular switch, responding to oxidative changes and activating stress response 
signaling pathways. The importance of ASK1 in regenerative responses was demonstrated 
during skin wound-induced regeneration of hair in mice, where ASK1 was required for 
recruitment of macrophages to the skin wounds, their activation and for production of 
inflammatory cytokines [429]. In the context of genuine AiP in Drosophila, ROS from 
dying cells mediates activation of JNK and p38 in neighboring surviving cells through 
ASK1 [139]. Activation of JNK and p38 results in expression of cytokines like Unpaired, 
an IL-6 paralog, which results in regenerative responses [138]. Thus, it will be interesting 
to determine if ROS from undead discs activate ASK1 in hemocytes attached to the disc, 
thereby causing activation of JNK, change in cell shape and production of cytokines. We 
tested ASK1 mutant in the ey>hid,p35 undead tissue background to check if that would 
cause hemocytes on the discs to revert back to a naïve morphology, but unfortunately, even 
under heterozygous conditions, loss of ASK1 was developmentally lethal. Thus, using a 
hemocyte-specific driver, we could test RNAi-mediated knockdown of ASK1 in the 
undead background. This would be difficult to achieve in the undead tissue model using 
the currently available genetic tools. For this purpose, it would be important to establish a 
complementary binary expression system to create Gal4/UAS-independent undead tissue 
in the eye imaginal disc. Use of the alternative LexA/LexAop or QF/QUAS expression 
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system to create undead tissue will allow for simultaneous use of the Gal4/UAS system to 
modulate hemocytes [430, 431]. Using the newly developed QF-HACK (homology 
assisted CRISPR knock-in [432]) constructs would make it easier to generate a ey-QF 
driver line to establish the undead model by co-expressing QUAS-hid and QUAS-p35 
transgenes. Using this dual binary system, we can investigate the requirement of ASK1 in 
hemocytes to mediate JNK activation, and thus change in cell shape and morphology. 
Further, we can determine if Rho-family GTPases are also important for this process. 
Additionally, we can examine if activation of these small GTPases induces hemocytes to 
undergo migration on the overgrown undead tissue, thereby explaining why we observe 
changes in hemocyte localization and an increased spread of hemocytes in the undead 
tissue.    
Next, we must determine what growth promoting signals are derived from 
hemocytes in the undead tissue. We have previously demonstrated a requirement for the 
Eiger-Grindelwald signaling axis in AiP, however, at that time we could not determine the 
exact source of secreted Eiger in our model. Hemocytes on the undead tissue showed an 
increased co-localization with Eiger, which is highly suggestive of hemocytes being the 
source of Eiger [124]. Additionally, several studies have reported that hemocytes 
associated with tumors secrete Eiger to influence tumor growth [248, 249]. All these pieces 
of evidence prompted us to propose that Eiger is coming from hemocytes, and through its 
receptor Grindelwald is activating JNK in the undead tissue [124]. Nevertheless, we need 
to establish a direct requirement for hemocyte-derived Eiger in AiP, which can be achieved 
by using the dual binary system and hemocyte-specific knockdown of Eiger. In addition to 
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Eiger, we can also evaluate if hemocytes on undead tissue secrete other cytokines, such as 
the Toll ligand Spätzle or JAK/STAT ligand Unpaired, which have been implicated in 
different aspects of tumorigenesis and wound repair [138, 245, 248]. We can also perform 
single-cell RNA-sequencing of hemocytes on the undead tissue and determine 
differentially expressed genes in this population compared to the hemocytes on control 
discs. These could include genes encoding additional secreted cytokines and mitogens, 
novel transcription factors governing activation status, factors involved in cytoskeleton 
organization, receptors important for hemocyte adhesion to the disc cells, and any BM 
components secreted by hemocytes. This will help us to uncover novel factors that are 
involved in hemocyte activation, as well as inform us about any heterogeneity in hemocyte 
populations present on the undead tissue. Since hemocytes have been reported to have 
opposing functions to promote or inhibit tumor growth, we can compare the transcriptome 
of hemocytes associated with our undead model to the hemocytes from tumors where they 
inhibit growth to determine the factors that could dictate this switch in hemocyte function. 
Additionally, because the hemocytes on the undead tissue show similar morphological 
characteristics to the hemocytes recruited to wounds for the purpose of tissue repair, it will 
be interesting to compare these two pools of hemocytes to determine if similar pathways 
are engaged to activate hemocytes in these diverse settings. Mammalian macrophages have 
distinct polarization states which direct their pro-tumorigenic and anti-tumorigenic 
functions [251]. Such polarization states have not yet been explored in depth for 
Drosophila hemocytes, although, using the undead model in conjunction with the different 
tumor models will allow us to investigate these questions in more detail.  
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Future Directions 
Systemic effect of undead tissue overgrowth in Drosophila  
 Tumor development is not just a confined and tissue autonomous process, but also 
involves interactions between the tumor and its microenvironment. Along with the local 
tissue microenvironment, tumor growth affects the physiology and functioning of 
peripheral tissues as well. It is becoming apparent that the undead tissue overgrowth model, 
similar to other tumors, is not purely a tissue-autonomous phenomenon. The undead tissue 
affects its microenvironment, by damaging the BM and recruiting and activating the 
hemocytes. These processes occur in the vicinity of the overgrown undead tissue, and could 
be considered to be a “local” effect of the overgrowth. It will be interesting to uncover if 
the overgrown undead tissue also has “systemic” effects in the animal, where it would 
affect distal tissues. Reciprocally, peripheral tissues and cell types are capable of affecting 
the overgrowth phenotype as well. Thus, there might exist a complex crosstalk between 
the undead tissue and other organs in the animal that would coordinate local and systemic 
effects of overgrown tissue.  
Neoplastic tumors in Drosophila have been reported to have a wide systemic effect 
on the animal development by affecting different cells and organs like the hemocytes, fat 
body (similar to mammalian liver), muscles, ovaries, and overall developmental timing 
[245, 248, 249, 433-437]. Previous studies have demonstrated that presence of tumors in 
the imaginal discs induced an increase in circulating hemocyte numbers [245, 248]. This 
is due to increased proliferation of circulating hemocytes driven by different tumor-derived 
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factors – scrib mutant tumors express cytokine Unpaired, which activates JAK/STAT 
signaling in hemocytes inducing their proliferation [245]; while in RasV12scrib- tumors, 
Eiger signaling in tumor leads to upregulation of Pvf1, which signals in hemocytes through 
its receptor Pvr to drive hemocyte proliferation [248]. Likewise, we examined the number 
of circulating hemocytes present in the hemolymph of our undead model, and observed a 
similar increase in circulating hemocyte numbers (Figure 2.1l). However, in contrast to the 
tumor models, the increase in hemocyte numbers in undead model was not due to increased 
proliferation of hemocytes, as determined by the mitotic marker phospho-histone H3. It 
will be interesting to dissect the mechanism by which undead tissue influences circulating 
hemocyte numbers. One possible mechanism could be the release of immature hemocytes 
into circulation from the lymph gland. During Drosophila hematopoiesis, hemocytes from 
the lymph gland are released into the hemolymph only at the end of the larval stage. 
Emptying of the lymph gland in earlier developmental stages occurs as part of an immune 
response to parasitic wasp infection, which causes an increase in circulating hemocytes 
[231]. We could check for lymph gland emptying in our undead model to determine if early 
release of hemocytes is the reason for their higher number in circulation. Another source 
for hemocytes in circulation could be the sessile hematopoietic pockets present along the 
epidermal body wall [233]. Hemocytes in the sessile niches can be released into circulation 
following certain developmental or infection cues [224]. We could monitor these sessile 
hemocyte niches to determine if hemocyte numbers change in these pockets between the 
control and undead larvae, indicating that hemocytes are leaving these niches to enter 
circulation. We could further identify different secretory factors that might be released 
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from the undead tissue that influence the lymph gland or the hematopoietic niches. Along 
with inducing increased hemocyte numbers in circulation, the undead tissue could also 
influence the activity of these hemocytes. While analyzing the hemolymph of our undead 
model for changes in circulating hemocytes, we observed that many of these hemocytes 
also displayed some changes in morphology, including slightly bigger cell shape and 
presence of short cellular protrusions. This is a really exciting result and indicates that 
hemocytes in circulation may also be getting “activated” by the undead tissue. It is possible 
that ROS from undead tissue propagates through the hemolymph, thereby activating the 
hemocytes in circulation. Such changes in morphology and activation of circulating 
hemocytes could translate to changes in behavior of these cells, thus priming them for 
robust responses towards the undead tissue. Future work could definitely help understand 
the mechanisms by which undead tissue affects the hemocytes in circulation.   
Studies have also investigated the effects of epithelial tumors in the imaginal discs 
on the fat body in Drosophila larvae. The fat body participates in a signaling crosstalk 
between the tumors, which is integrated by hemocytes. Hemocytes on tumors secrete the 
ligand Spätzle that activates the Toll/NF-κB signaling pathway in the fat body, leading to 
the induction of anti-microbial peptide Defensin in the fat body. This induction of Defensin 
within the fat body is, in turn, required to induce tumor cell death [248, 433]. It will be 
interesting to identify if any similar signaling crosstalk exists between the undead tissue 
and fat body, and whether it promotes or inhibits growth of the undead tissue.  Additionally, 
tumors also cause fat body wasting, a phenomenon known as cachexia. ImpL2, a secreted 
insulin antagonist, is produced by malignant tumors and drives this wasting phenotype by 
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inhibiting insulin signaling [434, 435]. Along with fat body, tumor-induced cachexia also 
induces wasting of ovaries and muscles. Interestingly, only neoplastic tumors and not 
hyperplastic tumors induce tissue wasting [434]. We observe many similarities in between 
neoplastic tumors and the undead model, thus making it tempting to examine peripheral 
tissues like the fat body or muscles in the undead model to determine if they also exhibit a 
wasting-like phenotype.  
Previous work has shown that tumors in imaginal discs delay or block 
metamorphosis, and this developmental delay is due to increased tissue autonomous 
induction of Dilp8 (Drosophila insulin-like peptide 8). Dilp8 causes developmental delays 
by inhibiting ecdysone biosynthesis [436, 437]. Interestingly, our undead model also 
displays a delay in metamorphosis, though the development is not as severely delayed as 
that observed for neoplastic tumors (RasV12scrib-, RasV12lgl-). When we manipulated Dilp8 
levels in the undead tissue, we observed a slight rescue of the overgrowth phenotype and a 
slight rescue of metamorphosis delay. These preliminary results are very promising and 
definitely worth exploring in the future.  
 
The “dark side” of AiP: Parallels between undead model and tumors 
Apoptosis has long been considered a process that prevents cancer. Historically, 
this view has been supported by the discovery of tumor suppressive roles of p53, where 
loss-of-function mutations in p53 inhibit apoptosis and are associated with poor cancer 
prognosis [438-440]. Although resistance to apoptosis is an important feature of cancers, 
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cancer cells are not fully apoptosis-resistant [441]. Indeed, most of the therapy regimens 
are aimed at killing cancer cells by inducing apoptosis. Counter-intuitively, however, in 
some cancer types, high levels of apoptosis in tumors also correlate with poor prognosis 
[442-448]. This paradox can be explained by the now emerging idea that dying cells have 
a profound effect on their surrounding environment, which includes paracrine signaling 
from dying cells to stimulate proliferation, invasion and metastasis, thereby promoting 
cancer progression.    
As outlined in the Introduction chapter, the association of apoptosis and apoptotic 
signaling with wound-healing and regeneration has been well established. Given the 
striking similarities between tissue regeneration and cancer, the involvement of AiP for 
tumorigenesis is of direct relevance. Additional support for this idea comes from the 
finding that caspase-driven production of PGE2, important for promoting liver 
regeneration, can stimulate tumor growth and repopulation following radiation therapy in 
mice and human cancer cells [216]. Similar observations were made in bladder cancer, 
where PGE2 derived from apoptotic cells stimulated proliferation of cancer stem cells to 
promote resistance to chemotherapy. Importantly, in this context, inhibiting PGE2 
abrogated the AiP responses and sensitized the tumor to therapy, highlighting the 
contributions of AiP for tumor resistance [217]. The involvement of AiP in the etiology of 
human cancers has been reported in multiple different studies [210-213, 218, 219, 449, 
450]. In addition, the physiological pathways involved in regeneration may be deregulated 
in tumors or hijacked by cancer cells for their growth and metastasis. The Drosophila 
undead AiP model is an excellent example where the “undead” cells exploit the 
147 
 
compensatory proliferation mechanism such that persistent caspase-derived mitogenic 
signals stimulate overgrowth of the tissue, reminiscent of how tumor cells may hijack the 
regenerative pathways. Moreover, the apoptosis resistance that many tumor cells have 
acquired make them resemble “undead” cells. Thus, the undead tissue serves as a great 
model to understand the multiple contributions of AiP for tumor growth and persistence. 
In addition to the ability to rapidly proliferate and overgrow, the undead model shares many 
similarities with tumors that extend to the signaling pathways important for promoting 
overgrowth, and its interaction with the microenvironment. 
One key signaling event in AiP is the activation of JNK. Blocking the activity of 
JNK in undead tissue suppresses the secretion of mitogens, thereby suppressing the 
overgrowth [123, 129]. Also, as JNK functions in the feedback amplification loop, 
blocking JNK activity also abrogates ROS production and recruitment of hemocytes [124]. 
This makes JNK the “master-regulator” of signaling in AiP. JNK is also well studied for 
its tumor promoting roles in a variety of different cancer models [451-453], and the 
association between JNK, ROS, AiP and cancer is best established in mouse models of 
hepatocellular carcinoma (HCC) [164, 454-457]. Analogous to the HCC mouse models, 
Drosophila tumor models also show involvement of JNK signaling pathways for their 
growth and invasion. A recent study demonstrated that in the RasV12scrib- tumor context, 
both initiator (Dronc) and effector caspases (DrICE and Dcp1) are necessary for promoting 
tumor growth [349]. This pro-tumorigenic property of caspases is dependent on generation 
of ROS and activation of JNK. Similar to the undead model, caspase-induced ROS are 
necessary to recruit hemocytes to the RasV12scrib- tumor tissue, which in turn signal back 
148 
 
to the tumor to activate JNK, thus setting up an amplification loop that promotes neoplastic 
growth [349]. Likewise, we demonstrated that several neoplastic tumor models (from 
Figure 2.7, including RasV12dlg- model and ap>EGFR;psqRNAi a wing disc tumor model 
[458]) show the correlation between JNK activation, ROS production and hemocyte 
activation (Figure 2.7, 2.8). It will be important to understand if caspases also drive the 
tumor growth in these models, and if there exists an amplification loop involving ROS, 
JNK and hemocytes similar to that observed in the undead model. 
Another key feature of cancers is the ability to invade other tissues and metastasize 
[459]. The metastatic process initiates after cells in a tissue migrate out of their niche, a 
process that requires BM damage. Several Drosophila tumor models have described BM 
degradation phenotypes and have helped to identify the mechanisms involved during cell 
invasion and metastasis [460]. We have described here that BM damage is a characteristic 
of only the invasive neoplastic tumor models, and not hyperplastic tumor models, and it 
correlates with production of ROS by the neoplastic tumors (Figure 2.7). Additionally, BM 
damage also correlates with activation of JNK and hemocytes in neoplastic tumor models, 
but not in hyperplastic growth models (Figure 2.8). In our undead model, we see similar 
correlation between BM damage, ROS production, JNK activation and hemocytes, 
indicating the relevance of undead model for tumorigenesis. However, the undead cells do 
not show the ability to invade distant tissues like other neoplastic tumors; though, they do 
share the ability to migrate, a prerequisite for invasion. A study reported that in undead 
cells, residual effector caspase activity drives migration of cells by activating JNK, and 
downstream Mmp1 [461]. The ability of undead cells to migrate, but not invade distal 
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tissues is puzzling, and may indicate some inhibitory factors in play that block invasion, or 
the need for activation of other pathways that would promote invasion. Future work could 
help uncover the events that would make undead cells amenable for tissue invasion. 
However, the pro-migratory activity of caspases is conserved in many cancers. Similar to 
the Drosophila RasV12scrib- tumor model where activity of caspases is required for invasion 
and metastasis, in human cancers, caspase 3 activation promotes cell migration and 
invasion in glioblastoma, melanoma, and ovarian cancer [462-465]. Taken together, all 
these examples underline the importance of AiP in inducing proliferation and cancer 
initiation, and even though the signaling pathways may be different for each context, the 
conservation of key factors is remarkable. 
The undead model in Drosophila has been instrumental in advancing the field of 
compensatory proliferation, and as more evidence comes into the forefront, the 
contributions of the undead model for understanding tumorigenesis become more apparent. 
The undead model shares many of the hallmarks of cancer, namely the increased 
proliferation, evasion of cell death, BM degradation, cell migration, and tumor-promoting 
inflammation by TAMs. These parallels emphasize the importance of caspase-driven AiP 
in cancer, at the same time corroborating the efficacy of Drosophila as a model system to 
study cancer initiation and growth. Based on all these observations, the view that the 
undead model is just a hyperplastic overgrowth model needs to be revised. Future work 
investigating the mechanisms of caspase-driven AiP in the undead model will help identify 
novel factors and pathways important for AiP, and also determine if the undead model 
shares more of the hallmark properties of tumors.   
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